STOCK TITAN

RenX Enterprises flags $24.7M working capital deficit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

RenX Enterprises Corp. reported revenue of $12.7 million for the nine months ended September 30, 2026, versus $4.9 million a year earlier, while net loss was $26.0 million versus $12.3 million. Third-quarter revenue was $4.5 million, compared with $3.5 million, and net loss was $8.7 million versus $4.4 million.

Operating cash use was $7.4 million, compared with $425,565 in 2025. At September 30, 2026, cash was $201,379; current assets were $3.16 million and current liabilities were $27.90 million. RenX reported negative working capital of $24,741,590 and said these conditions raise substantial doubt about its ability to continue as a going concern. Total debt was $24.03 million, including $21.08 million in current maturities.

April private-placement closings generated approximately $5.7 million and $5.4 million in net proceeds; the second closing proceeds were used to repay $5.1 million of February notes. Further closings of up to $87 million are subject to conditions and mutual agreement, and the company said there is no assurance they will occur.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 3 points

How the balance works

Positive

  • Moderate pointNine-month revenue reached $12.7 million, versus $4.9 million in 2025.

Negative

  • Major pointNine-month net loss was $26.0 million, versus $12.3 million in 2025.
  • Major pointGoing-concern disclosure cites $24.7 million negative working capital.
  • Moderate pointOperating cash use was $7.4 million, versus $425,565 in 2025.

Filing Explained

The 10-Q reports that an additional closing under the April placement was completed after September 30, updating the previously conditional future closings to include a completed financing step; the April notes’ terms were amended in connection with that closing.

Nine-month revenue $12.7 million Nine months ended September 30, 2026; $4.9 million for the same 2025 period.
Nine-month net loss $26.0 million Nine months ended September 30, 2026; $12.3 million for the same 2025 period.
Net cash used in operating activities $7,398,530 Nine months ended September 30, 2026; $425,565 used in the same 2025 period.
Negative working capital $24,741,590 As of September 30, 2026.
Cash $201,379 As of September 30, 2026.
Total debt $24,025,437 As of September 30, 2026, net of debt discount and issuance costs.
Current maturities of notes payable $21,083,357 As of September 30, 2026, net of debt discount and issuance costs.
Third-quarter revenue $4,485,401 Three months ended September 30, 2026; $3,515,708 for the same 2025 period.
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
negative working capital financial
"negative working capital of $24,741,590"
Negative working capital happens when a company’s short-term obligations (bills, supplier invoices, debt coming due) exceed its short-term resources (cash, money owed by customers, sellable inventory). For investors it signals how easily a business can meet immediate bills — it can be a warning sign of cash stress or, in some models, an efficient operation that collects cash faster than it pays suppliers; think of a household that consistently has to borrow before payday versus one that gets paid in advance.
Senior Convertible Notes financial
"issuance and sale in a private placement of Senior Convertible Notes"
A senior convertible note is a loan a company issues that ranks near the top of payment priority and can be exchanged for the company’s stock under preset terms. Think of it as an IOU that promises interest payments and first dibs on repayments if assets are liquidated, but also gives the lender the option to become an owner later; investors watch these for repayment safety, interest income, and potential stock dilution.
Alternate Conversion financial
"purchasers have the right to convert their April 2026 Notes"
embedded derivative financial
"qualified as an embedded derivative"
An embedded derivative is a built-in feature inside a contract—like a bond, loan, or lease—that causes part of the payout to change based on something else, such as a stock price, interest rate, or commodity price. It matters to investors because that hidden feature can add separate risk and volatility to a security’s value and accounting treatment, like finding a removable engine in a car that changes how fast it can go and how much it’s worth.
original issue discount financial
"representing an original issue discount"
Original issue discount (OID) is the difference between a debt security’s face value and the lower price at which it is first sold, treated as additional interest that accrues over the life of the instrument. For investors it matters because OID raises the effective yield and changes taxable income and the holding’s cost basis over time — think of buying a $100 voucher for $90 and recognizing the $10 gain as earned interest as the voucher approaches maturity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did RENX report for the first nine months of 2026?

RENX reported $12.7 million in revenue for the nine months ended September 30, 2026, compared with $4.9 million for the same period in 2025.

How much did RENX lose in the first nine months of 2026?

RENX reported a $26.0 million net loss for the nine months ended September 30, 2026, compared with $12.3 million for the same period in 2025.

Why did RENX report substantial doubt about continuing as a going concern?

RenX said its accumulated losses and negative working capital raise substantial doubt about its ability to continue as a going concern. At September 30, 2026, its accumulated deficit was $58,450,625 and negative working capital was $24,741,590. The company said it has initiated monetization of legacy real estate properties, but gave no assurance it would achieve its objectives.

What is the alternate conversion price for RENX’s April 2026 notes?

Beginning September 1, 2026, purchasers may convert at the greater of the $0.534 floor price or 92% of the lowest volume-weighted average price during the ten trading days before conversion. The notes also limit conversion when a holder and its affiliates would exceed 4.99% ownership, or 9.99% if the holder elects that limit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001959023 RenX Enterprises Corp. false --12-31 Q3 2026 0.001 0.001 5,000,000 5,000,000 30,416 30,416 938,847 938,847 0.001 0.001 360,000 360,000 550 550 327,811 327,811 0.001 0.001 7,169 7,169 7,169 7,169 0 0 0.001 0.001 1,441 1,441 1,441 1,441 0 0 0.001 0.001 500,000,000 500,000,000 3,244,285 3,236,102 946,742 938,559 8,183 8,183 3 0 12 12 6 6 6 480,000 480,000 6 6 2,500,000 2,500,000 14 14 2 2 389,469 389,469 10.89 10.89 507,935 507,935 11.18 11.18 428,446 428,446 12.4 12.4 1,235,882 1,235,882 12.5 12.5 860,995 860,995 12.4 12.4 91,778 91,778 0 0 3,196,215 3,196,215 15.5 14.5 1,796,979 1,796,979 11.5 11.5 5,050,517 5,050,517 12.5 12.5 750,000 750,000 7 7 312,350 312,350 12.89 12.89 94,605 94,605 12.89 12.89 305,985 305,985 7.74 7.74 39,066 39,066 9 9 425,800 425,800 11.26 11.26 256,402 256,402 0 0 368,317 368,317 0 0 306,239 306,239 0 0 333,374 333,374 2.5 2.5 181,423 181,423 8.2 8.2 101,329 101,329 7.5 7.5 15,701 15,701 7.5 7.5 19,880 19,880 7.7 7.7 18,347 18,347 22,192 22,192 17,443 17,443 861,485 861,485 6.35 6.35 317,571 317,571 7.29 7.29 10,423 10,423 4 4 158,429 158,429 8 8 357,260 357,260 496,993 496,993 6.67 6.67 18,818 18,818 6,000 6,000 173,370 173,370 7.71 7.71 601,417 601,417 7.25 7.25 30,416 550 27.20 7,169 1,441 5 5 5 5 5 2.5 6 6 5 5 0 1 6 1 6 105,000 3 3 4 4 6 6 http://fasb.org/us-gaap/2026#PrimeRateMember false false false false Based upon units-of-production During the nine months ended September 30, 2026, $2,769,189 was paid in cash and shares of common stock, valued at $3,592,954, were issued as additional payment. 00019590232026-01-012026-09-30 xbrli:shares 00019590232026-11-16 thunderdome:item iso4217:USD 00019590232026-09-30 00019590232025-12-31 0001959023us-gaap:NonrelatedPartyMember2026-09-30 0001959023us-gaap:NonrelatedPartyMember2025-12-31 0001959023us-gaap:RelatedPartyMember2026-09-30 0001959023us-gaap:RelatedPartyMember2025-12-31 iso4217:USDxbrli:shares 0001959023us-gaap:SeriesAPreferredStockMember2026-09-30 0001959023us-gaap:SeriesAPreferredStockMember2025-12-31 0001959023us-gaap:SeriesBPreferredStockMember2026-09-30 0001959023us-gaap:SeriesBPreferredStockMember2025-12-31 0001959023us-gaap:SeriesCPreferredStockMember2026-09-30 0001959023us-gaap:SeriesCPreferredStockMember2025-12-31 0001959023us-gaap:SeriesDPreferredStockMember2026-09-30 0001959023us-gaap:SeriesDPreferredStockMember2025-12-31 00019590232026-07-012026-09-30 00019590232025-07-012025-09-30 00019590232025-01-012025-09-30 0001959023us-gaap:CommonStockMember2024-12-31 0001959023us-gaap:PreferredStockMember2024-12-31 0001959023us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001959023us-gaap:RetainedEarningsMember2024-12-31 0001959023us-gaap:NoncontrollingInterestMember2024-12-31 00019590232024-12-31 0001959023renx:ConversionOfNotesPayableMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:RetainedEarningsMember2025-01-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:NoncontrollingInterestMember2025-01-012025-09-30 0001959023renx:ConversionOfNotesPayableMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMemberus-gaap:RetainedEarningsMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMemberus-gaap:NoncontrollingInterestMember2025-01-012025-09-30 0001959023renx:PrefundedWarrantMember2025-01-012025-09-30 0001959023us-gaap:CommonStockMember2025-01-012025-09-30 0001959023us-gaap:PreferredStockMember2025-01-012025-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001959023us-gaap:RetainedEarningsMember2025-01-012025-09-30 0001959023us-gaap:NoncontrollingInterestMember2025-01-012025-09-30 0001959023us-gaap:CommonStockMember2025-09-30 0001959023us-gaap:PreferredStockMember2025-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001959023us-gaap:RetainedEarningsMember2025-09-30 0001959023us-gaap:NoncontrollingInterestMember2025-09-30 00019590232025-09-30 0001959023us-gaap:CommonStockMember2025-06-30 0001959023us-gaap:PreferredStockMember2025-06-30 0001959023us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001959023us-gaap:RetainedEarningsMember2025-06-30 0001959023us-gaap:NoncontrollingInterestMember2025-06-30 00019590232025-06-30 0001959023us-gaap:CommonStockMember2025-07-012025-09-30 0001959023us-gaap:PreferredStockMember2025-07-012025-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001959023us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001959023us-gaap:NoncontrollingInterestMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:NoncontrollingInterestMember2025-07-012025-09-30 0001959023renx:ConversionOfNotesPayableMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMemberus-gaap:NoncontrollingInterestMember2025-07-012025-09-30 0001959023renx:FirstWarrantsMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMemberus-gaap:NoncontrollingInterestMember2025-07-012025-09-30 0001959023renx:SecondWarrantsMember2025-07-012025-09-30 0001959023us-gaap:CommonStockMember2025-12-31 0001959023us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001959023us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001959023us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001959023us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001959023us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001959023us-gaap:RetainedEarningsMember2025-12-31 0001959023us-gaap:CommonStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023us-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesBPreferredStockToCommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfSeriesAPreferredStockToCommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001959023renx:ConversionOfNotesPayableMember2026-01-012026-09-30 0001959023us-gaap:CommonStockMember2026-09-30 0001959023us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001959023us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001959023us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001959023us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001959023us-gaap:RetainedEarningsMember2026-09-30 0001959023us-gaap:CommonStockMember2026-06-30 0001959023us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001959023us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001959023us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001959023us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001959023us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001959023us-gaap:RetainedEarningsMember2026-06-30 00019590232026-06-30 0001959023us-gaap:CommonStockMember2026-07-012026-09-30 0001959023us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023us-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001959023us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:CommonStockMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:RetainedEarningsMember2026-07-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:CommonStockMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:SeriesDPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMemberus-gaap:RetainedEarningsMember2026-07-012026-09-30 0001959023renx:ConversionOfNotesPayableMember2026-07-012026-09-30 0001959023renx:ForgivenessOfAccountsPayableAndAccruedExpensesMember2026-01-012026-09-30 0001959023renx:ForgivenessOfAccountsPayableAndAccruedExpensesMember2025-01-012025-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-01-012026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-01-012025-09-30 0001959023renx:WarrantsMember2026-01-012026-09-30 0001959023renx:WarrantsMember2025-01-012025-09-30 0001959023renx:ConversionOfPromissoryNoteIntoSeriesCPreferredStockAndWarrantMember2026-01-012026-09-30 0001959023renx:ConversionOfPromissoryNoteIntoSeriesCPreferredStockAndWarrantMember2025-01-012025-09-30 0001959023renx:ConversionOfPromissoryNoteIntoSeriesDPreferredStockMember2026-01-012026-09-30 0001959023renx:ConversionOfPromissoryNoteIntoSeriesDPreferredStockMember2025-01-012025-09-30 0001959023renx:ForgivenessOfAmountsDueFromAffiliatesMember2026-01-012026-09-30 0001959023renx:ForgivenessOfAmountsDueFromAffiliatesMember2025-01-012025-09-30 0001959023renx:PriorDebtIssuanceMember2026-01-012026-09-30 0001959023renx:PriorDebtIssuanceMember2025-01-012025-09-30 xbrli:pure 0001959023renx:ReverseStockSplitMember2024-10-082024-10-08 0001959023renx:ReverseStockSplitMember2026-03-262026-03-26 0001959023renx:SaleOfMaterialsMember2026-07-012026-09-30 0001959023renx:SaleOfMaterialsMember2025-07-012025-09-30 0001959023renx:LogisticsCollectionAndDisposalServicesMember2026-07-012026-09-30 0001959023renx:LogisticsCollectionAndDisposalServicesMember2025-07-012025-09-30 0001959023renx:SaleOfMaterialsMember2026-01-012026-09-30 0001959023renx:SaleOfMaterialsMember2025-01-012025-09-30 0001959023renx:LogisticsCollectionAndDisposalServicesMember2026-01-012026-09-30 0001959023renx:LogisticsCollectionAndDisposalServicesMember2025-01-012025-09-30 0001959023renx:CommissionsMember2026-01-012026-09-30 0001959023renx:CommissionsMember2025-01-012025-09-30 0001959023renx:NormanBerryIiOwnerLlcMember2026-09-30 0001959023renx:NormanBerryIiOwnerLlcMember2026-01-012026-09-30 0001959023renx:NormanBerryIiOwnerLlcMember2025-01-012025-09-30 utr:T 0001959023renx:SandReservesMember2026-09-30 0001959023renx:WebsiteCostsMember2026-09-30 utr:Y 0001959023us-gaap:TradeNamesMember2026-09-30 0001959023us-gaap:LicensingAgreementsMember2026-09-30 0001959023renx:ComputerEquipmentAndSoftwareMember2026-09-30 0001959023renx:ComputerEquipmentAndSoftwareMember2025-12-31 0001959023us-gaap:EquipmentMember2026-09-30 0001959023us-gaap:EquipmentMember2025-12-31 0001959023us-gaap:EquipmentMembersrt:MinimumMember2026-09-30 0001959023us-gaap:EquipmentMembersrt:MaximumMember2026-09-30 0001959023renx:SandReservesMember2025-12-31 0001959023us-gaap:FurnitureAndFixturesMember2026-09-30 0001959023us-gaap:FurnitureAndFixturesMember2025-12-31 0001959023us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2026-09-30 0001959023us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2026-09-30 0001959023us-gaap:LandImprovementsMember2026-09-30 0001959023us-gaap:LandImprovementsMember2025-12-31 0001959023us-gaap:LandImprovementsMembersrt:MinimumMember2026-09-30 0001959023us-gaap:LandImprovementsMembersrt:MaximumMember2026-09-30 0001959023us-gaap:VehiclesMember2026-09-30 0001959023us-gaap:VehiclesMember2025-12-31 0001959023renx:WebsiteCostsMember2025-12-31 0001959023us-gaap:TradeNamesMember2025-12-31 0001959023us-gaap:LicensingAgreementsMember2025-12-31 0001959023renx:NormanBerryIiOwnerLlcMember2025-12-31 0001959023renx:NormanBerryIiOwnerLlcMember2026-09-30 0001959023renx:NormanBerryIiOwnerLlcMember2025-12-31 0001959023us-gaap:FairValueInputsLevel1Member2026-09-30 0001959023us-gaap:FairValueInputsLevel2Member2026-09-30 0001959023us-gaap:FairValueInputsLevel3Member2026-09-30 0001959023us-gaap:FairValueInputsLevel1Member2025-12-31 0001959023us-gaap:FairValueInputsLevel2Member2025-12-31 0001959023us-gaap:FairValueInputsLevel3Member2025-12-31 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-31 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputDiscountRateMember2025-12-31 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputExpectedTermMember2026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputExpectedTermMember2025-12-31 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputPriceVolatilityMember2026-09-30 0001959023us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputPriceVolatilityMember2025-12-31 0001959023renx:LvHoldingMember2024-04-03 0001959023renx:SecondLienNoteMemberrenx:LvHoldingMember2024-04-03 0001959023renx:LvHoldingMember2026-01-06 0001959023renx:LvHoldingMember2026-01-062026-01-06 0001959023renx:NewLvNoteMemberrenx:LvHoldingMember2026-01-06 0001959023renx:NormanBerryIiOwnerLlcMember2026-01-06 0001959023renx:NormanBerryMemberrenx:LvHoldingMember2026-01-06 0001959023renx:BcvRenewEarthMember2025-11-10 0001959023renx:BcvRenewEarthMember2025-11-012025-11-10 0001959023renx:NormanBerryIiOwnerLlcMember2025-11-10 0001959023renx:BcvRenewEarthMember2026-09-30 0001959023renx:InitialFiveNotesMemberrenx:The1800DiagonalNotesMember2025-12-31 0001959023renx:InitialFiveNotesMemberrenx:The1800DiagonalNotesMember2026-09-30 0001959023renx:The1800DiagonalNotesMember2026-08-31 0001959023renx:The1800DiagonalNotesMember2025-01-012026-08-31 0001959023renx:The1800DiagonalNotesMembersrt:MinimumMember2026-08-31 0001959023renx:The1800DiagonalNotesMembersrt:MaximumMember2026-08-31 0001959023renx:The1800DiagonalNotesMember2026-09-30 0001959023renx:CedarCashAdvanceAgreementMemberrenx:CedarAdvanceLlcMember2025-03-13 0001959023renx:CedarCashAdvanceAgreementMemberrenx:CedarAdvanceLlcMember2025-03-132025-03-13 0001959023renx:CedarCashAdvanceAgreementMemberrenx:CedarAdvanceLlcMember2026-09-30 0001959023renx:CedarApril2026AgreementMemberrenx:CedarAdvanceLlcMember2026-04-27 0001959023renx:CedarApril2026AgreementMemberrenx:CedarAdvanceLlcMember2026-04-272026-04-27 0001959023renx:CedarApril2026AgreementMemberrenx:CedarAdvanceLlcMember2026-09-30 0001959023renx:CedarSeptember2026AgreementMemberrenx:CedarAdvanceLlcMember2026-09-16 0001959023renx:CedarSeptember2026AgreementMemberrenx:CedarAdvanceLlcMember2026-09-162026-09-16 0001959023renx:CedarSeptember2026AgreementMemberrenx:CedarAdvanceLlcMember2026-09-30 0001959023renx:CedarSeptember2026AgreementMemberrenx:CfgCashAdvanceAgreementMember2026-09-01 0001959023renx:CedarSeptember2026AgreementMemberrenx:CfgCashAdvanceAgreementMember2026-09-012026-09-01 0001959023renx:CedarSeptember2026AgreementMemberrenx:CfgCashAdvanceAgreementMember2026-09-30 0001959023renx:ResourceGroupMipaMember2025-06-02 0001959023renx:ResourceGroupUsHoldingsLlcMemberus-gaap:RelatedPartyMember2025-06-02 0001959023renx:BootCapitalLlcMember2025-12-15 0001959023renx:BootCapitalLlcMember2025-12-152025-12-15 0001959023renx:BootCapitalLlcMember2026-01-152026-01-15 0001959023renx:BootCapitalLlcMember2026-05-152026-05-15 0001959023renx:BootCapitalLlcMember2026-09-30 0001959023renx:SixthBoroughPartnersLlcMember2025-10-08 0001959023renx:SixthBoroughPartnersLlcMember2026-09-30 0001959023renx:PeakInvestorMember2026-01-16 0001959023renx:PeakInvestorMember2026-01-162026-01-16 utr:M 0001959023renx:PeakInvestorMembersrt:MinimumMember2026-01-162026-01-16 0001959023renx:PeakInvestorMember2026-09-30 0001959023renx:SeptemberPeakOneAgreementMember2026-09-17 0001959023renx:SeptemberPeakOneAgreementMember2026-09-172026-09-17 0001959023renx:SeptemberPeakOneAgreementMembersrt:MinimumMember2026-09-172026-09-17 0001959023renx:SeptemberPeakOneAgreementMember2026-09-30 0001959023renx:FirstFebruary2026NoteMemberrenx:February2026PrivatePlacementInvestorsMember2026-02-17 0001959023renx:SecondFebruary2026NoteMemberrenx:February2026PrivatePlacementInvestorsMember2026-02-17 0001959023renx:ThirdFebruary2026NoteMemberrenx:February2026PrivatePlacementInvestorsMember2026-02-17 0001959023renx:February2026PrivatePlacementInvestorsMember2026-02-172026-02-17 0001959023renx:February2026PrivatePlacementInvestorsMember2026-02-17 0001959023renx:February2026WarrantsMember2026-02-17 0001959023renx:FirstFebruary2026WarrantsMember2026-02-17 0001959023renx:SecondFebruary2026WarrantsMember2026-02-17 0001959023renx:February2026PrivatePlacementInvestorsMembersrt:MaximumMember2026-02-17 0001959023renx:February2026PrivatePlacementInvestorsMember2026-04-302026-04-30 0001959023renx:February2026PrivatePlacementInvestorsMember2026-09-30 0001959023renx:InitialApril2026WarrantsMember2026-04-30 0001959023renx:SecondApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-04-30 0001959023renx:SecondApril2026WarrantsMember2026-04-30 0001959023renx:AdditionalApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-04-30 0001959023renx:AdditionalApril2026WarrantsMember2026-04-30 0001959023renx:April2026SpaRraAmendmentRightsMember2026-08-26 0001959023renx:April2026PrivatePlacementInvestorsMember2026-05-042026-05-04 0001959023renx:April2026NotesSecondClosingMemberrenx:April2026PrivatePlacementInvestorsMember2026-08-26 0001959023renx:SecondClosingApril2026WarrantsMember2026-08-26 0001959023renx:April2026PrivatePlacementInvestorsMember2026-08-262026-08-26 0001959023renx:February2026PrivatePlacementInvestorsMember2026-08-262026-08-26 0001959023renx:April2026PrivatePlacementInvestorsMember2026-04-30 0001959023renx:April2026PrivatePlacementInvestorsMember2026-04-302026-04-30 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-04-30 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMembersrt:MinimumMember2026-04-30 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-04-302026-04-30 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMembersrt:MaximumMember2026-04-30 0001959023renx:AdditionalApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-04-302026-04-30 0001959023renx:ConversionOfApril2026NotesIntoCommonStockMember2026-01-012026-09-30 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-09-30 0001959023renx:AdditionalApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMember2026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:RelatedPartyMember2026-06-112026-06-11 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:SeriesCPreferredStockMember2026-06-112026-06-11 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:SeriesCPreferredStockMember2026-06-11 0001959023renx:CommonStockPurchaseWarrantsMemberrenx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:RelatedPartyMember2026-06-112026-06-11 0001959023renx:ConversionOfPromissoryNoteIntoSeriesDPreferredStockMember2026-09-302026-09-30 0001959023renx:LvNoteMemberrenx:LvHoldingMember2026-09-30 0001959023renx:LvNoteMemberrenx:LvHoldingMember2025-12-31 0001959023renx:SecondLienNoteMemberrenx:LvHoldingMember2026-09-30 0001959023renx:SecondLienNoteMemberrenx:LvHoldingMember2025-12-31 0001959023renx:BcvRenewEarthMember2025-12-31 0001959023renx:The1800DiagonalNotesMember2025-12-31 0001959023renx:CedarCashAdvanceAgreementMemberrenx:CedarAdvanceLlcMember2025-12-31 0001959023renx:CedarApril2026AgreementMemberrenx:CedarAdvanceLlcMember2025-12-31 0001959023renx:CfgCashAdvanceAgreementMember2026-09-30 0001959023renx:BootCapitalLlcMember2025-12-31 0001959023renx:SixthBoroughPartnersLlcMember2025-12-31 0001959023renx:SeptemberPeakOneAgreementMember2025-12-31 0001959023renx:AnsonEastMasterFundLpMember2026-09-30 0001959023renx:AnsonEastMasterFundLpMember2025-12-31 0001959023renx:AnsonInvestmentMasterFundLpMember2026-09-30 0001959023renx:AnsonInvestmentMasterFundLpMember2025-12-31 0001959023renx:AltoOpportunityMasterFundSpcMember2026-09-30 0001959023renx:AltoOpportunityMasterFundSpcMember2025-12-31 0001959023renx:ResourceGroupUsHoldingsLlcMemberus-gaap:RelatedPartyMember2026-09-30 0001959023renx:ResourceGroupUsHoldingsLlcMemberus-gaap:RelatedPartyMember2025-12-31 0001959023renx:GailBairdFoundationMember2026-09-30 0001959023renx:GailBairdFoundationMember2025-12-31 0001959023renx:CcgLoan1Memberrenx:CcgMember2026-09-30 0001959023renx:CcgLoan1Memberrenx:CcgMember2025-12-31 0001959023renx:CcgLoan2Memberrenx:CcgMember2026-09-30 0001959023renx:CcgLoan2Memberrenx:CcgMember2025-12-31 0001959023renx:CcgLoan3Memberrenx:CcgMember2026-09-30 0001959023renx:CcgLoan3Memberrenx:CcgMember2025-12-31 0001959023renx:CcgLoan4Memberrenx:CcgMember2026-09-30 0001959023renx:CcgLoan4Memberrenx:CcgMember2025-12-31 0001959023renx:CcgLoan5Memberrenx:CcgMember2026-09-30 0001959023renx:CcgLoan5Memberrenx:CcgMember2025-12-31 0001959023renx:JohnDeereEquipmentLoanMember2026-09-30 0001959023renx:JohnDeereEquipmentLoanMember2025-12-31 0001959023renx:JohnDeereEquipmentLoanMember2026-01-012026-09-30 0001959023renx:JohnDeereEquipmentLoanMember2025-01-012025-12-31 0001959023renx:LoebMember2026-09-30 0001959023renx:LoebMember2025-12-31 0001959023renx:LoebMember2026-01-012026-09-30 0001959023renx:LoebMember2025-01-012025-12-31 0001959023renx:IndexLoan2Memberus-gaap:RelatedPartyMember2026-09-30 0001959023renx:IndexLoan2Memberus-gaap:RelatedPartyMember2025-12-31 0001959023renx:McsMemberus-gaap:RelatedPartyMember2026-09-30 0001959023renx:McsMemberus-gaap:RelatedPartyMember2025-12-31 0001959023renx:ZeiSellerMember2026-09-30 0001959023renx:ZeiSellerMember2025-12-31 0001959023renx:Moorback6600StaMember2026-09-30 0001959023renx:Moorback6600StaMember2025-12-31 0001959023renx:BlendingLineStaMember2026-09-30 0001959023renx:BlendingLineStaMember2025-12-31 0001959023renx:GrappleTruckMember2026-09-30 0001959023renx:GrappleTruckMember2025-12-31 0001959023renx:FordT350Member2026-09-30 0001959023renx:FordT350Member2025-12-31 0001959023renx:AllegiantPartnersIncorporatedMember2026-09-30 0001959023renx:AllegiantPartnersIncorporatedMember2025-12-31 0001959023renx:JohnDeereEquipment2Member2026-09-30 0001959023renx:JohnDeereEquipment2Member2025-12-31 0001959023renx:JohnDeereEquipment3Member2026-09-30 0001959023renx:JohnDeereEquipment3Member2025-12-31 0001959023renx:JohnDeereEquipment4Member2026-09-30 0001959023renx:JohnDeereEquipment4Member2025-12-31 0001959023renx:JohnDeereEquipment5Member2026-09-30 0001959023renx:JohnDeereEquipment5Member2025-12-31 0001959023renx:FirstInsuranceFundingMember2026-09-30 0001959023renx:FirstInsuranceFundingMember2025-12-31 0001959023renx:FirstInsuranceFunding2Member2026-09-30 0001959023renx:FirstInsuranceFunding2Member2025-12-31 0001959023renx:FirstInsuranceFunding3Member2026-09-30 0001959023renx:FirstInsuranceFunding3Member2025-12-31 0001959023renx:FirstInsuranceFunding4Member2026-09-30 0001959023renx:FirstInsuranceFunding4Member2025-12-31 0001959023renx:CedarAdvanceMember2026-01-012026-09-30 0001959023renx:CedarAdvanceMember2025-01-012025-12-31 0001959023renx:CedarAdvanceMember2026-09-30 0001959023renx:CedarAdvanceMember2025-12-31 0001959023renx:Mca2uniqueFundingSolutionsMember2026-01-012026-09-30 0001959023renx:Mca2uniqueFundingSolutionsMember2025-01-012025-12-31 0001959023renx:Mca2uniqueFundingSolutionsMember2026-09-30 0001959023renx:Mca2uniqueFundingSolutionsMember2025-12-31 0001959023renx:June2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2026-01-012026-09-30 0001959023renx:June2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2025-01-012025-12-31 0001959023renx:June2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2026-09-30 0001959023renx:June2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2025-12-31 0001959023renx:BmoMember2026-09-30 0001959023renx:BmoMember2025-12-31 0001959023renx:HuntingtonMember2026-09-30 0001959023renx:HuntingtonMember2025-12-31 0001959023renx:XeroxCopierMember2026-09-30 0001959023renx:XeroxCopierMember2025-12-31 0001959023renx:PncMember2026-09-30 0001959023renx:PncMember2025-12-31 0001959023renx:SmflMember2026-09-30 0001959023renx:SmflMember2025-12-31 0001959023renx:VerdantMember2026-09-30 0001959023renx:VerdantMember2025-12-31 0001959023renx:March2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2026-01-012026-09-30 0001959023renx:March2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2025-01-012025-12-31 0001959023renx:March2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2026-09-30 0001959023renx:March2025CashAdvanceMemberrenx:Mca3cfgMerchantSolutionsMember2025-12-31 0001959023renx:Mca4CedarAdvanceMember2026-01-012026-09-30 0001959023renx:Mca4CedarAdvanceMember2025-01-012025-12-31 0001959023renx:Mca4CedarAdvanceMember2026-09-30 0001959023renx:Mca4CedarAdvanceMember2025-12-31 0001959023renx:InternationalHz620Member2026-09-30 0001959023renx:InternationalHz620Member2025-12-31 0001959023renx:FirstInsuranceFundingZeiMember2026-09-30 0001959023renx:FirstInsuranceFundingZeiMember2025-12-31 0001959023renx:ResourceGroupMipaMemberus-gaap:RestrictedStockMember2025-06-022025-06-02 0001959023renx:ResourceGroupMipaMemberus-gaap:CommonStockMember2025-06-022025-06-02 0001959023renx:ResourceGroupMipaMemberus-gaap:SeriesAPreferredStockMember2025-06-022025-06-02 0001959023renx:ResourceGroupMipaMemberus-gaap:RestrictedStockMember2025-06-02 0001959023renx:ResourceGroupMipaMemberrenx:PostClosingCommonStockMember2025-06-022025-06-02 0001959023renx:ResourceGroupMipaMember2025-06-022025-06-02 0001959023renx:ResourceGroupMipaMemberus-gaap:SeriesAPreferredStockMember2025-06-02 0001959023renx:ResourceGroupMipaMemberus-gaap:RelatedPartyMember2025-06-02 0001959023renx:ResourceGroupMipaMember2025-07-012025-09-30 0001959023renx:ResourceGroupMipaMember2025-01-012025-09-30 0001959023us-gaap:WarrantMember2026-01-012026-09-30 0001959023us-gaap:PreferredStockMember2026-01-012026-09-30 0001959023us-gaap:ConvertibleDebtSecuritiesMember2026-01-012026-09-30 0001959023renx:PrefundedWarrantMember2026-01-012026-09-30 0001959023renx:RelatedPartyDebtMember2026-01-012026-09-30 0001959023renx:WarrantsIssuedWithDebtMember2026-09-30 0001959023renx:WarrantsIssuedWithDebtMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMemberus-gaap:SeriesCPreferredStockMember2026-01-012026-09-30 0001959023renx:CommonStockPurchaseWarrantsMemberrenx:ConversionOfDebtIntoSeriesCPreferredStockAndWarrantsMember2026-01-012026-09-30 0001959023renx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMemberus-gaap:SeriesDPreferredStockMember2026-01-012026-09-30 0001959023renx:CommonStockPurchaseWarrantsMemberrenx:ConversionOfDebtIntoSeriesDPreferredStockAndWarrantsMember2026-01-012026-09-30 0001959023us-gaap:SeriesBPreferredStockMemberrenx:OctoberPurchaseAgreementMember2025-10-162025-10-16 0001959023us-gaap:SeriesBPreferredStockMemberrenx:OctoberPurchaseAgreementMember2025-10-16 0001959023renx:OctoberWarrantsMember2025-10-16 0001959023renx:OctoberPurchaseAgreementMember2025-10-162025-10-16 0001959023renx:OctoberWarrantsMember2026-01-012026-09-30 0001959023us-gaap:SeriesBPreferredStockMemberrenx:OctoberPurchaseAgreementMember2026-01-012026-09-30 0001959023us-gaap:SeriesAPreferredStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesBPreferredStockMember2026-01-012026-09-30 0001959023us-gaap:SeriesCPreferredStockMember2026-01-012026-09-30 0001959023srt:MinimumMemberus-gaap:SeriesCPreferredStockMember2026-09-30 0001959023srt:MaximumMemberus-gaap:SeriesCPreferredStockMember2026-09-30 0001959023us-gaap:SeriesDPreferredStockMember2026-01-012026-09-30 0001959023srt:MinimumMemberus-gaap:SeriesDPreferredStockMember2026-09-30 0001959023srt:MaximumMemberus-gaap:SeriesDPreferredStockMember2026-09-30 0001959023renx:PeakOneWarrantsMember2024-03-31 0001959023renx:PeakOneWarrantsMembersrt:MinimumMember2024-03-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-03-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-03-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-03-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-03-31 0001959023renx:PeakOneWarrantsMember2024-05-31 0001959023renx:PeakOneWarrantsMember2024-04-30 0001959023renx:PeakOneWarrantsMembersrt:MinimumMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MaximumMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2024-05-31 0001959023renx:PeakOneWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2024-05-31 0001959023renx:ArenaInvestorsWarrantsMember2024-08-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-08-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-08-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-08-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-08-31 0001959023renx:ArenaInvestorsWarrantsMember2024-10-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-10-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2024-10-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-10-31 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-10-31 0001959023renx:ArenaInvestorsWarrantsMember2025-04-30 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-04-30 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2025-04-30 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-04-30 0001959023renx:ArenaInvestorsWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2025-04-30 0001959023renx:OctoberWarrantsMembersrt:MinimumMember2025-10-16 0001959023renx:February2026WarrantsMember2026-06-12 0001959023renx:FirstFebruary2026WarrantsMember2026-06-12 0001959023renx:SecondFebruary2026WarrantsMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MaximumMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2026-06-12 0001959023renx:February2026WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2026-06-12 0001959023renx:InitialApril2026WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-04-30 0001959023renx:InitialApril2026WarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-04-30 0001959023renx:InitialApril2026WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-04-30 0001959023renx:InitialApril2026WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2026-04-30 0001959023renx:SecondApril2026WarrantsMember2026-04-26 0001959023renx:SecondApril2026WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-06-30 0001959023renx:SecondApril2026WarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-06-30 0001959023renx:SecondApril2026WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-06-30 0001959023renx:SecondApril2026WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2026-06-30 0001959023renx:ExchangeWarrantsMember2026-06-30 0001959023renx:ExchangeWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-06-30 0001959023renx:ExchangeWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-06-30 0001959023renx:ExchangeWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-06-30 0001959023renx:ExchangeWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2026-06-30 0001959023renx:SeptemberExchangeWarrantsMember2026-09-30 0001959023renx:SeptemberExchangeWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-06-30 0001959023renx:SeptemberExchangeWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-06-30 0001959023renx:SeptemberExchangeWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-06-30 0001959023renx:SeptemberExchangeWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2026-06-30 00019590232025-01-012025-12-31 0001959023renx:The2023PlanMember2023-02-28 0001959023renx:The2023PlanMember2023-02-282023-02-28 0001959023renx:The2023PlanMember2024-01-012024-01-01 0001959023renx:The2023PlanMember2025-01-012025-01-01 0001959023renx:The2023PlanMember2026-01-012026-01-01 0001959023renx:The2023PlanMember2025-08-312025-08-31 0001959023renx:The2023PlanMember2026-05-012026-05-31 0001959023renx:The2023PlanMember2026-09-30 0001959023us-gaap:RestrictedStockUnitsRSUMemberrenx:The2023PlanMember2026-09-08 0001959023us-gaap:RestrictedStockUnitsRSUMemberrenx:The2023PlanMember2026-09-302026-09-30 0001959023srt:MinimumMember2026-09-30 0001959023srt:MaximumMember2026-09-30 0001959023renx:BoardOfDirectorsMember2026-09-30 0001959023renx:BoardOfDirectorsMember2025-12-31 0001959023renx:BoardOfDirectorsMember2026-01-012026-09-30 0001959023renx:IndexExchangeAgreementMemberus-gaap:RelatedPartyMember2026-01-012026-09-30 0001959023renx:BurnhamExchangeAgreementMemberus-gaap:RelatedPartyMember2026-01-012026-09-30 0001959023renx:MarcBruneMember2026-01-012026-09-30 0001959023renx:MarcBruneMember2025-01-012025-09-30 0001959023renx:JdbConsultingServicesMember2026-01-012026-09-30 0001959023renx:JdbConsultingServicesMember2025-01-012025-09-30 0001959023renx:AmcEnvironmentalConsultingMember2026-01-012026-09-30 0001959023renx:AmcEnvironmentalConsultingMember2025-01-012025-09-30 0001959023renx:TristanBurnhamMember2026-01-012026-09-30 0001959023renx:TristanBurnhamMember2025-01-012025-09-30 0001959023renx:DerekVillarrealMember2026-01-012026-09-30 0001959023renx:DerekVillarrealMember2025-01-012025-09-30 0001959023renx:ResourceGroupUsHoldingsLlcMember2026-01-012026-09-30 0001959023renx:RealEstateDevelopmentMember2026-01-012026-09-30 0001959023renx:TechnologyMember2026-01-012026-09-30 0001959023renx:CompostSalesMember2026-01-012026-09-30 0001959023renx:LogisticsMember2026-01-012026-09-30 0001959023renx:RealEstateDevelopmentMember2026-09-30 0001959023renx:TechnologyMember2026-09-30 0001959023renx:CompostSalesMember2026-09-30 0001959023renx:LogisticsMember2026-09-30 0001959023renx:RealEstateDevelopmentMember2026-07-012026-09-30 0001959023renx:TechnologyMember2026-07-012026-09-30 0001959023renx:CompostSalesMember2026-07-012026-09-30 0001959023renx:LogisticsMember2026-07-012026-09-30 0001959023renx:RealEstateDevelopmentMember2025-01-012025-09-30 0001959023renx:TechnologyMember2025-01-012025-09-30 0001959023renx:CompostSalesMember2025-01-012025-09-30 0001959023renx:LogisticsMember2025-01-012025-09-30 0001959023renx:RealEstateDevelopmentMember2025-09-30 0001959023renx:TechnologyMember2025-09-30 0001959023renx:CompostSalesMember2025-09-30 0001959023renx:LogisticsMember2025-09-30 0001959023renx:RealEstateDevelopmentMember2025-07-012025-09-30 0001959023renx:TechnologyMember2025-07-012025-09-30 0001959023renx:CompostSalesMember2025-07-012025-09-30 0001959023renx:LogisticsMember2025-07-012025-09-30 0001959023renx:ConversionOfInitialApril2026NotesPrincipalAndInterestIntoCommonStockMemberus-gaap:SubsequentEventMember2026-10-012026-10-05 0001959023renx:InitialApril2026NotesMemberrenx:April2026PrivatePlacementInvestorsMemberus-gaap:SubsequentEventMember2026-10-05 0001959023renx:ExchangeOfFebruary2026NoteForNewNoteAndWarrantMemberus-gaap:SubsequentEventMember2026-11-022026-11-02 0001959023renx:ExchangeOfFebruary2026NoteForNewNoteAndWarrantMemberus-gaap:SubsequentEventMember2026-11-02 utr:D 0001959023renx:TheNewNoteMemberus-gaap:SubsequentEventMember2026-11-022026-11-02 0001959023renx:TheNewNoteMemberus-gaap:SubsequentEventMember2026-11-02 0001959023renx:TheNewNoteMembersrt:MinimumMemberus-gaap:SubsequentEventMember2026-11-02 0001959023renx:ConversionOfTheNewNoteIntoCommonStockMemberus-gaap:SubsequentEventMember2026-11-022026-11-02 0001959023renx:TheNewNoteMembersrt:MaximumMemberus-gaap:SubsequentEventMember2026-11-02 0001959023renx:WarrantIssuedWithTheNewNoteMemberus-gaap:SubsequentEventMember2026-11-02 0001959023renx:WarrantIssuedWithTheNewNoteMemberus-gaap:SubsequentEventMember2026-11-022026-11-02 0001959023renx:WarrantIssuedWithTheNewNoteMembersrt:MaximumMemberus-gaap:SubsequentEventMember2026-11-02 0001959023renx:TheNewNoteMemberus-gaap:SubsequentEventMember2026-11-16 0001959023renx:WarrantIssuedWithTheNewNoteMemberus-gaap:SubsequentEventMember2026-11-16 0001959023renx:ConversionOfTheNewNoteIntoCommonStockMemberus-gaap:SubsequentEventMember2026-11-162026-11-16 0001959023renx:TheNewNoteMemberus-gaap:SubsequentEventMember2026-11-162026-11-16 0001959023renx:TheNewNoteMembersrt:MinimumMemberus-gaap:SubsequentEventMember2026-11-16 0001959023renx:TheNewNoteMembersrt:MaximumMemberus-gaap:SubsequentEventMember2026-11-16 0001959023renx:LoebTermLoanMember2023-09-07 0001959023renx:LoebTermLoanMemberus-gaap:SubsequentEventMember2026-11-06 0001959023renx:LoebTermLoanMemberus-gaap:SubsequentEventMember2026-11-062026-11-06 0001959023renx:LoebTermLoanMemberus-gaap:SubsequentEventMember2026-11-072026-11-07

FORM 10-Q

Table of Contents



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission File Number: 001-41581

 

RENX ENTERPRISES CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

 

87-1375590

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

 

 

990 Biscayne Boulevard, Suite 501, Miami FL

 

33132

(Address of principal executive offices)

 

(Zip Code)

 

(786) 808-5776 

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share 

 

RENX

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  

 

Large accelerated filer  ☐

Accelerated filer  ☐  

Non-accelerated filer  ☒

Smaller reporting company  ☒

 

Emerging growth company  ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 

 

As of November 16, 2026 the issuer had a total of 3,501,979 shares of common stock, $0.001 par value per share, outstanding. 

 




Table of Contents

RENX ENTERPRISES CORP. AND SUBSIDIARIES

 

FORM 10-Q

 

TABLE OF CONTENTS

 

 

 

 

 

Page 
Number

PART I. FINANCIAL INFORMATION

 

1

ITEM 1.

 

Financial Statements

 

1

 

 

Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025

 

1

 

 

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)

 

2

 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)

 

3

 

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited)

 

5

 

 

Notes to Condensed Consolidated Financial Statements

 

6

ITEM 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

42

ITEM 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

53

ITEM 4.

 

Controls and Procedures

 

53

PART II. OTHER INFORMATION

 

54

ITEM 1.

 

Legal Proceedings

 

54

ITEM 1A.

 

Risk Factors

 

54

ITEM 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

60

ITEM 3.

 

Defaults Upon Senior Securities

 

60

ITEM 4.

 

Mine Safety Disclosures

 

60

ITEM 5.

 

Other Information

 

60

ITEM 6.

 

Exhibits

 

61

SIGNATURES

 

63

 

i


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1. Financial Statements 

 

RENX ENTERPRISES CORP. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

(Audited)

 

Assets

 

 

 

​

 

 

 

​

Current Assets

 

 

 

​

 

 

 

​

Cash

 

$

201,379

 

 

$

54,066

 

Prepaid assets and other current assets

 

 

875,831

 

 

 

638,166

 

Inventory

 

 

735,532

 

 

 

1,078,610

 

Accounts receivable, net

 

 

1,348,554

 

 

 

799,068

 

Current Assets

 

 

3,161,296

 

 

 

2,569,910

 

 

 

 

 

​

 

 

 

​

Land

 

 

2,393,785

 

 

 

2,393,785

 

Property and equipment, net

 

 

12,732,555

 

 

 

11,802,248

 

Project development costs and other non-current assets

 

 

91,289

 

 

 

91,289

 

Equity-based investments

 

 

849,740

 

 

 

828,440

 

Intangible assets, net

 

 

10,506,806

 

 

 

11,260,365

 

Right of use assets

 

 

350,596

 

 

 

290,092

 

Goodwill

 

 

6,240,432

 

 

 

6,240,432

 

Total Assets

 

$

36,326,499

 

 

$

35,476,561

 

 

 

 

 

​

 

 

 

​

Liabilities and Stockholders' Equity

 

 

 

​

 

 

 

​

Current Liabilities

 

 

 

​

 

 

 

​

Accounts payable and accrued expenses

 

$

5,893,174

 

 

$

5,530,211

 

Due to affiliates

 

 

600,604

 

 

 

2,094,833

 

Short-term notes payable, net

 

 

20,571,608

 

 

 

6,956,259

 

Notes payable - related party, current

 

 

511,749

 

 

 

5,562,266

 

Operating lease liabilities, current

 

 

83,422

 

 

 

60,446

 

Finance lease liabilities, current

 

 

236,130

 

 

 

183,359

 

Derivative liability

 

 

6,199

 

 

 

1,218,258

 

Total Current Liabilities

 

 

27,902,886

 

 

 

21,605,632

 

 

 

 

 

​

 

 

 

​

Long-term notes payable, net

 

 

2,942,080

 

 

 

8,243,678

 

Operating lease liabilities

 

 

285,871

 

 

 

250,119

 

Finance lease liabilities

 

 

1,147,373

 

 

 

982,887

 

Total Liabilities

 

 

32,278,210

 

 

 

31,082,316

 

 

 

 

 

​

 

 

 

​

Stockholders' Equity:

 

 

 

​

 

 

 

​

Series A Preferred stock, $0.001 par value, 5,000,000 shares authorized, 30,416 issued and outstanding as of September 30, 2026, 938,847 issued and outstanding as of December 31, 2025

 

 

31

 

 

 

939

 

Series B Preferred stock, $0.001 par value, 360,000 shares authorized, 550 issued and outstanding as of September 30, 2026, 327,811 issued and outstanding as of December 31, 2025

 

 

1

 

 

 

326

 

Series C Preferred stock, $0.001 par value, 7,169 shares authorized, 7,169 issued and outstanding as of September 30, 2026, 0 issued and outstanding as of December 31, 2025

 

 

7

 

 

 

-

 

Series D Preferred stock, $0.001 par value, 1,441 shares authorized, 1,441 issued and outstanding as of September 30, 2026, 0 issued and outstanding as of December 31, 2025

 

 

-

 

 

 

-

 

Common stock, $0.001 par value, 500,000,000 shares authorized, 3,244,285 issued and 3,236,102 outstanding as of September 30, 2026 and, 946,742 issued and 938,559 outstanding as of December 31, 2025

 

 

3,244

 

 

 

947

 

Additional paid-in capital

 

 

62,495,631

 

 

 

36,565,513

 

Treasury stock, at cost – 8,183 and 8,183 shares at September 30, 2026 and December 31, 2025, respectively

 

 

-

 

 

 

-

 

Accumulated deficit

 

 

(58,450,625

)

 

 

(32,173,480

)

Total Stockholders' Equity

 

 

4,048,289

 

 

 

4,394,245

 

Total Liabilities and Stockholders' Equity

 

$

36,326,499

 

 

$

35,476,561

 

 

The accompanying notes are an integral part of these condensed financial statements.

 

1


Table of Contents

 

RenX Enterprises Corp. and Subsidiaries

Condensed Consolidated Statements of Operations

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Revenue

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Sales

 

$

4,485,401

 

 

$

3,515,708

 

 

$

12,699,431

 

 

$

4,936,388

 

Total

 

 

4,485,401

 

 

 

3,515,708

 

 

 

12,699,431

 

 

 

4,936,388

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Cost of Revenue

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Costs of revenue

 

 

2,949,075

 

 

 

2,607,085

 

 

 

8,473,154

 

 

 

3,476,441

 

Total

 

 

2,949,075

 

 

 

2,607,085

 

 

 

8,473,154

 

 

 

3,476,441

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Gross Profit

 

 

1,536,326

 

 

 

908,623

 

 

 

4,226,277

 

 

 

1,459,947

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Operating expenses

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Payroll and related expenses

 

 

1,259,570

 

 

 

1,038,146

 

 

 

3,325,263

 

 

 

2,175,571

 

General and administrative expenses

 

 

1,496,332

 

 

 

1,275,276

 

 

 

4,834,143

 

 

 

3,154,765

 

Professional and consulting fees

 

 

754,706

 

 

 

760,840

 

 

 

2,508,187

 

 

 

1,228,020

 

Marketing and business development expense

 

 

1,034,464

 

 

 

166,666

 

 

 

2,332,334

 

 

 

407,105

 

Bad debt expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,025,000

 

Total

 

 

4,545,072

 

 

 

3,240,928

 

 

 

12,999,927

 

 

 

9,990,461

 

Operating loss

 

 

(3,008,746

)

 

 

(2,332,305

)

 

 

(8,773,650

)

 

 

(8,530,514

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Other income (expense)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Interest expense

 

 

(5,660,849

)

 

 

(2,004,260

)

 

 

(9,802,032

)

 

 

(3,789,105

)

Change in fair value of derivative liability

 

 

-

 

 

 

-

 

 

 

(1,268,162

)

 

 

-

 

Loss on settlement of derivative liability

 

 

-

 

 

 

-

 

 

 

(3,881,922

)

 

 

-

 

Loss on exchange transaction

 

 

(32,794

)

 

 

-

 

 

 

(2,247,921

)

 

 

-

 

Gain (loss) on sale of equipment

 

 

14,093

 

 

 

-

 

 

 

(66,196

)

 

 

-

 

Interest income

 

 

-

 

 

 

(62,325

)

 

 

-

 

 

 

(14,653

)

Other income

 

 

(2,143

)

 

 

48,569

 

 

 

1,227

 

 

 

80,000

 

Total

 

 

(5,681,693

)

 

 

(2,018,016

)

 

 

(17,265,006

)

 

 

(3,723,758

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

$

(8,690,439

)

 

$

(4,350,321

)

 

$

(26,038,656

)

 

$

(12,254,272

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss per share

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic and diluted

 

$

(3.27

)

 

$

(22.33

)

 

$

(10.86

)

 

$

(86.98

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Weighted average shares outstanding:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic and diluted

 

 

2,658,142

 

 

 

194,792

 

 

 

2,398,591

 

 

 

140,891

 

 

The accompanying notes are an integral part of these condensed financial statements.

 

2


Table of Contents

 

RenX Enterprises Corp. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholder’s Equity (Unaudited) 

 

 

 

$0.001 Par Value

 

 

 

 

​

 

 

 

​

 

Additional

 

 

 

 

​

 

Non-

 

 

Total

 

 

 

Common Stock

 

 

Preferred Stock (Series A)

 

 

Paid-in

 

 

Accumulated

 

 

controlling

 

 

Stockholder’s

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Interest

 

 

Equity

 

Balance at January 1, 2025

 

 

74,344

 

 

$

74

 

 

 

-

 

 

$

-

 

 

$

16,660,564

 

 

$

(16,039,022

)

 

$

231,562

 

 

$

853,178

 

Conversion of notes payable and accrued interest

 

 

100,589

 

 

 

101

 

 

 

-

 

 

 

-

 

 

 

2,278,057

 

 

 

-

 

 

 

-

 

 

 

2,278,158

 

Exercise of prefunded warrant

 

 

4,167

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

(4

)

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock for debt issuance

 

 

17,127

 

 

 

17

 

 

 

-

 

 

 

-

 

 

 

413,221

 

 

 

-

 

 

 

-

 

 

 

413,238

 

Forgiveness of related party debt

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

391,524

 

 

 

-

 

 

 

-

 

 

 

391,524

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

177,011

 

 

 

-

 

 

 

-

 

 

 

177,011

 

Deconsolidation of Sugar Phase

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(66,667

)

 

 

(66,667

)

Issuance of warrants for debt issuance

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

170,743

 

 

 

-

 

 

 

-

 

 

 

170,743

 

Issuance of common and preferred stock for acquisition of Resource

 

 

18,841

 

 

 

19

 

 

 

1,500,000

 

 

 

1,500

 

 

 

9,231,063

 

 

 

-

 

 

 

-

 

 

 

9,232,582

 

Issuance of common stock for warrant exercise

 

 

11,793

 

 

 

12

 

 

 

-

 

 

 

-

 

 

 

214,469

 

 

 

-

 

 

 

-

 

 

 

214,481

 

Issuance of common stock for cash

 

 

15,485

 

 

 

15

 

 

 

-

 

 

 

-

 

 

 

560,406

 

 

 

-

 

 

 

-

 

 

 

560,421

 

Issuance of common stock for services

 

 

7,500

 

 

 

8

 

 

 

-

 

 

 

-

 

 

 

153,046

 

 

 

-

 

 

 

-

 

 

 

153,054

 

Issuance of common stock for prior debt issuance

 

 

2,215

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,254,272

)

 

 

-

 

 

 

(12,254,272

)

Balance at September 30, 2025

 

 

252,061

 

 

$

252

 

 

 

1,500,000

 

 

$

1,500

 

 

$

30,250,098

 

 

$

(28,293,294

)

 

$

164,895

 

 

$

2,123,451

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance at June 30, 2025

 

 

156,605

 

 

$

157

 

 

 

1,500,000

 

 

$

1,500

 

 

$

28,295,427

 

 

$

(23,942,973

)

 

$

164,895

 

 

 

4,519,006

 

Stock- based compensation

 

 

(546

)

 

 

(1

)

 

 

-

 

 

 

-

 

 

 

1

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock for debt issuance

 

 

7,427

 

 

 

7

 

 

 

-

 

 

 

-

 

 

 

198,645

 

 

 

-

 

 

 

-

 

 

 

198,652

 

Conversion of notes payable

 

 

51,582

 

 

 

52

 

 

 

-

 

 

 

-

 

 

 

828,106

 

 

 

-

 

 

 

-

 

 

 

828,158

 

Issuance of common stock for warrant exercise

 

 

4,289

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

78,000

 

 

 

-

 

 

 

-

 

 

 

78,004

 

Issuance of common stock for cash

 

 

15,485

 

 

 

15

 

 

 

-

 

 

 

-

 

 

 

560,406

 

 

 

-

 

 

 

-

 

 

 

560,421

 

Issuance of common stock for warrant exercise

 

 

7,504

 

 

 

8

 

 

 

-

 

 

 

-

 

 

 

136,469

 

 

 

-

 

 

 

-

 

 

 

136,477

 

Issuance of common stock for services

 

 

7,500

 

 

 

8

 

 

 

-

 

 

 

-

 

 

 

153,046

 

 

 

-

 

 

 

-

 

 

 

153,054

 

Issuance of common stock for prior debt issuance

 

 

2,215

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,350,321

)

 

 

-

 

 

 

(4,350,321

)

Balance at September 30, 2025

 

 

252,061

 

 

$

252

 

 

 

1,500,000

 

 

$

1,500

 

 

$

30,250,098

 

 

$

(28,293,294

)

 

$

164,895

 

 

$

2,123,451

 

 

3


Table of Contents

 

 

 

 

 

​

 

 

 

​

 

Preferred Stock

 

 

Preferred Stock

 

 

Preferred Stock

 

 

Preferred Stock

 

 

Additional

 

 

 

 

​

 

Total

 

 

 

Common Stock

 

 

(Series A)

 

 

(Series B)

 

 

(Series C)

 

 

(Series D)

 

 

Paid-in

 

 

Accumulated

 

 

Stockholder’s

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance at January 1, 2026

 

 

946,742

 

 

$

947

 

 

 

938,847

 

 

$

939

 

 

 

327,811

 

 

$

326

 

 

 

-

 

 

$

-

 

 

 

-

 

 

$

-

 

 

$

36,565,513

 

 

$

(32,173,480

)

 

$

4,394,245

 

Issuance of stock for warrant exercise

 

 

135,107

 

 

 

135

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(135

)

 

 

-

 

 

 

-

 

Cash paid for stock split

 

 

(35

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Conversion of Series B preferred stock to common stock

 

 

1,202,577

 

 

 

1,203

 

 

 

-

 

 

 

-

 

 

 

(327,261

)

 

 

(325

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,592,076

 

 

 

-

 

 

 

3,592,954

 

Series B preferred stock accrued dividends

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

238,489

 

 

 

(238,489

)

 

 

-

 

Issuance of stock for services

 

 

90,000

 

 

 

90

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

221,468

 

 

 

-

 

 

 

221,558

 

Conversion of Series A preferred stock to common stock

 

 

272,534

 

 

 

272

 

 

 

(908,431

)

 

 

(908

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

636

 

 

 

-

 

 

 

-

 

Forgiveness of related party debt

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

490,000

 

 

 

-

 

 

 

490,000

 

Issuance of warrants for debt issuance

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,640,629

 

 

 

-

 

 

 

9,640,629

 

Exchange of related party debt for Series C preferred stock and warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,169

 

 

 

7

 

 

 

-

 

 

 

-

 

 

 

9,384,192

 

 

 

-

 

 

 

9,384,199

 

Exchange of related party debt for Series D preferred stock and warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,441

 

 

 

-

 

 

 

1,479,568

 

 

 

-

 

 

 

1,479,568

 

Conversion of notes payable and acrrued interest to common stock

 

 

597,360

 

 

 

597

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

883,195

 

 

 

-

 

 

 

883,792

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(26,038,656

)

 

 

(26,038,656

)

Balance at September 30, 2026

 

 

3,244,285

 

 

$

3,244

 

 

 

30,416

 

 

$

31

 

 

 

550

 

 

$

1

 

 

 

7,169

 

 

$

7

 

 

 

1,441

 

 

$

-

 

 

$

62,495,631

 

 

$

(58,450,625

)

 

$

4,048,289

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance at June 30, 2026

 

 

2,621,925

 

 

$

2,622

 

 

 

30,416

 

 

$

31

 

 

 

550

 

 

$

1

 

 

 

7,169

 

 

$

7

 

 

 

-

 

 

$

-

 

 

$

56,799,473

 

 

$

(49,760,186

)

 

$

7,041,948

 

Issuance of stock for services

 

 

25,000

 

 

 

25

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

42,975

 

 

 

-

 

 

 

43,000

 

Issuance of warrants for debt issuance

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,290,420

 

 

 

-

 

 

 

3,290,420

 

Exchange of related party debt for Series D preferred stock and warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,441

 

 

 

-

 

 

 

1,479,568

 

 

 

-

 

 

 

1,479,568

 

Conversion of notes payable and acrrued interest to common stock

 

 

597,360

 

 

 

597

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

883,195

 

 

 

-

 

 

 

883,792

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,690,439

)

 

 

(8,690,439

)

Balance at September 30, 2026

 

 

3,244,285

 

 

$

3,244

 

 

 

30,416

 

 

$

31

 

 

 

550

 

 

$

1

 

 

 

7,169

 

 

$

7

 

 

 

1,441

 

 

$

-

 

 

$

62,495,631

 

 

$

(58,450,625

)

 

$

4,048,289

 

 

The accompanying notes are an integral part of these condensed financial statements.

 

4


Table of Contents

RenX Enterprises Corp. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

 

 

 

For the

 

 

For the

 

 

 

Nine Months

 

 

Nine Months

 

 

 

Ended

 

 

Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

(Unaudited)

 

Cash flows from operating activities:

 

 

 

​

 

 

 

​

Net loss

 

$

(26,038,656

)

 

$

(12,254,272

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

​

 

 

 

​

Change in fair value of derivative liability

 

 

1,268,162

 

 

 

-

 

Loss on settlement of derivative liability

 

 

3,881,922

 

 

 

-

 

Loss on exchange transaction

 

 

2,247,921

 

 

 

-

 

Depreciation

 

 

1,582,640

 

 

 

576,893

 

Amortization

 

 

753,559

 

 

 

62,510

 

Bad debt expense

 

 

-

 

 

 

3,025,000

 

Amortization of debt issuance costs

 

 

6,106,162

 

 

 

1,591,345

 

Amortization of right of use asset

 

 

38,371

 

 

 

15,384

 

Stock based compensation

 

 

-

 

 

 

177,011

 

Impairment of intangible assets

 

 

-

 

 

 

965,812

 

Loss on sale of equipment

 

 

66,196

 

 

 

-

 

Common stock for services

 

 

221,558

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

​

 

 

 

​

Account receivable

 

 

(549,486

)

 

 

50,307

 

Inventory

 

 

343,078

 

 

 

(138,298

)

Prepaid expenses

 

 

(237,665

)

 

 

512,525

 

Prepaid assets and other current assets

 

 

-

 

 

 

-

 

Notes receivable

 

 

-

 

 

 

2,500

 

Due to affiliates

 

 

658,118

 

 

 

1,179,183

 

Accounts payable and accrued expenses

 

 

2,299,737

 

 

 

3,823,833

 

Operating lease liabilities

 

 

(40,147

)

 

 

(15,298

)

Net cash (used in) provided by operating activities

 

 

(7,398,530

)

 

 

(425,565

)

 

 

 

 

​

 

 

 

​

Cash flows from investing activities:

 

 

 

​

 

 

 

​

Additions to intangible assets

 

 

-

 

 

 

(6,668

)

Cash received in acquisition

 

 

-

 

 

 

309,557

 

Purchase of CIP materials

 

 

-

 

 

 

-

 

Proceeds from sale of property and equipment

 

 

39,093

 

 

 

-

 

Purchase of property and equipment

 

 

(2,209,734

)

 

 

(176,565

)

Project development costs

 

 

-

 

 

 

4,950

 

Cash received from JV

 

 

-

 

 

 

(1,500

)

Additions to equity based investments

 

 

(21,300

)

 

 

-

 

Net cash (used in) provided by investing activities

 

 

(2,191,941

)

 

 

129,774

 

 

 

 

 

​

 

 

 

​

Cash flows from financing activities:

 

 

 

​

 

 

 

​

Debt issuance costs

 

 

(2,416,365

)

 

 

(361,477

)

Payments on finance lease

 

 

(191,245

)

 

 

(62,032

)

Cash paid from split

 

 

-

 

 

 

(58

)

Proceeds from notes payable

 

 

18,582,820

 

 

 

1,756,892

 

Principal payments on debt

 

 

(3,468,237

)

 

 

(2,276,653

)

Cash received from issuance of stock

 

 

-

 

 

 

602,835

 

Cash received for warrant exercise

 

 

-

 

 

 

233,414

 

Cash payment of derivative liability

 

 

(2,769,189

)

 

 

-

 

Net cash provided by (used in) financing activities

 

 

9,737,784

 

 

 

(107,079

)

 

 

 

 

​

 

 

 

​

Net change in cash from continuing operations

 

 

147,313

 

 

 

(402,870

)

 

 

 

 

​

 

 

 

​

Net cash provided by (used in) discontinued operations:

 

 

 

​

 

 

 

​

Cash provided by operating activities

 

 

-

 

 

 

237,507

 

Cash provided by investing activities

 

 

-

 

 

 

177,989

 

Cash used in financing activities

 

 

-

 

 

 

(7,355

)

Net cash provided by discontinued operations

 

 

-

 

 

 

408,141

 

Net change in cash

 

 

147,313

 

 

 

5,271

 

 

 

 

 

​

 

 

 

​

Cash – beginning of period

 

 

54,066

 

 

 

227,766

 

 

 

 

 

​

 

 

 

​

Cash – end of period

 

$

201,379

 

 

$

233,037

 

Supplemental disclosure of non-cash operating activities:

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Forgiveness of related party accounts payable and accrued expenses

 

$

490,000

 

 

$

-

 

Issuance of common stock for derivative liability settlement

 

$

3,592,954

 

 

$

-

 

Issuance of common stock for warrant exercise

 

$

135

 

 

$

-

 

Conversion of Series A preferred stock to common stock

 

$

272

 

 

$

-

 

Conversion of notes payable and accounts payable and accrued expenses for Series C preferred stock and warrants

 

$

7,169,072

 

 

$

-

 

Conversion of due to affilate for Series D preferred stock and warrants

 

$

1,446,774

 

 

$

-

 

Forgiveness of amounts due from affiliates

 

$

-

 

 

$

391,524

 

Issuance of warrants for debt issuance

 

$

9,640,629

 

 

$

413,239

 

Conversion of notes payable to common stock

 

$

883,792

 

 

$

2,278,158

 

Pre-funded warrants

 

$

-

 

 

$

83

 

Issuance of stock for prior debt issuance

 

$

-

 

 

$

44

 

 

The accompanying notes are an integral part of these condensed financial statements. 

 

5


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

1.

Description of Business

 

RenX Enterprises Corp. (the “Company” or “RenX”) is a vertically integrated, full-service operator in the engineered soils and organic recycling industry, operating through Resource Group US Holdings LLC (“Resource Group”), which the Company acquired in June 2025 in a transaction that marked a significant strategic shift in the Company’s core business. The Company, through its subsidiaries, centers its operations on the transformation of targeted organic green waste materials into environmentally friendly soil and mulch products. Through its subsidiary, Zimmer Equipment Inc. (“ZEI”), the Company provides comprehensive waste logistics and collection services for its own products as well as for products of third parties through ZEI’s owned fleet of high-capacity transportation equipment and third-party contractors engaged by ZEI. ZEI offers year-round collection and disposal services through high-capacity grapple trucks, open-top walking floor trailers, and variable-sized containers serving green waste generators, landscaping companies, golf courses, communities, and municipalities. Resource Group works with ZEI to streamline operations by internalizing certain transportation services, reducing over-the-road mileage, lowering disposal costs, and maximizing efficiency. The Company also continues to seek to monetize its legacy real estate assets and joint venture interests.

 

The Company is a Delaware corporation, originally formed in 2021 under the name SGB Development Corp. to engage in real property development using purpose-built, prefabricated modules constructed from both wood and steel. From its inception through 2023, the Company’s operations primarily focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States, including direct acquisitions of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family and multifamily housing projects. In 2023 and early 2024, the Company expanded that strategy by investing in real estate-related artificial intelligence (“AI”) technologies and entering into additional joint ventures in the Southern Texas market aimed at developing sustainable single-family housing. Following the strategic shift described above, the Company is no longer pursuing real estate-related AI activities, and the Company has announced plans to monetize its legacy real estate holdings by selling properties where third-party appraisals indicate meaningful value appreciation, with proceeds to be reinvested in its current operations. In December 2025, the Company changed its name to RenX Enterprises Corp. to reflect its new strategic direction.

 

The Company operates in three segments: compost sales, logistics, and real estate development

 

Going Concern

 

The Company began operations during 2021 and has incurred net losses since inception and has an accumulated deficit, which raises substantial doubt about its ability to continue as a going concern. As of  September 30, 2026, the Company has an accumulated deficit of $58,450,625, and negative working capital of $24,741,590. The Company has funded its operations through bridge note financing, project level financing, and the issuance of its equity and debt securities. The above conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company has initiated a strategic monetization of its legacy real estate properties, which may yield additional financing proceeds to fund operations, however there is no assurance that the Company will be successful in achieving its objectives.

 

Reverse Stock Split

 

On October 8, 2024, the Company effected a 1-for-20 reverse stock split of its then-outstanding common stock (“2024 Stock Split”).

 

On March 26, 2026, the Company effected a second 1-for-20 reverse stock split of its then-outstanding common stock (“2026 Stock Split”).

 

All share and per share amounts set forth in the condensed consolidated financial statements of the Company have been retroactively restated to reflect the 2024 Stock Split and 2026 Stock Split as if they had occurred as of the earliest period presented and unless otherwise stated, all other share and per share amounts for all periods presented in this Quarterly Report on Form 10-Q for the nine months ended September 30, 2026 have been adjusted to reflect the reverse stock splits effected in October 2024 and March 2026.

 

6


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

2.

Summary of Significant Accounting Policies

 

Basis of presentation and principles of consolidation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for annual financial statements. The consolidated financial statements and notes should be read in conjunction with the audited condensed consolidated financial statements and notes for the year ended  December 31, 2025 included in the Company’s Annual Report on Form 10-K for the year ended  December 31, 2025, as filed with the Securities and Exchange Commission on April 1, 2026. In the opinion of management, all adjustments, consisting of normal accruals, considered necessary for a fair presentation of the interim financial statements have been included. Results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the year ending  December 31, 2026. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, LV Peninsula Holding, LLC (“LV Holding”), MyVonia Innovations LLC (“MyVonia LLC”), Resource Group, Resource Group US LLC (“Resource”), Zimmer Equipment Inc. (“ZEI”) and ETS Realty 1, LLC (“ETS”), as well as Sugar Phase I LLC (“Sugar Phase”) and Pulga Internacional LLC (“Pulga”) (until the time of deconsolidation of Sugar Phase and Pulga).

 

Recently adopted accounting pronouncements — New accounting pronouncements implemented by the Company are discussed below or in the related notes, where appropriate.

 

Accounting estimates — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates.

 

Revenue recognition — The Company determines, at contract inception, whether it will transfer control of a promised good or service over time or at a point in time, regardless of the length of contract or other factors. The recognition of revenue aligns with the timing of when promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, the Company applies the following five steps in accordance with its revenue policy:

 

 

(1)

Identify the contract with a customer

 

 

(2)

Identify the performance obligations in the contract

 

 

(3)

Determine the transaction price

 

 

(4)

Allocate the transaction price to performance obligations in the contract

 

 

(5)

Recognize revenue as performance obligations are satisfied

 

7


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

2.

Summary of Significant Accounting Policies (cont.)

 

The revenue the Company has generated has resulted primarily from the sale of materials (compost, engineered soils, and mulch) as well as the collection and disposal services of waste, which at times, is processed into saleable materials. Such revenue is recognized at the point in time when control of the product transfers to the customer, which typically occurs upon delivery or customer pickup at the Company’s facility. For revenue from commissions related to residential real estate purchased and sales transactions, the Company applies recognition of revenue when the customer obtains control over such service, which is at a point in time.

 

Revenue from the sale of materials amounted to $1,090,103 and $759,698 and revenue from logistics, collection and disposal services provided by ZEI amounted to $3,395,298 and $2,756,010, for the three months ended  September 30, 2026 and 2025, respectively.

 

Revenue from the sale of materials amounted to $3,086,838 and $1,184,894, and revenue from logistics, collection and disposal services provided by ZEI amounted to $9,612,593 and $3,733,324, for the nine months ended September 30, 2026 and 2025, respectively. Revenue from commissions amounted to $0 and $18,170 for the nine months ended September 30, 2026 and 2025, respectively.

 

Accounts receivable and allowance for credit losses — Accounts receivable are receivables generated from sales to customers. Amounts included in accounts receivable are deemed to be collectible within the Company’s operating cycle. The Company recognizes accounts receivable at invoiced amounts. 

 

The Company adopted ASC 326, Current Expected Credit Losses, on January 1, 2023, which requires the measurement and recognition of expected credit losses using a current expected credit loss model. The allowance for credit losses on expected future uncollectible accounts receivable is estimated considering forecasts of future economic conditions in addition to information about past events and current conditions.

 

The allowance for credit losses reflects the Company’s best estimate of expected losses inherent in the accounts receivable balances. Management provides an allowance for credit losses based on the Company’s historical losses, specific customer circumstances, and general economic conditions. Periodically, management reviews accounts receivable and adjusts the allowance based on current circumstances and charges off uncollectible receivables when all attempts to collect have been exhausted and the prospects for recovery are remote. Recoveries are recognized when they are received. Actual collection losses may differ from the Company’s estimates and could be material to its consolidated financial position, results of operations, and cash flows. As of  September 30, 2026 and  December 31, 2025, the Company’s allowance for credit losses amounted to $102,461 and $160,075, respectively.

 

Inventory — Inventory consists of dirt, sand, mulch and compost. The Company’s inventory is valued at the lower of cost (first-in, first-out method) or net realizable value, and consists of all finished goods. As of  September 30, 2026 and  December 31, 2025 there was inventory of $735,532 and $1,078,610, respectively.

 

Variable Interest Entities — The Company accounts for certain legal entities as variable interest entities (“VIE”). When evaluating a VIE for consolidation, the Company must determine whether or not there is a variable interest in the entity. Variable interests are investments or other interests that absorb portions of an entity’s expected losses or receive portions of the entity’s expected returns. If it is determined that the Company does not have a variable interest in the VIE, no further analysis is required and the VIE is not consolidated. If the Company holds a variable interest in a VIE, the Company consolidates the VIE when there is a controlling financial interest in the VIE and therefore are deemed to be the primary beneficiary. The Company is determined to have a controlling financial interest in a VIE when it has both the power to direct the activities of the VIE that most significantly impact the VIE economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to that VIE. This determination is evaluated periodically as facts and circumstances change. 

 

8


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

2.

Summary of Significant Accounting Policies (cont.)

 

Investment Entities — The Company previously obtained a 50% membership interest in Norman Berry II Owner LLC (“Norman Berry”). The purpose of the investment in Norman Berry is to develop and provide affordable housing in the Atlanta, Georgia metropolitan area. The Company has determined it is not the primary beneficiary of Norman Berry and thus does not consolidate Norman Berry’s activities in its financial statements. The Company uses the equity method to report Norman Berry’s activities as an investment in its condensed consolidated financial statements. As of  September 30, 2026 the Company continued to hold a 50% interest in Norman Berry. During the nine months ended September 30, 2026, the Company contributed an additional $21,300 for its investment. The Norman Berry partnership recently obtained final city council and entitlement approval for the project. The next step involves completing the consolidation of the various lots into a single parcel, and the Company’s development team and surveyors are preparing the required documentation and submittals for city review and approval. Survey documents reflecting the approved M-I zoning designation are expected to be submitted to the city’s Planning Department for administrative review to obtain final parcel-map approval.

 

During the nine months ended September 30, 2026 and 2025, Norman Berry did not have any material earnings or losses as the investments are in development. In addition, management believes there was no impairment as of  September 30, 2026 and  December 31, 2025.

 

Property, plant and equipment — Property, plant and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated lives of each asset. Repairs and maintenance are charged to expense when incurred. Included in property, plant and equipment, are recoverable reserves acquired in connection with the Resource acquisition described below. Such reserves represent the approximately 9 million tons of entitled sand reserves on the land obtained in connection with the Resource acquisition as well. The estimated amount was based on third-party engineering and appraisal reports. Cost depletion on these depletable reserves is based upon units-of-production.

 

Intangible assets — Intangible assets consist of $22,210 of website costs that will be amortized over 5 years, $5,458,400 of trade name that will be amortized over 15 years, and $6,368,100 of a license agreement that will be amortized over 10 years which is the life of the license.

 

Project Development Costs — Project development costs are stated at cost. At  September 30, 2026 and  December 31, 2025, the Company’s project development costs are expenses incurred related to development costs on various projects that are capitalized during the period the project is under development. 

 

Fair value measurements — Financial instruments, including accounts payable and accrued expenses are carried at cost, which the Company believes approximates fair value due to the short-term nature of these instruments. The short-term notes payable are carried at cost which approximates fair value due to corresponding market rates. Financial instruments, such as derivative liabilities are measured at fair value at each reporting date (see Note 6 for additional information).

 

9


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

2.

Summary of Significant Accounting Policies (cont.)

 

Derivative liability — The Company evaluates all features contained in financing agreements to determine if there are any embedded derivatives that require separate accounting from the underlying agreement under ASC 815 – Derivatives and Hedging. An embedded derivative that requires separation is accounted for as a separate liability or asset from the host agreement. The separated embedded derivative is accounted for at fair market value, with changes in fair value recognized in the statements of operations within the other financing costs line item. The Company determined that certain features under the October Private Placement (See Note 10 — Stockholders’ Equity) qualified as an embedded derivative. The derivative was accounted for separately from the underlying Series B Preferred Stock and is accounted for at fair value.

 

Warrants — The Company reviews the terms of warrants to purchase its common stock to determine whether warrants should be classified as liabilities or stockholders’ equity in its condensed consolidated balance sheets. In order for a warrant to be classified in stockholders’ equity, the warrant must be (i) indexed to the Company’s equity and (ii) meet the conditions for equity classification. If a warrant does not meet the conditions for stockholders’ equity classification, it is carried on the condensed consolidated balance sheets as a warrant liability measured at fair value, with subsequent changes in the fair value of the warrant recorded in the condensed consolidated statements of operations. If a warrant meets both conditions for equity classification, the warrant is initially recorded, at its relative fair value on the date of issuance, in stockholders’ equity in the condensed consolidated balance sheets, and the amount initially recorded is not subsequently remeasured at fair value. 

 

Income taxes — The Company accounts for income taxes utilizing the asset and liability approach. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted.

 

The calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for anticipated tax audit issues based on the Company’s estimate of whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the liabilities are no longer determined to be necessary. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.

 

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was signed into law, extending key provisions of the 2017 Tax Cuts and Jobs Act including, but not limited to, the restoration of 100% bonus depreciation, the introduction of new Section 174A permitting immediate expensing of domestic research and experimental expenditures, modifications to Section 163(j) interest expense limitations, updates to the rules governing global intangible low-taxed income, amendments to energy credit provisions, and the expansion of Section 162(m) aggregation requirements. The impact of the OBBBA has not had a material impact on the Company’s condensed consolidated financial statements.

 

10


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

2.

Summary of Significant Accounting Policies (cont.)

 

Business Combinations — The Company accounts for business acquisitions using the acquisition method of accounting in accordance with ASC 805 “Business Combinations”, which requires recognition and measurement of all identifiable assets acquired and liabilities assumed at their fair value as of the date control is obtained. The Company determines the fair value of assets acquired and liabilities assumed based upon its best estimates of the acquisition-date fair value of assets acquired and liabilities assumed in the acquisition. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Subsequent adjustments to fair value of any contingent consideration are recorded to the Company’s condensed consolidated statements of operations. Costs that the Company incurs to complete the business combination are charged to general and administrative expenses as they are incurred.

 

For acquisitions of assets that do not constitute a business, any assets and liabilities acquired are recognized at their cost based upon their relative fair value of all asset and liabilities acquired.

 

Recently Issued Accounting Pronouncements - In November 2024, the FASB issued ASU No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.” This ASU requires that each interim and annual reporting period, an entity discloses more information about the components of certain expense captions that is currently disclosed in the financial statements. This update is effective for annual reporting periods beginning after December 15, 2026. Early adoption is permitted. Management is currently evaluating the effects this guidance will have on its financial statements.

 

3

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation and amortization and depreciated using the straight-line method over their useful lives. At  September 30, 2026 and  December 31, 2025 the Company’s property and equipment, net consisted of the following:

 

 

 

 

 

​

 

 

 

​

 

Estimated

 

 

 

 

 

​

 

 

 

​

 

Life

 

 

 

2026

 

 

2025

 

 

(in years)

 

Computer equipment and software

 

$

7,293

 

 

$

7,293

 

 

 

5

 

Equipment

 

 

8,786,424

 

 

 

6,835,836

 

 

 

5 - 10

 

Reserves

 

 

3,636,379

 

 

 

3,636,379

 

 

 

*

 

Furniture and fixtures

 

 

1,572,843

 

 

 

1,529,412

 

 

 

4 - 7

 

Land improvements

 

 

327,059

 

 

 

321,922

 

 

 

7 - 20

 

Vehicles and trailer

 

 

6,232,966

 

 

 

5,824,464

 

 

 

5

 

Less: accumulated depreciation

 

 

(7,830,409

)

 

 

(6,353,058

)

 

 

 

​

Property, plant and equipment, net

 

$

12,732,555

 

 

$

11,802,248

 

 

 

 

​

 

*

Based upon units-of-production

 

Included in property and equipment is $2,569,566 and $2,110,471 of finance lease right of use assets as of  September 30, 2026 and  December 31, 2025, respectively.

 

Depreciation expense for the three months ended  September 30, 2026 and 2025 amounted to $473,427 and $431,097, respectively, of which $51,914 and $58,271 related to finance leases, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 amounted to $1,582,640 and $576,893, respectively, of which $157,861 and $77,694 related to finance leases, respectively.

 

11


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

4.

Intangible Assets

 

At  September 30, 2026 and  December 31, 2025 the Company’s intangible assets consisted of the following:

 

 

 

2026

 

 

2025

 

Website costs

 

$

22,210

 

 

$

22,210

 

Trade name

 

 

5,458,400

 

 

 

5,458,400

 

License agreement

 

 

6,368,100

 

 

 

6,368,100

 

Less: accumulated amortization

 

 

(1,341,904

)

 

 

(588,345

)

 

 

$

10,506,806

 

 

$

11,260,365

 

 

Amortization expense for the three months ended  September 30, 2026 and 2025 amounted to $251,287 and $1,111, respectively. Amortization expense for the nine months ended September 30, 2026 and 2025 amounted to $753,559 and $62,510, respectively.

 

The following table represents the total estimated amortization of intangible assets for the succeeding years:

 

 

 

Estimated

 

 

 

amortization

 

For the year ending December 31:

 

expense

 

2026 (remaining)

 

$

250,986

 

2027

 

 

1,004,545

 

2028

 

 

1,004,545

 

2029

 

 

999,503

 

2030 and thereafter

 

 

7,247,227

 

 

 

$

10,506,806

 

 

5.

Equity-based investments

 

As of  September 30, 2026, the Company’s investment in Norman Berry amounted to $849,740. As of  December 31, 2025, the Company’s investment in Norman Berry amounted to $828,440. The financial position of the Company’s equity-based investments are summarized below as of  September 30, 2026 and  December 31, 2025:

 

 

 

September 30,

 

 

December 31,

 

Balance sheet information:

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

(Audited)

 

Total assets

 

$

1,000,000

 

 

$

1,000,000

 

Total liabilities

 

$

-

 

 

$

-

 

Members’ equity

 

$

1,000,000

 

 

$

1,000,000

 

 

12


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

6.

Fair Value Measurements

 

The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.

 

The Company uses three levels of inputs that may be used to measure fair value:

 

Level 1 Quoted prices in active markets for identical assets or liabilities.

 

Level 2 Quoted prices for similar assets and liabilities in active markets or inputs that are observable.

 

Level 3 Inputs that are unobservable (for example, cash flow modeling inputs based on assumptions).

 

Transfer into and transfers out of the hierarchy levels are recognized as if they had taken place at the end of the reporting period. There have been no changes in Level 1, Level 2, and Level 3 and no changes in valuation. The fair value of the Company’s derivative liability was determined using significant unobservable measures and therefore classified as Level 3. The Company does not have any financial instruments in the Level 1 or Level 2 category.

 

 

 

Fair value measured as of September 30, 2026

 

 

 

 

 

​

 

Quoted

 

 

Significant

 

 

 

 

​

 

 

 

 

​

 

prices in

 

 

other

 

 

Significant

 

 

 

Total at

 

 

active

 

 

observable

 

 

unobservable

 

 

 

September 30,

 

 

markets

 

 

inputs

 

 

inputs

 

 

 

2026

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Liabilities:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Derivative liability

 

$

6,199

 

 

$

-

 

 

$

-

 

 

$

6,199

 

 

​

​

Fair value measured as of December 31, 2025

​

​

​

​

​

​

​

Quoted

​

​

Significant

​

​

​

​

​

​

​

​

​

​

​

prices in

​

​

other

​

​

Significant

​

​

​

Total at

​

​

active

​

​

observable

​

​

unobservable

​

​

​

December 31,

​

​

markets

​

​

inputs

​

​

inputs

​

​

​

2025

​

​

(Level 1)

​

​

(Level 2)

​

​

(Level 3)

​

Liabilities:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Derivative liability

​

$

1,218,258

​

​

$

-

​

​

$

-

​

​

$

1,218,258

​

 

13


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

6.

Fair Value Measurements (cont.)

 

The table below shows the inputs used to determine the fair value of the derivative liability:

 

​

​

September 30,

​

​

December 31,

​

​

​

2026

​

​

2025

​

Risk-free interest rate

​

​

3.7

%

​

​

3.68

%

Market discount rate

​

​

0 - 30

%

​

​

30

%

Term (years)

​

​

4.54

​

​

​

4.79

​

Expected volatility

​

​

140

%

​

​

140

%

 

The following table sets forth a summary of the change in the fair value of the derivative liability that are measured at fair value on a recurring basis for the nine months ended September 30, 2026:

 

Balance, as of December 31, 2025

 

$

1,218,258

 

Payments made *

 

 

(6,362,143

)

Change in fair value

 

 

1,268,162

 

Loss on settlement

 

 

3,881,922

 

Balance, as of September 30, 2026

 

$

6,199

 

 

*

During the nine months ended September 30, 2026, $2,769,189 was paid in cash and shares of common stock, valued at $3,592,954, were issued as additional payment.

 

14


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party

 

The following outlines the Company’s Notes Payable and Notes Payable – Related Party. Any related party notes payable are noted as such.

 

LV Note

 

On April 3, 2024, LV Holding, entered into a Modification and Extension Agreement, effective as of April 1, 2024 (the “Extension Agreement”), to extend to April 1, 2025 the maturity date of a promissory note in the amount of $5,000,000 (the “LV Note”). As consideration for the Extension Agreement, LV Holding agreed to pay an extension fee of $50,000. Additionally, the Extension Agreement provided for the LV Note’s interest rate to be increased to a fixed rate of 17.00%. In addition, pursuant to a loan agreement dated April 3, 2024 (the “2nd Lien Loan Agreement”), LV Holding issued a promissory note, in the principal amount of $1,000,000 (the “2nd Lien Note”), secured by a revised Deed of Trust and Security Agreement, dated April 3, 2024 (the “Revised Deed of Trust”) on the Company’s Lago Vista site, and a Modification to Real Estate Mortgage, dated April 3, 2024 (“Mortgage Modification”), to the mortgage, dated March 30, 2023, on the Company’s McLean site in Durant, Oklahoma. The 2nd Lien Note is subordinate to the LV Note. The 2nd Lien Note required monthly installments of interest only at a fixed rate of 17.00%, had a maturity date of April 1, 2025 and could be prepaid by LV Holding at any time without interest or penalty. LV Holding’s obligations under the 2nd Lien Note were guaranteed by the Company pursuant to a Guaranty, dated April 3, 2024.

 

The Company and Norman Berry entered into a Restructuring and Collateral Agreement, dated January 6, 2026 and effective as of December 31, 2025 (the “Restructuring Agreement”), with an institutional investor relating to the outstanding promissory note in the principal amount of approximately $7.0 million issued by LV Holding and secured by the Company’s Lake Travis project site in Lago Vista, Texas (the “Lago Vista Property”). Pursuant to the Restructuring Agreement, among other things: (i) LV Holding delivered a Deed in Lieu of Foreclosure conveying title to the Lago Vista Property to the lender in exchange for the lender’s agreement to conditionally extinguish $5.0 million of the outstanding note; (ii) LV Holding entered into a Loan Modification Agreement, dated December 31, 2025, securing the remaining $2.0 million balance of the outstanding note with the Company’s property in Durant, Oklahoma; (iii) LV Holding issued a conditional promissory note, dated January 6, 2026 (the “New LV Note”), in the principal amount of $5.0 million, which will automatically become effective on or before the date that is 24 months after its execution if the development, construction, flood-plain remediation and all material improvements to the Lago Vista Property have not been substantially completed in accordance with the agreed project plan or the entire outstanding indebtedness owed to the lender is not paid, and which, upon effectiveness, would bear interest at a rate of 13.50% per annum, provide for interest-only payments for 12 months and mature on December 1, 2028; and (iv) the Company pledged its 50% membership interest in Norman Berry to the lender as collateral (which membership interest also serves as alternative collateral under the New BCV Loan Agreement) and granted the lender a security interest in a $209,333 promissory note executed by Norman Berry payable to the Company. Upon a sale of the Lago Vista Property by the lender, the Company is entitled to receive 70% of any net sale proceeds in excess of $5.0 million plus any additional new funds provided for finalization of the project, including accrued interest and/or penalties.

 

15


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

BCV

 

On November 10, 2025, the Company entered into a new Loan Agreement (the “New BCV Loan Agreement”) with a Luxembourg-based specialized investment fund, BCV Renew Earth (“BCV Renew Earth”), for up to $5,000,000 in proceeds, under which it initially received $2,000,000. The New BCV Loan Agreement provides that the loan provided thereunder will bear interest at 14% per annum and mature on May 10, 2027. The New BCV Loan Agreement is secured primarily by the Company’s property in Durant, Oklahoma and its 50% membership interest in Norman Berry as alternative collateral, to be used only if the note is in default (that membership interest is also pledged to the lender under the Restructuring Agreement relating to the Lago Vista Property). As of  September 30, 2026, the principal balance amounted to $3,738,400.

 

1800 Diagonal

 

Between April and December 2025, the Company issued five promissory notes to 1800 Diagonal Lending LLC (“1800 Diagonal”), the Fifth through Ninth 1800 Diagonal Notes, in an aggregate original principal amount of $626,500, each issued at an original issue discount and payable in scheduled monthly installments. As of  September 30, 2026, all five notes had been repaid in full and no principal balance remained outstanding. The terms of these notes are described in the Company’s 2025 Annual Report on Form 10-K.

 

Between December 2025 and August 2026, the Company issued five promissory notes in favor of 1800 Diagonal in the aggregate principal amount of $643,710 for a total purchase price of $557,488, representing an original issue discount of $86,222, which bear interest at rates between 12-13%. Under the terms of the notes, the Company is required to make monthly payments of accrued, unpaid interest and outstanding principal, subject to adjustment on set dates, with the final maturity date being June 2027. The Company has the right to accelerate payments or prepay in full at any time with no prepayment penalty. In connection with these notes, the Company incurred $33,000 in debt issuance costs.

 

As of  September 30, 2026 the total principal balance of 1800 Diagonal Notes amounted to $474,440.

 

Cedar

 

On March 13, 2025, the Company entered into a Cash Advance Agreement (the “Cedar Cash Advance Agreement”) with Cedar Advance LLC (“Cedar”) pursuant to which the Company sold to Cedar $750,000 of its future receivables for a purchase price of $610,000 less underwriting fees and expenses paid and the repayment of prior amounts due Cedar, for net funds provided of $49,900. Pursuant to the Cedar Cash Advance Agreement, Cedar  withdrew approximately $15,000 a week directly from the Company until the $750,000 due to Cedar is paid in full. In the event of a default (as defined in the Cedar Cash Advance Agreement), Cedar, among other remedies, could demand payment in full of all amounts remaining due under the Cedar Cash Advance Agreement. As of  September 30, 2026, there was no outstanding  balance. 

 

On April 27, 2026, the Company refinanced a portion of its remaining obligations to Cedar by entering into a new Cash Advance Agreement (the “Cedar April 2026 Agreement”), pursuant to which the Company sold to Cedar $118,915 of its future receivables for a purchase price of $85,000, less underwriting fees and expenses paid and the repayment of prior amounts due Cedar, for net funds provided of $80,000. Pursuant to the Cedar April 2026 Agreement, Cedar  withdrew approximately $3,716 a week directly from the Company until the $118,915 due to Cedar was paid in full. In the event of a default (as defined in the Cedar April 2026 Agreement), Cedar, among other remedies, could demand payment in full of all amounts remaining due under the Cedar April 2026 Agreement. As of  September 30, 2026, there was no outstanding  balance. 

 

On September 16, 2026, the Company entered into a new Cash Advance Agreement (the “Cedar September 2026 Agreement”), pursuant to which the Company sold to Cedar $71,500 of its future receivables for a purchase price of $53,000, less underwriting fees and expenses paid and the repayment of prior amounts due Cedar, for net funds provided of $50,000. Pursuant to the Cedar September 2026 Agreement, Cedar is expected to withdraw $1,987.50 a week directly from the Company until the $71,500 due to Cedar is paid in full. In the event of a default (as defined in the Cedar September 2026 Agreement), Cedar, among other remedies, can demand payment in full of all amounts remaining due under the Cedar September 2026 Agreement. As of  September 30, 2026, the  balance amounted to $50,056. 

 

CFG 
 

On September 1, 2026, the Company entered into a Cash Advance Agreement (the “CFG Cash Advance Agreement”) with CFG Merchant Solutions, LLC (“CFG”) pursuant to which the Company sold to CFG $278,000 of its future receivables for a purchase price of $200,000 less underwriting fees and expenses paid due CFG, for net funds provided of $199,000. Pursuant to the CFG Cash Advance Agreement, CFG is expected to withdraw $5,450 a week directly from the Company until the $278,000 due to CFG is paid in full. In the event of a default (as defined in the CFG Cash Advance Agreement), CFG, among other remedies, can demand payment in full of all amounts remaining due under the CFG Cash Advance Agreement. As of  September 30, 2026, the  balance amounted to $278,000.

 

16


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

Resource Group Note – Related Party

 

On June 2, 2025, the Company entered into an Amendment (the “Amendment”) to the Membership Interest Purchase Agreement, dated February 25, 2025 (the “Resource Group MIPA”), with Resource Group US Holdings LLC, a Florida limited liability company (“Resource Group”), and the members of Resource Group (the “Equityholders”). The Amendment altered the consideration to be paid by the Company to the Equityholders in connection with the purchase of 100% of the membership interests of Resource Group. Pursuant to the Amendment, the purchase price for the membership interests of Resource Group included, amongst other things, $480,000 in principal amount of unsecured 6% promissory notes due on the first anniversary of the closing; the full consideration for the acquisition is described in Note 8 — Business Combination and Acquisition of Assets. No default under this note has been declared and the Company is in the process of documenting an exchange of this debt for equity.

 

As of  September 30, 2026, the principal balance amounted to $480,000.

 

Boot Capital

 

On December 15, 2025, the Company issued a promissory note (the “Boot Capital Note”) in favor of Boot Capital LLC in the principal amount of $87,750 for a purchase price of $75,000, representing an original issue discount of $12,750. Under the terms of the Boot Capital Note, beginning on January 15, 2026, the Company was required to make four monthly payments of accrued, unpaid interest and outstanding principal, subject to adjustment, in the amount of $14,874, thereafter the monthly payments  decreased to $7,933 for five payments. The Company had the right to accelerate payments or prepay in full at any time with no prepayment penalty. As of  September 30, 2026, there was no outstanding  balance.

 

Sixth Borough Partners

 

On October 8, 2025, the Company issued a promissory note (the “Sixth Borough Note”) in favor of Sixth Borough Partners LLC in the principal amount of $250,000. The note did not bear interest, and the principal amount was due and payable on the sixth month anniversary of the issuance date, or the date of a qualified financing event as defined in the note. As of  September 30, 2026, there was no outstanding principal balance.

 

Peak One

 

 On January 16, 2026, the Company issued a debenture in the principal amount of $310,000 to Peak One Opportunity Fund L.P. (“Peak One”). The debenture was sold to Peak One for a purchase price of $250,000, representing an original issue discount of approximately nineteen percent (19%).  The Company paid an additional $7,500 in fees related to the issuance of this debt. The debenture was scheduled to mature twelve months from its date of issuance and bore interest at a rate of 10% per annum payable on the maturity date. The Company had the right to redeem the debenture at any time, subject to certain limitations, for an amount equal to 110% of the sum of the principal amount so redeemed plus accrued interest. Additionally, under the debenture, while any portion of the debenture remained outstanding, in the event that the Company received cash proceeds of more than $1,000,000 from the sale of securities or assets, then the holder had the right to require the Company to apply up to 50% of the gross proceeds to repay the amounts due under the debenture. 

 

As of  September 30, 2026, there was no outstanding  balance.

 

On September 17, 2026, the Company issued a debenture in the principal amount of $310,000 to the Peak One for a purchase price of $250,000, representing an original issue discount of nineteen percent (19%).  The Company paid an additional $7,500 in fees related to the issuance of this debt. The debenture matures twelve months from its date of issuance and bears interest at a rate of 10% per annum. The debenture is payable in monthly amortization payments commencing November 17, 2026 with the remaining balance payable on the maturity date. The Company has the right to redeem the debenture at any time, subject to certain limitations, for an amount equal to 110% of the sum of the principal amount so redeemed plus accrued interest. Additionally, under the debenture, while any portion of the debenture remains outstanding, in the event that the Company receives cash proceeds of more than $1,000,000 from the sale of securities or assets, then the holder has the right to require the Company to apply up to 50% of the gross proceeds to repay the amounts due under the debenture.  


 

As of  September 30, 2026, the principal balance amounted to $310,000.

 

17


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

February 2026 Private Placement

 

On February 12, 2026, the Company entered into a securities purchase agreement (the “February 2026 Purchase Agreement”) with institutional investors for the issuance and sale in a private placement transaction (the “February 2026 Private Placement”) of Senior Convertible Notes ( “February 2026 Notes”) in the principal amounts of $1,275,000, $3,825,000 and $942,985, respectively. The February 2026 Notes are initially convertible, at the option of the holder, into an aggregate of 1,075,264 shares of the Company’s common stock at a conversion price of $5.62 per share (the “February 2026 Conversion Price”). In connection with the February 2026 Private Placement, the Company also issued the purchasers warrants (collectively, the “February 2026 Warrants”) to purchase an aggregate of 1,937,600 shares of common stock (which is equal to the face value of the February 2026 Notes divided by the exercise price of the February 2026 Warrants), of which (i) February 2026 Warrants to purchase 1,075,264 shares of common stock (the “First February 2026 Warrants”) are exercisable immediately upon issuance and (ii) February 2026 Warrants to purchase 862,335 shares of common stock (the “Second February 2026 Warrants) could not be exercised by the purchasers unless and until stockholder approval (as set forth in the February 2026 Purchase Agreement) was obtained, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 12, 2026.. The First February 2026 Warrants have a term of six years from the date of issuance and are exercisable at a price of $3.1188 per share of common stock, and the Second February 2026 Warrants  have a term of six years from the date that stockholder approval was obtained and are also exercisable at a price of $3.1188 per share of common stock.

 

The February 2026 Private Placement closed on February 17, 2026. The net proceeds to the Company from the February 2026 Private Placement were approximately $5.4 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company and excluding any deductions for make whole payments made to certain of the purchasers.

 

The February 2026 Notes mature 13 months from their date of issuance (subject to extension under certain circumstances), bear interest at a rate of 12% per annum, and are payable in ten monthly installments in an amount equal to 110% of (i) 1/10th of the principal of the February 2026 Notes (ii) plus accrued interest, with the first installment due and payable on the earlier of 180 days from the closing date or 90 days following the date that the February 2026 registration statement required to be filed by the Company with the SEC pursuant to the registration rights agreement entered into with the purchasers in connection with the February 2026 Private Placement is declared effective by the Securities and Exchange Commission (the “SEC”). The February 2026 Notes are unsecured and are senior to all other indebtedness of the Company and its subsidiaries, with each February 2026 Note ranking pari passu with all other February 2026 Notes.

 

The February 2026 Notes are convertible, at the option of the holder, at any time after the date of issuance, into that number of shares of common stock equal to the principal amount of the February 2026 Notes, plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the February 2026 Conversion Price of $5.62 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations and similar events. The holders of the February 2026 Notes are prohibited from converting the February 2026 Notes into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such exercise.

 

18


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

The February 2026 Notes are redeemable by the Company at any time, at the Company’s option, in whole or in part, at a redemption price equal to 110% of the sum of the principal amount to be redeemed plus accrued interest, if any.

 

The February 2026 Notes contain customary events of default. If an event of default occurs, from and after the occurrence, and during the continuance of, an such event of default, the interest rate of the February 2026 Notes shall automatically increase to 18% per annum until such event of default is cured. Additionally, if an event of default occurs, the holders of outstanding February 2026 Notes may, regardless of whether such event of default has been cured, require the Company to redeem all or any portion of the outstanding February 2026 Notes at a price equal to the greater of (i) the product of (A) the value of the February 2026 Notes to be redeemed multiplied by (B) 110% and (ii) the product of (X) the value of the February 2026 Notes to be redeemed, divided by the February 2026 Conversion Price, multiplied by (Y) the product of (1) 110% multiplied by (2) the greatest closing sale price of the common stock on any trading day during the period commencing on the date immediately preceding such event of default and ending on the date the Company makes the entire payment.

 

In connection with the issuance and the sale of the Second April 2026 Notes in the Second Closing, as described below, $5,100,000 of the February 2026 Notes were paid, and the principal amount of the February 2026 Notes  outstanding amounted to $942,985 as of September 30, 2026.

 

 

 

April 2026 Private Placement 

 

On April 30, 2026, the Company entered into a securities purchase agreement (the “April 2026 Purchase Agreement”) with certain institutional investors related to a tranched private placement transaction (the “April 2026 Private Placement”) of Senior Convertible Notes ( “April 2026 Notes”) and warrants (the “April 2026 Warrants”) to purchase shares of common stock as more particularly set forth below. Pursuant to the April 2026 Purchase Agreement, the Company (i) issued and sold to the purchasers, at the initial closing on May 4, 2026 (the “Initial Closing”), April 2026 Notes in the aggregate principal amount of $6,300,000 (the “Initial April 2026 Notes”) and warrants (the “Initial April 2026 Warrants”) to purchase an aggregate of 3,917,099 shares of common stock (which is equal to 180% of the face value of the Initial April 2026 Notes divided by $2.895 (the “Initial April 2026 Conversion Price”)), (ii) agreed to issue and sell to the purchasers, at a second closing (the “Second Closing”), April 2026 Notes in the aggregate principal amount of $6,700,000 (the “Second April 2026 Notes”) and Warrants (the “Second April 2026 Warrants”) to purchase an aggregate of 4,165,805 shares of common stock (which is equal to 180% of the face value of the Second April 2026 Notes divided by the Initial April 2026 Conversion Price), such issuance to occur promptly after effectiveness of a registration statement (the “Initial April 2026 Registration Statement”) registering the shares of common stock issuable upon conversion of the Initial April 2026 Notes (the “Initial April 2026 Conversion Shares”) and the Second April 2026 Notes (the “Second April 2026 Conversion Shares”), in each case calculated based on the Initial April 2026 Conversion Price, and the shares of common stock issuable upon exercise of the Initial April 2026 Warrants (the “Initial April 2026 Warrant Shares”) and the Second April 2026 Warrants (the “Second April 2026 Warrant Shares”); and (iii) agreed to sell and issue to the purchasers additional April 2026 Notes in the aggregate principal amount of up to $87,000,000 (the “Additional April 2026 Notes”) and April 2026 Warrants (the “Additional April 2026 Warrants”) to purchase an aggregate of 54,093,267 shares of common stock (which is equal to 180% of the principal amount of the Additional April 2026 Notes that are issued, divided by the Initial April 2026 Conversion Price (the “Additional April 2026 Warrant Shares”)), such issuances of Additional April 2026 Notes and Additional April 2026 Warrants to be at additional closings (each, an “Additional Closing”) from time to time as determined by the purchasers and the Company, subject to mutual consent to such sales and issuances and certain conditions being met. Pursuant to the April 2026 Purchase Agreement, the Company agreed to use the net proceeds from the April 2026 Private Placement, following the Second Closing, for the repayment of February 2026 Notes, in an amount equal to 110% of the outstanding aggregate principal amount of such February 2026 Notes. On August 26, 2026, the Company and the purchasers entered into an Amendment to Securities Purchase Agreement and Registration Rights Agreement (the “April 2026 SPA & RRA Amendment”), which amended the April 2026 Purchase Agreement to provide that: (i) the date of the Second Closing would be August 26, 2026 (the “Second Closing Date”); and (ii) on the Second Closing Date, the purchasers, severally and not jointly, shall have the right to purchase up to $6,700,000 (pro rata by initial subscription amounts with respect to the First Closing) of April 2026 Notes and April 2026 Warrants. The April 2026 SPA & RRA Amendment also amended certain terms of the registration rights agreement entered into with the purchasers.

 

19


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

The Initial Closing  occurred on May 4, 2026 (the “Initial Closing Date”). The net proceeds to the Company from the Initial Closing  were approximately $5.7 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company. The Second Closing occurred on August 26, 2026, at which the Company sold and issued the purchasers April 2026 Notes in the aggregate principal amount of $5,662,716.07 together with the April 2026 Warrants to purchase 3,520,859 shares of common stock. The net proceeds to the Company from the Second Closing were approximately $5.4 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company. As required by the April 2026 Purchase Agreement, the Company utilized the net proceeds of the Second Closing to repay $5,100,000 due under the February 2026 Notes, in an amount equal to 110% of the outstanding aggregate principal amount of such February 2026 Notes.

 

Subject to the satisfaction of certain closing conditions, including the mutual agreement of the purchasers and us, Additional Closings for an aggregate of up to $87,000,000 may occur from time to time after the Second Closing. There can be no assurance that any Additional Closings will occur. 

 

At the Company’s 2026 Annual Meeting of Stockholders held on June 12, 2026, the Company’s stockholders approved, pursuant to Nasdaq Listing Rule 5635(d), the issuance of the shares of common stock issuable upon conversion of the Initial April 2026 Notes, the Second April 2026 Notes and the Additional April 2026 Notes. The Company filed the Initial April 2026 Registration Statement with the SEC on May 15, 2026, and amended it on each of June 22, 2026 and July 13, 2026. The Initial April 2026 Registration Statement was declared effective by the SEC on August 5, 2026. 

 

The April 2026 Notes mature 12 months from their date of issuance (subject to extension under certain circumstances, bear interest at a rate of 10% per annum, and are payable in full on the maturity date. The April 2026 Notes are unsecured and are senior to all other Indebtedness (as such term is defined in the April 2026 Notes) of the Company and its subsidiaries. The April 2026 Notes contain certain customary and other events of default. If an event of default occurs, from and after the occurrence, and during the continuance of, such an event of default, the interest rate of the April 2026 Notes shall automatically increase to 18% per annum until such event of default is cured. Additionally, if an event of default occurs, the holders of outstanding April 2026 Notes may, regardless of whether such event of default has been cured, require the Company to redeem all or any portion of the outstanding April 2026 Notes at a price equal to the greater of (i) the product of (A) the value of the April 2026 Notes to be redeemed multiplied by (B) 110% and (ii) the product of (X) the value of the April 2026 Notes to be redeemed, divided by the Initial April 2026 Conversion Price, multiplied by (Y) the product of (1) 110% multiplied by (2) the greatest closing sale price of the common stock on any trading day during the period commencing on the date immediately preceding such event of default and ending on the date the Company makes the entire payment.

 

The April 2026 Notes are initially convertible, at the option of the holder, at any time after the date of issuance, into that number of shares of common stock equal to the principal amount of the April 2026 Notes, plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the Initial April 2026 Conversion Price of $2.895 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations and similar events. As a result of the stockholder approvals obtained on June 12, 2026, commencing 120 calendar days following the Initial Closing Date ( September 1, 2026), the purchasers have the right to convert their April 2026 Notes or any portion thereof into shares of common stock (an “Alternate Conversion”) at a conversion price equal to the greater of (x) a floor price of $0.534 (which is equal to 20% of the Nasdaq Minimum Price applicable to the Initial April 2026 Notes) (the “ April 2026 Note Floor Price”) and (y) 92% of the lowest volume weighted average price in the ten trading days prior to the date of such Alternate Conversion. The holders of the April 2026 Notes are prohibited from converting the April 2026 Notes into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such exercise. 

 


 

 

20


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

The Initial April 2026 Warrants and the Second April 2026 warrants each have a term of six years from the date of their respective issuances and are exercisable at a price of $2.67 per share of common stock (the “April 2026 Exercise Price”). 

 

The April 2026 Notes are redeemable by the Company at any time, at the Company’s option, in whole or in part, at a redemption price equal to 110% of the sum of the principal amount to be redeemed plus accrued interest, if any.

 

During the nine months ended September 30, 2026, $883,792 in principal and accrued interest of the April 2026 Notes were converted into common stock, and the principal amount outstanding amounted to $6,080,000 as of September 30, 2026. In addition, Second April 2026 Notes in the aggregate principal amount of $6,228,988 were outstanding as of September 30, 2026.

 

The terms of the April 2026 Notes issued in the Initial Closing and Second Closing were amended in connection with an Additional Closing that was completed after September 30, 2026. See Note 16-Subsequent Events.

 

Related Party Note Exchange — Series C Convertible Preferred Stock

 

On June 9, 2026, the Amended and Restated Promissory Note, dated January 1, 2025, originally issued by the Company to MCS Lending, LLC, a related party, was assigned to Index Equity US, LLC, a related party (the “Index”). On June 11, 2026, the Company entered into an exchange agreement with Index, which was amended on June 15, 2026 (as amended, the “ Index Exchange Agreement”), pursuant to which the Company exchanged $7,169,072 of principal and accrued interest outstanding under such note for (i) 7,169 shares of a newly designated series of Series C Convertible Preferred Stock, par value $0.001 per share “Series C Preferred Stock”), and (ii) a common stock purchase warrant to purchase up to 619,084 shares of common stock, and such note and the indebtedness evidenced thereby were cancelled. Bjarne Borg, a member of the Company’s Board of Directors, is the manager of Index. The total fair value of the Series C Preferred Stock and warrants issued amounted to $9,384,199 and resulted in the Company recording a loss on exchange transaction of $2,215,127. See Note 10 — Stockholder’s Equity and Note 13 — Related Party Transactions for additional information regarding the terms of the Series C Preferred Stock and the warrant.

 

Related Party Note Exchange — Series D Convertible Preferred Stock

 

On September 30, 2026, the Company entered into an exchange agreement (the “Burnham Exchange Agreement”) with James D. Burnham, pursuant to which the Company exchanged $1,446,774 of principal and accrued interest outstanding under a Promissory Note, dated June 2, 2025 (the “Burnham Note”), for (i) 1,441 shares of a newly designated series of Series D Convertible Preferred Stock, par value $0.001 per share (the “Series D Preferred Stock”), and (ii) a common stock purchase warrant to purchase up to 124,438 shares of common stock, and the Burnham Note and the indebtedness evidenced thereby were cancelled. The Burnham Note was included in due to affiliates on the accompanying condensed consolidated balance sheet as of December 31, 2025. The total fair value of the Series D Preferred Stock and warrants issued amounted to $1,479,568 and resulted in the Company recording a loss on exchange transaction of $32,794. James D. Burnham serves as the Company’s Director of Growth & M&A and previously served as a director on the Company’s Board of Directors. See Note 10 — Stockholder’s Equity and Note 13 — Related Party Transactions for additional information regarding the terms of the Series D Preferred Stock and the warrant.

 

 

 

21


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

As of  September 30, 2026 and  December 31, 2025, notes payable consisted of the following:

 

 

 

2026

 

 

2025

 

LV Note

 

$

1,000,000

 

 

$

1,000,000

 

2nd Lien Note

 

 

1,000,000

 

 

 

1,000,000

 

New BCV Loan Agreement

 

 

3,738,400

 

 

 

2,000,000

 

1800 Diagonal Notes

 

 

474,440

 

 

 

478,610

 

Cedar Cash Advance Agreement

 

 

-

 

 

 

427,000

 

Cedar April 2026 Agreement

 

 

-

 

 

 

-

 

Cedar September 2026 Agreement

 

 

50,056

 

 

 

 

 

CFG Merchant Solutions

 

 

278,000

 

 

 

 

 

Boot Capital Note

 

 

-

 

 

 

87,750

 

Sixth Borough Note

 

 

-

 

 

 

250,000

 

Peak One

 

 

310,000

 

 

 

-

 

Anson East Master Fund LP

 

 

5,445,000

 

 

 

-

 

Anson Investment Master Fund LP

 

 

4,642,500

 

 

 

-

 

Alto Opportunity Master Fund, SPC

 

 

3,164,473

 

 

 

-

 

Member Note (related party) - $480,000 in principal amount of unsecured 6% promissory notes due on the first anniversary of the closing of the Resource Group acquisition closing

 

 

480,000

 

 

 

480,000

 

Gail Baird Foundation – Mortgage note payable with an original principal amount of $2,500,000 dated October 23, 2023 with a maturity date of April 21, 2025 and interest rate of 14% per annum plus an exit fee equal to 2% of outstanding principal at the time of payoff. Guaranteed by a former member of Resource Group, collateralized by land held by the Company and the entire principal balance due upon maturity. Despite the fact that the principal and accrued interest were not paid upon maturity, the lender has not declared the note in default and we continue to pay standard interest thereon

 

 

2,500,000

 

 

 

2,410,000

 

CCG Loan1 – Note payable with an original principal amount of $389,469 dated July 12, 2022 with a maturity date of April 12, 2026, interest rate of 10.89% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

-

 

 

 

38,362

 

CCG Loan 2 – Note payable with an original principal amount of $507,935 dated August 26, 2022 with a maturity date of May 26, 2026, interest rate of 11.18% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

-

 

 

 

62,506

 

CCG Loan 3 – Note payable with an original principal amount of $428,446 dated October 13, 2023 with a maturity date of August 13, 2027, interest rate of 12.4% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

115,553

 

 

 

200,706

 

CCG Loan 4 – Note payable with an original principal amount of $1,235,882 dated December 16, 2025 with a maturity date of December 16, 2029, interest rate of 12.50% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

823,706

 

 

 

970,416

 

CCG Loan 5 – Note payable with an original principal amount of $860,995 dated December 16, 2025 with a maturity date of December 16, 2029, interest rate of 12.4% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

565,309

 

 

 

665,995

 

John Deere Equipment – Note payable with an original principal amount of $91,778 dated March 4, 2022 with a maturity date of March 4, 2026, no interest and monthly principal payments.

 

 

-

 

 

 

3,824

 

Loeb – Note payable with an original principal amount of $3,196,215 dated September 7, 2023 with a maturity date of September 7, 2027, interest rate of 15.5% per annum during 2023 and 14.5% per annum during 2024 and forward, secured by underlying equipment and monthly payments of principal and interest with $1,796,979 due upon maturity.

 

 

1,901,439

 

 

 

2,167,994

 

 

22


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

Index Loan 2 (related party) – Note payable dated November 8, 2022 due on demand and interest rate of 11.5% per annum.

 

 

31,749

 

 

 

31,749

 

MCS (related party) – Note payable with an original principal amount of $5,050,517 dated January 31, 2023 with a maturity date of January 31, 2027, interest rate of 12.5% per annum, with the entire principal amount due upon maturity.

 

 

-

 

 

 

5,050,517

 

ZEI Seller Loan – Note payable with an original principal amount of $750,000 dated March 21, 2022 with an original maturity date of April 30, 2025 and interest rate of 7% per annum and entire principal balance due upon maturity.

 

 

-

 

 

 

50,000

 

Moorback 6600 STA – Note payable with an original principal amount of $312,350 dated January 31, 2024 with a maturity date of February 28, 2029, interest rate of 12.89% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

174,895

 

 

 

220,850

 

Blending Line STA – Note payable with an original principal amount of $94,605 dated February 1, 2024 with a maturity date of March 5, 2029, interest rate of 12.89% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

52,971

 

 

 

66,890

 

911 Grapple Truck – Note payable with an original principal amount of $305,985 dated September 1, 2024 with a maturity date of August 30, 2029, interest rate of 7.74% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

197,532

 

 

 

240,175

 

Ford T350 – Note payable with an original principal amount of $39,066 dated October 1, 2024 with a maturity date of September 30, 2029, interest rate of 9% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

29,255

 

 

 

35,169

 

Allegiant Partners Incorporated - Note payable with an original principal amount of $425,800 dated October 17, 2025 with a maturity date of October 25, 2030, interest rate of 11.26% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

364,485

 

 

 

415,115

 

John Deere Equipment 2 - Note payable with an original principal amount of $256,402 dated December 10, 2025 with a maturity date of November 10, 2029, interest rate of 0.0% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

202,985

 

 

 

245,719

 

John Deere Equipment 3 - Note payable with an original principal amount of $368,317 dated December 10, 2025 with a maturity date of November 10, 2029, interest rate of 0.0% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

291,584

 

 

 

360,644

 

John Deere Equipment 4 - Note payable with an original principal amount of $306,239 dated December 19, 2025 with a maturity date of December 19, 2029, interest rate of 0.0% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

248,819

 

 

 

306,239

 

John Deere Equipment 5 - Note payable with an original principal amount of $333,374 dated February 26, 2026 with a maturity date of February 26, 2031, interest rate of 2.5% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

296,570

 

 

 

-

 

First Insurance Funding – Note payable with an original principal amount of $181,423 dated January 1, 2026 with a maturity date of November 1, 2026, interest rate of 8.2% per annum, representing the financing of insurance premiums, with monthly payments of principal and interest.

 

 

35,407

 

 

 

-

 

First Insurance Funding 2 – Note payable with an original principal amount of $101,329 dated February 25, 2026 with a maturity date of September 1, 2026, interest rate of 7.5% per annum, representing the financing of insurance premiums, with monthly payments of principal and interest.

 

 

12,666

 

 

 

-

 

First Insurance Funding 3– Note payable with an original principal amount of $15,701 dated February 15, 2026 with a maturity date of October 15, 2026, interest rate of 7.5% per annum, representing the financing of insurance premiums, with monthly payments of principal and interest.

 

 

15,375

 

 

 

-

 

First Insurance Funding 4 - Note payable with an original principal amount of $19,880 dated September 17, 2026 with a aturity date of September 17, 2027, interest rate of 7.7% per annum, representing the financing insurance premiums, with monthly payments of principal and interest.

 

 

19,881

 

 

 

-

 

Cedar Advance - Cash advance agreement dates August 11, 2026 with a maturity date of February 2027 and weekly estimated payments of $18,347.

 

 

718,876

 

 

 

-

 

 

 

23


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

MCA2-Unique Funding Solutions - Cash advance agreement dated May 6, 2025 with a maturity date of November 13, 2025 and weekly estimated payments of $22,192.

 

 

-

 

 

 

124,229

 

MCA3-CFG Merchant Solutions - Cash advance agreement dated June 20, 2025 with a maturity date of May 13, 2026 and weekly estimated payments of $17,443.

 

 

351,163

 

 

 

595,465

 

BMO Note payable – Note payable with an original principal amount of $861,485 dated August 22, 2022 with a maturity date of September 30, 2028, interest rate of 6.35% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

321,784

 

 

 

433,512

 

Huntington Note Payable – Note payable with an original amount of $317,571 dated December 23, 2022 with a maturity date of December 31, 2028, interest rate of 7.29% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

135,551

 

 

 

175,925

 

Xerox Copier Note Payable – Note payable with an original amount of $10,423 dated July 1, 2020 with a maturity date of September 30, 2025, interest rate of 4% per annum, secured by underlying equipment and monthly payments of principal and interest

 

 

-

 

 

 

1,626

 

PNC Equipment Finance – Note payable with an original amount of $158,429 dated December 27, 2022 with a maturity date of January 31, 2029, interest rate of 8% per annum, secured by underlying equipment and monthly payments of principal and interest.

 

 

70,724

 

 

 

90,805

 

SMFL Note Payable – Note payable with an original amount of $357,260 dated December 27, 2022 with a maturity date of January 31, 2029, no interest, secured by underlying equipment and monthly payments of principal and interest.

 

 

122,623

 

 

 

178,630

 

Verdant – Note payable with an original amount of $496,993 dated September 18, 2022 with a maturity date of October 16, 2027, interest rate of 6.67% per annum, secured by underlying equipment and monthly payments of principal and interest

 

 

141,300

 

 

 

132,909

 

MCA3-CFG Merchant Solutions - Cash advance agreement dated March 21, 2025 with a maturity date of January 21, 2026 and weekly estimated payments of $18,818.

 

 

283,465

 

 

 

256,807

 

MCA4 - Cedar Advance- Cash advance agreement dated June 16, 2025 with a maturity date of December 16, 2026 and weekly estimated payments of $6,000.

 

 

-

 

 

 

91,800

 

International HZ620 Loan - Note payable with an original principal amount of $173,370 dated July 29, 2025 with a maturity date of July 29, 2031, 7.71% interest and monthly principal payments.

 

 

145,607

 

 

 

163,715

 

First Insurance Funding – ZEI - Note payable with an original principal amount of $601,417 dated May 9, 2026 with a maturity date of March 9, 2027, interest rate of 7.25% per annum, representing the financing of insurance premiums, with monthly payments of principal and interest.

 

 

415,250

 

 

 

-

 

 

 

 

 

​

 

 

 

​

Total

 

 

31,169,393

 

 

 

21,511,653

 

Less: debt discount and debt issuance costs

 

 

(7,143,956

)

 

 

(749,450

)

Total debt

 

 

24,025,437

 

 

 

20,762,203

 

Less: current maturities, net

 

 

(21,083,357

)

 

 

(12,518,525

)

Long-term debt, net

 

$

2,942,080

 

 

$

8,243,678

 

 

24


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

7.

Notes Payable and Notes Payable – Related Party (cont.)

 

Scheduled maturities of notes payable is as follows for the succeeding years:

 

2026 (remaining)

 

$

2,946,441

 

2027

 

 

22,502,365

 

2028

 

 

3,790,697

 

2029

 

 

891,946

 

2030

 

 

309,415

 

Thereafter

 

 

728,529

 

 

 

 

31,169,393

 

Less: debt discount and debt issuance costs

 

 

(7,143,956

)

Total debt

 

 

24,025,437

 

Less: current maturities

 

 

(21,083,357

)

Long-term debt, net

 

$

2,942,080

 

 

For the three months ended  September 30, 2026 and 2025, the Company recognized amortization of debt issuance costs and debt discount of $4,142,583 and $653,822, respectively, on all debt outstanding. For the nine months ended September 30, 2026 and 2025, the Company recognized amortization of debt issuance costs and debt discount of $6,106,162 and $1,591,345, respectively, on all debt outstanding. As of  September 30, 2026, the unamortized debt issuance costs and discount amounted to $7,143,956.

 

8.

Business Combination and Acquisition of Assets

 

On June 2, 2025, the Company completed the acquisition of Resource Group. Pursuant to the Amendment, the purchase price for the membership interests of Resource Group was amended to be comprised of (i) $480,000 in principal amount of unsecured 6% promissory notes due on the first anniversary of the closing, (ii) the issuance of restricted shares of the Company’s common stock (the “Closing Shares”) equal to 19.99% of the Company’s outstanding shares of common stock on the date the Resource Group acquisition was executed, which amounted to 18,841 shares of common stock; (iii) 1,500,000 shares of non-voting Series A Convertible Preferred Stock (the “Series A Preferred Stock”) which was convertible into 450,000 restricted shares of the Company’s common stock, and (iv) an aggregate of 2,059 additional shares of Company common stock post-closing. In accordance with ASC 805, the Resource Group acquisition is accounted for as a business combination. The Resource Group acquisition was made for the purpose of primarily shifting the Company’s future business.

 

The purchase consideration amounted to:

 

Note payable

​

$

480,000

​

Equity compensation

​

​

9,232,582

​

​

​

$

9,712,582

​

 

25


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

8.

Business Combination and Acquisition of Assets (cont.)

 

The total equity compensation was valued as follows: common stock at the closing price upon acquisition which amounted to $452,182, and the Series A Preferred Stock at a value of $8,780,400 which was calculated at the estimated conversion price of the common stock with a discount for lack of marketability in the amount of 18.7% based upon a Black-Scholes Value method.

 

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed for the Resource Group Acquisition:  

 

Cash and cash equivalents

​

$

309,557

​

Accounts receivable

​

​

927,807

​

Inventory

​

​

949,670

​

Prepaid expenses and other current assets

​

​

47,352

​

Land

​

​

1,500,000

​

Property and equipment

​

​

9,220,199

​

Intangible assets and goodwill

​

​

18,066,933

​

Right of use assets

​

​

319,468

​

Accounts payable and accrued expenses

​

​

(3,263,930

)

Due to affiliates

​

​

(2,311,180

)

Notes payable

​

​

(14,435,721

)

Operating lease liabilities

​

​

(339,767

)

Finance lease liabilities

​

​

(1,277,806

)

​

​

$

9,712,582

​

 

The following unaudited pro forma consolidated results of operations for the three months ended  September 30, 2025 assume the acquisition Resource Group was completed on January 1, 2024:

 

 

 

For the

 

 

 

Three

 

 

 

Months

 

 

 

Ended

 

 

 

September 30,

 

 

 

2025

 

 

 

(Unaudited)

 

Pro-forma total revenues

 

$

3,515,708

 

Pro-forma net loss

 

$

(4,350,321

)

 

26


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

8.

Business Combination and Acquisition of Assets (cont.)

 

The following unaudited pro forma consolidated results of operations for the nine months ended September 30, 2025 assume the acquisition Resource Group was completed on January 1, 2024:

 

 

 

For the

 

 

 

Nine

 

 

 

Months

 

 

 

Ended

 

 

 

September 30,

 

 

 

2025

 

 

 

(Unaudited)

 

Pro-forma total revenues

 

$

14,651,756

 

Pro-forma net loss

 

$

(13,331,156

)

 

9.

Net Loss Per Share

 

Basic net loss per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of common and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares consist of the common shares issuable upon the exercise of warrants, preferred stock, and outstanding convertible debt. Potentially dilutive common shares are excluded from the calculation if their effect is antidilutive.

 

At  September 30, 2026, there were warrants to purchase 10,017,189 shares of common stock, preferred stock convertible into 2,983,724 shares of common stock, and convertible debt that is initially convertible into 4,223,997 shares of common stock outstanding that could potentially dilute future net loss per share.

 

10.

Stockholders' Equity

 

As of  September 30, 2026, the Company had 3,244,285 shares of common stock issued and 3,236,102 shares outstanding.  

 

During the nine months ended September 30, 2026, the Company issued 135,107 shares of common stock pursuant to cashless warrant exercises.

 

During the nine months ended September 30, 2026, the Company issued 90,000 shares of common stock for services, with a total value of $221,558, determined based on the closing stock price of the Company’s common stock as of the date of grant.

 

During the nine months ended September 30, 2026, the Company forgave $490,000 of related party debt which has been recorded as an increase to additional paid in capital.

 

During the nine months ended September 30, 2026, the Company issued warrants to purchase 9,375,558 shares of common stock in connection with debt issuances which had a value of $9,640,629, which represented the relative fair value of the warrants issued in conjunction with the debt.

 

During the nine months ended September 30, 2026, in connection with the Index Exchange Agreement, the Company issued (i) 7,169 shares of a newly designated series of Series C Preferred Stock and (ii) a common stock purchase warrant to purchase up to 619,084 shares of common stock. The total fair value of the Series C Preferred Stock and warrants issued amounted to $9,384,199 and resulted in the Company recording a loss on exchange transaction of $2,215,127. The fair value of the preferred shares was measured using a Monte Carlo valuation model and the fair value of the warrants issued was measured using a Black-Scholes Value model.

 

During the nine months ended September 30, 2026, the Company issued 597,360 shares of common stock upon the conversion of outstanding notes payable. The conversions were made within the terms of the underlying agreements, and no gain or loss has been recorded.

 

During the nine months ended September 30, 2026, in connection with the Burnham Exchange Agreement, the Company issued (i) 1,441 shares of a newly designated series of Series D Preferred Stock and (ii) a common stock purchase warrant to purchase up to 124,438 shares of common stock. The total fair value of the Series D Preferred Stock and warrants issued amounted to $1,479,568 and resulted in the Company recording a loss on exchange transaction of $32,794. The fair value of the preferred shares was measured using a Monte Carlo valuation model and the fair value of the warrants issued was measured using a Black-Scholes Value model.

 

27


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

October Private Placement Agreement

 

On October 16, 2025, the Company entered into a securities purchase agreement (the “October Purchase Agreement”) with institutional investors for the issuance and sale in a private placement transaction (the “October Private Placement”) of 360,000 shares of a newly designated series of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”) convertible at an initial conversion price of $27.20 per share into 330,882 shares of common stock and common warrants (the “October Warrants”) to purchase up to 330,882 shares of common stock, exercisable at an initial exercise price of $27.20 per share, subject, among other things, to adjustment, stockholder approval and certain beneficial ownership limitations set by each holder, for a combined purchase price of $25.00 for each share of Series B Preferred Stock and accompanying October Warrants, which pricing was designed to be in accordance with the Nasdaq Minimum Price requirement. The October Private Placement closed on October 17, 2025. The net proceeds to the Company from the Private Placement were approximately $8 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company.

 

During the nine months ended September 30, 2026, 327,261 shares of Series B Preferred Stock were converted into common stock, within the original terms and no gain or loss was recorded. Additionally, during the nine months ended September 30, 2026, the Company issued 135,107 shares of common stock from the exercise of October Warrants.

 

Additionally, the Company recorded a derivative liability associated with certain embedded features in the Series B Preferred Stock. These instruments were classified as liabilities at fair value in accordance with ASC 815 due to their settlement provisions and other contractual terms. See below for a description of the terms of the Series B Preferred Stock. The Company measured its bifurcated embedded derivative liability at fair value on a recurring basis using level 3 inputs. These financial instruments are measured using management’s best estimate of fair value, where the inputs into the determination of fair value require significant management judgment to estimation. The derivative liability was measured using a Monte Carlo valuation model. Valuations based on unobservable inputs are highly subjective and require significant judgments. Changes in such judgments could have a material impact on fair value estimates. The initial amount of the derivative liability amounted to $3,631,210 and has been recorded as deemed dividend to the preferred shareholders.

 

Preferred Shares

 

Series A Preferred Stock – During the nine months ended September 30, 2026, 908,431 shares of Series A Preferred stock were converted into 272,534 shares of common stock, within the original terms and no gain or loss was recorded. As of  September 30, 2026, the Company had 30,416 shares of Series A Preferred stock issued and outstanding. The holders of Series A Preferred Stock are not entitled to receive any dividends or distributions. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of shares of Series A Preferred Stock are entitled to be paid, with respect to each share of Series A Preferred Stock then outstanding held by the holder, out of the assets of the Company available for distribution to its stockholders, before any payment shall be made to the holders of common stock by reason of their ownership thereof, an amount in cash per share of Series A Preferred Stock equal to the stated value (the amount payable pursuant to this sentence is hereinafter referred to as the “Series A Preferred Liquidation Value”). After payment of the Series A Preferred Liquidation Value as set forth above, the shares of Series A Preferred Stock shall no longer be deemed to be outstanding and the holders thereof shall have no further rights as holders of Series A Preferred Stock. Except as otherwise required by law, the Series A Preferred Stock shall have no voting rights; provided, however, as long as any shares of Series A Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of Series A Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series A Preferred Stock or alter or amend the Certificate of Designation for the Series A Preferred Stock. Subject to, and following, the approval by the Company’s stockholders of the issuance of the Company’s common stock upon the conversion of the Series A Preferred Stock, each share of Series A Preferred Stock shall thereafter be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into six (6) fully paid and nonassessable shares of common stock (the “Series A Preferred Conversion Ratio”) (0.30 per share). Shares of Series A Preferred Stock may not be redeemed by the Company absent the consent of the holder thereof. Redeemed shares of Series A Preferred Stock shall return to the status of and constitute authorized but unissued shares of preferred stock, without classification as to series until such shares are once more classified as a particular series by the Board of Directors pursuant to the provisions of the Company’s certificate of incorporation.

 

28


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

Series B Preferred Stock - As of  September 30, 2026, the Company had 550 shares of preferred Series B stock issued and outstanding. Holders of shares of Series B Preferred Stock are entitled to receive, and the Company is obligated to pay, but only out of any funds legally available for the declaration of dividends, annual non-compounding dividends payable at the rate per share (as a percentage of the stated value per share of Series B Preferred Stock) of 9% per annum. Dividends on shares of Series B Preferred Stock accrue and are cumulative from the issuance date and accrue from day to day thereafter for so long as Series B Preferred Stock is outstanding. Dividends may be declared and paid on Series B Preferred Stock when and as determined by the Board of Directors of the Company out of any funds legally available for such purpose. Dividends are payable (i) on each conversion date (with respect only to Series B Preferred Stock being converted), (ii) on each such other date as the Board of Directors of the Company may determine; (iii) upon liquidation and (iv) upon occurrence of a fundamental transaction, in cash or, solely in the event of (i) above, in cash or in duly authorized, validly issued, fully paid and non-assessable shares of common stock (as determined by the Company), (the amount to be paid in shares of common stock, the “Dividend Share Amount Payment”); provided, however, that upon the conversion of Series B Preferred Stock prior to the Mandatory Conversion Date (as defined in the Certificate of Designation for the Series B Preferred Stock), the Company shall also pay to the holders of Series B Preferred Stock so converted, an amount equal to the Make-Whole Amount (as defined in the Certificate of Designation for the Series B Preferred Stock), less the amount of all prior dividends made on such converted Series B Preferred Stock before the relevant conversion date (the “Make-Whole Payment”), payable at the option of the Company, in cash or in duly authorized, validly issued, fully paid and non-assessable shares of common stock. With respect to any Dividend Share Amount Payments and Make-Whole Payments paid in shares of common stock, the number of shares of common stock to be issued to a holder shall be an amount equal to the quotient of (x) the amount of the Dividend Shares Amount and Make-Whole Payment payable to such holder divided by (y) the lower of (a) the conversion price then in effect and (b) the VWAP on the trading day prior to the applicable conversion date (the lower of (a) and (b), the “Dividend Conversion Price”), provided that the Dividend Conversion Price shall not be less than the floor price set forth in the Series B Certificate of Designations (the “Series B Preferred Floor Price”). If the Dividend Conversion Price is lower than the Series B Preferred Floor Price and the Company elects to pay the Dividend Share Amount Payment and Make-Whole Payment in shares of common stock, in addition to the number of shares of common stock payable calculated using the Series B Preferred Floor Price, the Company shall pay the holder an amount in cash equal to the product of (A) any bid price selected by holder for the Company’s common stock as published on Bloomberg within one hour preceding the submission of the conversion notice by the holder, and (B) the difference obtained by subtracting (1) the quotient obtained by dividing (a) the amount of the dividend payable to such holder by (b) the Series B Preferred Floor Price, from (2) the quotient obtained by dividing (x) the amount of the dividend payable to such holder by (y) the Dividend Conversion Price without giving effect to the Series B Preferred Floor Price. As previously disclosed, the Make-Whole Payment has been determined to be a derivative liability.

 

Upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, each holder shall be entitled to receive the amount of cash, securities or other property to which such holder would be entitled to receive with respect to such shares of Series B Preferred Stock if such shares had been converted to common stock immediately prior to such liquidation (without giving effect for such purposes to the applicable beneficial ownership limitations), subject to the preferential rights of holders of any class or series of capital stock of the Company specifically ranking by its terms senior to the Series B Preferred Stock as to distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily.

 

29


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

Except as otherwise provided by the Certificate of Designation of the Series B Preferred Stock, or as otherwise required by the law, the Series B Preferred Stock shall have no voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock or alter or amend the Certificate of Designation of the Series B Preferred Stock, (b) authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to, or otherwise pari passu with, the Series Preferred Stock, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders, (d) increase the number of authorized shares of Series B Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.

 

On the mandatory conversion date, which is the five year anniversary of the issuance date (the “Series B Preferred Mandatory Conversion Date”), all outstanding shares of Series B Preferred Stock and, to the extent that the Company elects to pay dividends in shares of common stock, all accrued but unpaid dividends thereon through and including the Series B Preferred Mandatory Conversion Date shall be automatically converted into shares of common stock at the conversion price of $27.20; provided, however, that to the extent that an automatic conversion would result in a holder and its affiliates exceeding the applicable beneficial ownership limitation, if applicable, then such holder’s Series B Preferred Stock shall not be automatically converted into common stock and shall remain outstanding, and the shares of common stock issuable upon the automatic conversion of Series B Preferred Stock to such extent shall be held in abeyance for such holder until such time or times as conversion of such Series B Preferred Stock would not result in such holder and its affiliates exceeding the beneficial ownership limitation.

 

Each share of Series B Preferred Stock shall be convertible, at any time and from time to time from and after the issuance date through the Series B Preferred Mandatory Conversion Date, at the option of the holder thereof, into a number of shares of common stock (subject to certain limitations) equal to the sum of (A) the quotient of (i) the aggregate stated value of those shares being converted, divided by (ii) the applicable conversion price, plus (B) to the extent that the Company elects to pay the Dividend Share Amount Payment and Make-Whole Payment in shares of common stock, the quotient of (X) the sum of all accrued but unpaid dividends thereon plus the Make-Whole Payment, divided by (Y) the Dividend Conversion Price. Holders shall effect conversions by providing the Corporation with the form of Notice of Conversion.

 

Series C Preferred Stock - As of  September 30, 2026, the Company had 7,169 shares of Series C Preferred Stock issued and outstanding with a stated value of $1,000 per share. Dividends accrue on outstanding shares of Series C Preferred Stock at the rate of 8% per annum, compounding quarterly and, if dividends are not paid in cash, the rate increases to 9% per annum. Dividends may be paid in cash from any funds legally available for the declaration of dividends, in additional shares of Series C Preferred Stock, or by increasing the stated value on the Company’s books by the amount of the dividend. Dividends are payable as and when the Board of Directors of the Company may determine, upon liquidation and upon occurrence of a Fundamental Transaction (as such term is defined in the Certificate of Designation of the Series C Preferred Stock).

 

In the event of the liquidation, dissolution or winding-up of the Company, whether voluntarily or involuntarily, the holders of shares of Series C Preferred Stock will be entitled to receive an amount in cash per share of Series C Preferred Stock equal to 150% of the stated value of such shares prior and in preference to holders of shares of common stock and pari passu with the Company’s Series A Preferred Stock and Series B Preferred Stock.

 

30


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

Each share of Series C Preferred Stock is initially convertible, at the option of the holder thereof, at any time after the Company receives stockholder approval of the conversion thereof, at an initial conversion price of $2.895 per share. The conversion price is subject to standard proportional adjustment for stock dividends, stock splits or similar events, subject to a floor price of $1.50 (the “Series C Preferred Floor Price”). The conversion price is also subject to the full-ratchet style adjustment for dilutive issuances, subject to the Series C Preferred Floor Price and with exempt issuances (as specified in the Certificate of Designations for the Series C Preferred Stock) carved out. If a holder elects to convert following a dilutive issuance that causes the conversion price to be less than the Series C Preferred Floor Price, then the holder would receive the number of shares of common stock based upon the Series C Preferred Floor Price plus a cash true-up. Holders of shares of the Series C Preferred Stock are prohibited from converting shares of Series C Preferred Stock into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion, subject to adjustment by the holder to up to 19.99% of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion upon 61 days’ prior notice.

 

The Certificate of Designation provides that holders of shares of Series C Preferred Stock are entitled to vote on an as-converted basis, based on the initial conversion price of $2.895 per share (disregarding any subsequent adjustments that may be made to the conversion price), alongside holders of common stock as a single class, subject to certain limitations. The Company and Index have contractually agreed that for voting purposes, the number of whole shares of Common Stock into which the shares of Series C Convertible Preferred Stock held are then convertible, the adjustment provisions for dilutive issuances shall be disregarded. In addition, as long as any shares of Series C Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of Series C Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series C Preferred Stock or alter or amend the Certificate of Designation of the Series C Preferred Stock, authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to, or otherwise pari passu with, the Series C Preferred Stock, amend its certificate of incorporation in any manner that adversely affects any rights of the holders of Series C Preferred Stock, increase the number of authorized shares of Series C Preferred Stock, declare dividends on or redeem junior securities while accrued dividends remain unpaid, enter into affiliate transactions exceeding $1 million without disinterested director approval or enter into any agreement with respect to any of the foregoing.

 

The Certificate of Designation provides that holders of Series C Preferred Stock are entitled to redeem their shares after three years at a redemption price equal to 110% of the stated value of such shares, plus accrued and unpaid dividends However, the Company and Index have contractually agreed that redemptions by Index are prohibited.. The Company may redeem all or part of the Series C Preferred Stock at any time after the 24-month anniversary of the issuance date by giving the holder at least 30 days’ written notice. The buyback price depends on timing: 115% of stated value if redeemed between the 24-month and 36-month anniversaries, and 110% of stated value after the 36-month anniversary, in each case plus accrued and unpaid dividends. In addition, in the event the Company enters into a transaction which results in a change of control of 50% or more of its then outstanding shares of common stock on a fully diluted basis, sells substantially all its assets, or effects a “going-private” transaction such that it is no longer a publicly reporting company, a holder of shares of Series C Preferred Stock will be entitled to redeem its shares at a redemption price equal to the greater of (i) the stated value of such shares, plus all accrued and unpaid dividends or (ii) the as-converted market value of the shares of common stock issuable upon conversion of the shares of Series C Preferred Stock based on the average of the last closing price of the common stock during the five trading days preceding the date of the holder’s redemption notice.

 

If a Fundamental Transaction (as such term is defined in the Certificate of Designation) occurs, then, upon any subsequent conversion of the Series C Preferred Stock effected within two business days following the date that the Company announces that the Fundamental Transaction has occurred, the holders of shares of Series C Preferred Stock shall have the right to receive, in lieu of the right to receive shares of common stock, for each share of common stock that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of one share of common stock.

 

Series D Preferred Stock - As of September 30, 2026, the Company had 1,441 shares of Series D Preferred Stock issued and outstanding with a stated value of $1,000 per share. Dividends accrue on outstanding shares of Series D Preferred Stock at the rate of 8% per annum, compounding quarterly and accruing day to day and, if dividends are not paid in cash, the rate increases to 9% per annum. Dividends may be paid in cash from any funds legally available for the declaration of dividends, in additional shares of Series D Preferred Stock, or by increasing the stated value on the Company’s books by the amount of the dividend. Dividends are payable as and when the Board of Directors of the Company may determine, upon liquidation and upon occurrence of a Fundamental Transaction (as such term is defined in the Certificate of Designation of the Series D Preferred Stock).

 

In the event of the liquidation, dissolution or winding-up of the Company, whether voluntarily or involuntarily, the holders of shares of Series D Preferred Stock will be entitled to receive an amount in cash per share of Series D Preferred Stock equal to 150% of the stated value of such shares prior and in preference to holders of shares of common stock and pari passu with the Company’s Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock.

 

Each share of Series D Preferred Stock is initially convertible, at the option of the holder thereof, at any time after the Company receives stockholder approval of the conversion thereof, at an initial conversion price of $2.895 per share. The conversion price is subject to standard proportional adjustment for stock dividends, stock splits or similar events, subject to a floor price of $1.50 (the “Series D Preferred Floor Price”). The conversion price is also subject to the full-ratchet style adjustment for dilutive issuances, subject to the Series D Preferred Floor Price and with exempt issuances (as specified in the Certificate of Designations for the Series D Preferred Stock) carved out. If a holder elects to convert following a dilutive issuance that causes the conversion price to be less than the Series D Preferred Floor Price, then the holder would receive the number of shares of common stock based upon the Series D Preferred Floor Price plus a cash true-up. Holders of shares of the Series D Preferred Stock are prohibited from converting shares of Series D Preferred Stock into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion, subject to adjustment by the holder to up to 19.99% of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion upon 61 days’ prior notice.

 

The Certificate of Designation provides that holders of shares of Series D Preferred Stock are entitled to vote on an as-converted basis, based on the initial conversion price of $2.895 per share (disregarding any subsequent adjustments that may be made to the conversion price), alongside holders of common stock as a single class, subject to certain limitations and Nasdaq rules. In addition, as long as any shares of Series D Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of Series D Preferred Stock, alter or change adversely the powers, preferences or rights given to the Series D Preferred Stock or alter or amend the Certificate of Designation of the Series D Preferred Stock, authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to, or otherwise pari passu with, the Series D Preferred Stock, amend its certificate of incorporation in any manner that adversely affects any rights of the holders of Series D Preferred Stock, increase the number of authorized shares of Series D Preferred Stock, declare dividends on or redeem junior securities while accrued dividends remain unpaid, enter into affiliate transactions exceeding $1 million without disinterested director approval or enter into any agreement with respect to any of the foregoing.

 

The Company may redeem all or part of the Series D Preferred Stock at any time after the 24-month anniversary of the issuance date by giving the holder at least 30 days’ written notice. The buyback price depends on timing: 115% of stated value if redeemed between the 24-month and 36-month anniversaries, and 110% of stated value after the 36-month anniversary, in each case plus accrued and unpaid dividends. 

 

If a Fundamental Transaction (as such term is defined in the Certificate of Designation) occurs, then, upon any subsequent conversion of the Series D Preferred Stock effected within two business days following the date that the Company announces that the Fundamental Transaction has occurred, the holders of shares of Series D Preferred Stock shall have the right to receive, in lieu of the right to receive shares of common stock, for each share of common stock that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of one share of common stock.

 

 

 

 

31


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

Warrants

 

In conjunction with the issuance of debentures issued in February and March 2024 to Peak One , the Company issued warrants to purchase an aggregate of 626 shares of common stock. The warrants each expire five years from their respective date of issuance. The warrants are each exercisable, at the option of the holder, at any time, at an exercise price equal to $1,012.00 per share, subject to adjustment for any stock splits, stock dividends, recapitulations, and similar events, as well as anti-dilution price protection provisions that are subject to a floor price of $156.00. The initial fair value of the Peak Warrants amounted to an aggregate of $124,363 and was recorded as a debt discount at the time of issuance of the debentures, as applicable. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

4.22

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

131

%

 

In conjunction with the issuance of additional debentures issued to Peak One in April and May 2024, the Company issued warrants to purchase an aggregate of 1,313. The warrants each expire five years from their respective date of issuance. The warrants are exercisable, at the option of the holder, at any time, at an exercise price equal to $260.00 per share (in the case of the April 2024 warrants) and $304.00 per share (in the case of the May 2024 warrants), subject to adjustment for any stock splits, stock dividends, recapitalizations, and similar events, as well as anti-dilution price protection provisions that are subject to a floor price of $156.00). The initial fair value of warrants amounted to an aggregate of $188,074 and was recorded as a debt discount at the time of issuance of the debentures, as applicable. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

4.52 - 4.65

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

133 - 138

%

 

In conjunction with the issuance of debentures sold and issued to certain investors (the “Arena Investors”), in August 2024, the Company issued warrants to purchase an aggregate of 3,248 shares of common stock. The warrants each expire five years from their respective date of issuance. The warrants are exercisable, at the option of the holder, at any time, at an exercise price equal to $111.60 per share, subject to adjustment for any stock splits, stock dividends, recapitulations, and similar events, as well as anti-dilution price protection provisions that are subject to a floor price as described in the warrants. The initial fair value of warrants amounted to an aggregate of $214,267 and was recorded as a debt discount at the time of issuance of the debenture, as applicable. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

3.75

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

136

%

 

32


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

In conjunction with the issuance of additional debentures to the Arena Investors in October 2024, the Company issued warrants to purchase an aggregate of 8,545 shares of common stock. The warrants each expire five years from their respective date of issuance. The warrants are exercisable, at the option of the holder, at any time, at an exercise price equal to $69.52 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations, and similar events, as well as anti-dilution price protection provisions that are subject to a floor price as described in the warrants. The initial fair value of warrants amounted to an aggregate of $390,939 and was recorded as a debt discount at the time of issuance of the debenture, as applicable. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

4.07

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

136

%

 

In conjunction with the issuance of additional debentures to the Arena Investors in April 2025, the Company issued warrants to purchase an aggregate of 23,052 shares of common stock. The warrants each expire five years from their respective date of issuance. The warrants are exercisable, at the option of the holder, at any time, at an exercise price equal to $32.43 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations, and similar events, as well as anti-dilution price protection provisions that are subject to a floor price as described in the warrants. The initial fair value of warrants amounted to an aggregate of $170,811 and was recorded as a debt discount at the time of issuance of the debenture, as applicable. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

4.48

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

125

%

 

In conjunction with the October Private Placement, the Company issued warrants to purchase an aggregate of 330,882 shares of common stock. The October Warrants were not exercisable until the shareholders of the Company approved the exercise thereof, which approval was obtained on December 8, 2025. The October Warrants will expire two and one-half years following such stockholder approval . In the case of certain Dilutive Issuances (as such term is defined in the October Warrants), the exercise price and the number of shares issuable under the October Warrants will be adjusted; provided, however that the exercise price shall not be adjusted to be below the floor price of $4.84.

 

33


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

In conjunction with the February 2026 Purchase Agreement, the Company issued warrants to purchase an aggregate of 1,937,600 shares of common stock. The warrants each expire six years from their respective date of issuance. The warrants to purchase 1,075,264 shares of common stock (the “First Warrants”) are exercisable immediately upon issuance and (ii) warrants to purchase 862,335 shares of common stock (the “Second Warrants) could not be exercised by the holders until stockholder approval was obtained, which was obtained on June 12, 2026 at the 2026 Annual Meeting. The warrants are exercisable, at an exercise price equal $3.12 per share, subject to adjustment for any stock splits, stock dividends, recapitulations, and similar events. On June 12, 2026 at the 2026 Annual Meeting, the Company received Stockholder Approval and the Second Warrants became exercisable and were deemed to be issued. The initial fair value of the First Warrants and Second Warrants amounted to an aggregate of $1,967,922 and $602,211, respectively, and were recorded as a debt discount at the time of issuance. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

3.67 - 4.18

%

Contractual term (years)

​

​

6

​

Dividend yield

​

​

0

%

Expected volatility

​

​

165 - 211

%

 

In conjunction with the Initial Closing of the April 2026 Private Placement, the Company issued warrants (the “Initial April 2026 Warrants”) to purchase an aggregate of 3,917,099 shares of common stock. The Initial April 2026 Warrants have a term of six years from the date of issuance and are exercisable at a price of $2.67 per share of common stock. The initial fair value of the Initial April 2026 Warrants amounted to an aggregate of $3,780,076 and was recorded as a debt discount at the time of issuance. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

​

​

3.67

%

Contractual term (years)

​

​

6

​

Dividend yield

​

​

0

%

Expected volatility

​

​

210

%

 

In conjunction with the Second Closing of the April 2026 Private Placement, the Company issued warrants (the “Second April 2026 Warrants”) to purchase an aggregate of 3,520,859 shares of common stock. The Second April 2026 Warrants have a term of six years from the date of issuance and are exercisable at a price of $2.67 per share of common stock. The initial fair value of the  Second April 2026 Warrants amounted to an aggregate of $3,290,420 and was recorded as a debt discount at the time of issuance. The fair value was calculated using a Black-Scholes Value model, with the following assumptions.

 

Risk-free interest rate

 

 

3.97

%

Contractual term (years)

 

 

6

 

Dividend yield

 

 

0

%

Expected volatility

 

 

200

%

 

Pursuant to the Index Exchange Agreement, the Company issued a common stock purchase warrant to purchase up to 619,084 shares of common stock (the “Index Exchange Warrants”) to Index. The Index Exchange Warrants shall be immediately exercisable upon issuance, have a term of five years from the date of issuance, and be exercisable for shares of common stock at the exercise price of $2.895 per share; provided that the exercise price and number of shares of common stock issuable upon exercise of the Index Exchange Warrants are subject to customary adjustments pursuant to stock dividends, stock splits or similar events. The initial fair value of the Index Exchange Warrants amounted to an aggregate of $985,309. The fair value was calculated using a Black-Scholes Value model, with the following assumptions:

 

Risk-free interest rate

​

​

4.14

%

Contractual term (years)

​

​

5

​

Dividend yield

​

​

0

%

Expected volatility

​

​

130

%

 

Pursuant to the  Burnham Exchange Agreement, the Company issued a common stock purchase warrant to purchase up to 124,438 shares of common stock (the “Burnham Exchange Warrants”) to Mr. Burnham. The  Burnham Exchange Warrants shall be immediately exercisable upon issuance, have a term of five years from the date of issuance, and be exercisable for shares of common stock at the exercise price of $2.895 per share; provided that the exercise price and number of shares of common stock issuable upon exercise of the Burnham Exchange Warrants are subject to customary adjustments pursuant to stock dividends, stock splits or similar events. The initial fair value of the Burnham Exchange Warrants amounted to an aggregate of $211,574. The fair value was calculated using a Black-Scholes Value model, with the following assumptions:

 

Risk-free interest rate

 

 

5.03

%

Contractual term (years)

 

 

5

 

Dividend yield

 

 

0

%

Expected volatility

 

 

120

%

 

34


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

10.

Stockholders' Equity (cont.)

 

Warrant activity for the nine months ended September 30, 2026 are summarized as follows:

 

 

 

 

 

​

 

 

 

​

 

Weighted

 

 

 

 

​

 

 

 

 

​

 

 

 

​

 

Average

 

 

 

 

​

 

 

 

 

​

 

Weighted

 

 

Remaining

 

 

 

 

​

 

 

 

 

​

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Term

 

 

Intrinsic

 

Warrants

 

Warrants

 

 

Price

 

 

(Years)

 

 

Value

 

Outstanding and exercisable - January 1, 2026

 

 

33,217

 

 

$

22.60

 

 

 

3.6

 

 

 

-

 

Granted

 

 

10,119,080

 

 

 

2.77

 

 

 

 

​

 

 

 

​

Exercised

 

 

(135,107

)

 

 

(2.90

)

 

 

 

​

 

 

 

​

Outstanding and exercisable - September 30, 2026

 

 

10,017,190

 

 

$

2.77

 

 

 

5.5

 

 

$

-

 

 

11.

Share-based Compensation

 

On February 28, 2023, the Company’s Board of Directors approved the issuance of up to 10,000 shares of the Company’s common stock in the form of incentive stock options, non-qualified stock options, options, stock appreciation rights, restricted stock, or restricted stock units (as amended from time to time, the “2023 Plan”). The 2023 Plan expires February 2033 and is administered by the Company’s Compensation Committee of the Board of Directors. Any employee, director, consultant, and other service provider, or affiliates, are eligible to participate in the 2023 Plan. The maximum number of shares of common stock that may be issued under the 2023 Plan automatically increases on January 1 of each calendar years for a period of ten years commencing on January 1, 2024, by a number of shares of common stock equal to 4.5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, provided, however that the Board of Directors may act prior to January 1 of a given calendar year to provide that the increase for such year will be a lesser number of shares of Common Stock. All available shares may be utilized toward the grant of any type of award under the 2023 Plan. On January 1, 2024, 1,148 shares of the Company’s common stock were added to the 2023 Plan pursuant to the evergreen provision. On January 1, 2025, 3,339 shares of the Company’s common stock were added to the 2023 Plan pursuant to the evergreen provision. On January 1, 2026, 42,204 shares of the Company’s common stock were added to the 2023 Plan pursuant to the evergreen provision. In August 2025, the Company’s Board approved, subject to stockholder approval, an amendment to the 2023 Plan to increase the number of shares authorized for issuance thereunder by 60,000 shares of common stock. Stockholders approved this amendment on September 29, 2025. In May 2026, the Company’s Board approved, subject to stockholder approval, an amendment to the 2023 Plan to (i) increase the number of shares authorized for issuance thereunder by 381,139 shares of common stock, and (ii) increase the total number of shares of common stock with respect to which awards may be granted to any non-employee director in his or her capacity as a non-employee director in any single calendar year by 72,500 shares of common stock. Stockholders approved this amendment on June 12, 2026 at the 2026 Annual Meeting. As of  September 30, 2026, there were 473,292 shares of the Company’s common stock available for issuance under the 2023 Plan.

 

On September 8, 2026, the Compensation committee of the Board of Directors approved grants of an aggregate of 122,500 restricted stock units ("RSUs") to certain members of management under the 2023 Plan. As of September 30, 2026, no shares have been formally issued pursuant to such awards and there has not been a mutual understanding of the key terms and conditions of the underlying agreements. As such, under ASC 718, Compensation- Stock Compensation, such grants have not been granted.

 

35


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

12.

Leases

 

The Company leases various equipment under non-cancellable operating lease agreements. The leases have remaining lease terms ranging from approximately one year to six years. Such leases have been recognized as operating leases.

 

Supplemental balance sheet information related to leases is as follows:  

 

 

 

 

September 30,

 

Balance Sheet Location

 

 

2026

 

 

 

 

 

 

​

Operating Leases

 

 

 

 

​

Right-of-use assets

 

 

$

350,596

 

 

 

 

 

 

​

Current liabilities

Lease liability, current maturities

 

 

83,422

 

Non-current liabilities

Lease liability, net of current maturities

 

 

285,871

 

Total operating lease liabilities

 

 

$

369,293

 

 

 

 

 

 

​

Weighted Average Remaining Lease Term

 

 

 

 

​

Operating leases

 

 

 

4.50

 

Weighted Average Discount Rate

 

 

 

 

​

Operating leases

 

 

 

9

%

 

The Company also leases various equipment under non-cancellable lease agreements, which have been determined to be finance leases. The leases have remaining lease terms ranging from approximately one year to six years. 

 

Supplemental balance sheet information related to leases is as follows:   

 

 

 

 

September 30,

 

Balance Sheet Location

 

 

2026

 

 

 

 

 

 

​

Finance Leases

 

 

 

 

​

Right-of-use assets (included in property and equipment)

 

 

$

2,569,566

 

 

 

 

 

 

​

Current liabilities

Lease liability, current maturities

 

 

236,130

 

Non-current liabilities

Lease liability, net of current maturities

 

 

1,147,373

 

Total finance lease liabilities

 

 

$

1,383,503

 

 

 

 

 

 

​

Weighted Average Remaining Lease Term

 

 

 

 

​

Finance leases

 

 

$

3.20

 

Weighted Average Discount Rate

 

 

 

 

​

Finance leases

 

 

 

9

%

 

36


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

12.

Leases (cont.)

 

As the leases do not provide an implicit rate, the Company used an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments, which is reflective of the specific term of the leases and economic environment of each geographic region. 

 

Anticipated future lease costs, which are based in part on certain assumptions to approximate minimum annual rental commitments under non-cancellable leases, are as follows: 

 

2026 (remaining)

 

$

113,033

 

2027

 

 

480,061

 

2028

 

 

481,832

 

2029

 

 

478,438

 

2030

 

 

405,619

 

Thereafter

 

 

156,427

 

Total lease payments

 

 

2,115,410

 

Less: Imputed interest

 

 

(362,614

)

Present value of lease liabilities

 

$

1,752,796

 

 

13.

Related Party Transactions

 

As of  September 30, 2026 and  December 31, 2025, the Company had $0 and $610,000, respectively, included in accounts payable and accrued expenses related to fees payable to the Company’s Board of Directors. These amounts primarily related to pro-rated cash retainers attributable to the third and fourth quarters of 2024 and the first quarter of 2025. During the nine months ended September 30, 2026, the Company’s Board of Directors forgave $490,000 of previously accrued fees, which was recorded as an increase to additional paid-in capital.

 

As of  September 30, 2026 and  December 31, 2025, the Company had $600,604 and $2,094,833, respectively, due to related parties. These amounts primarily resulted from advances from affiliates of the Company, that are non-interest bearing, and are payable on demand. 

 

As disclosed in Note 7, the Company had notes payable to related parties of $511,749 and $5,562,266 as of  September 30, 2026 and  December 31, 2025, respectively. During the nine months ended September 30, 2026, $7,169,072 of outstanding principal and accrued interest of related party debt was extinguished in connection with the Index Exchange Agreement. During the nine months ended September 30, 2026, $1,446,774 of related party debt was extinguished in connection with the Burnham Exchange Agreement.

 

 

As disclosed in Note 7, on June 11, 2026, the Company entered into the Index Exchange Agreement with Index, a related party, pursuant to which the Company exchanged $7,169,072 of principal and accrued interest outstanding under that Amended and Restated Promissory Note, dated January 1, 2025, for (i) 7,169 shares of a newly designated series of Series C Preferred Stock, and (ii) a common stock purchase warrant to purchase up to 619,084 shares of common stock, and such note and the indebtedness evidenced thereby were cancelled. Bjarne Borg, a member of the Company’s Board of Directors, is the manager of Index. See Note 7 — Notes Payable and Notes Payable – Related Party and Note 10 — Stockholder’s Equity for additional information regarding the terms of the Series C Preferred Stock and the warrant.

 

37


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

13.

Related Party Transactions (cont.)

 

The Company incurred consulting fees from Marc Brune, father of Nicolai Brune, the Company's Chief Financial Officer, in the amount of $216,844 and $135,000 during the nine months ended September 30, 2026 and 2025, respectively.

 

The Company incurred consulting fees payable to JDB Consulting Services, Inc., a company controlled by James D. Burnham, who served as a member of the Company’s Board of Directors until July 1, 2026, in the amount of $75,000 and $100,000 during the nine months ended September 30, 2026 and 2025, respectively. The amended and restated consulting agreement with JDB Consulting Services, Inc. was deemed terminated as of July 1, 2026 in connection with Mr. Burnham’s employment agreement.

 

The Company incurred consulting fees payable to AMC Environmental Consulting., a company controlled by Anthony M. Cialone, who serves as a member of the Company’s Board of Directors, in the amount of $150,000 and $100,000 during the nine months ended September 30, 2026 and 2025, respectively.

 

The Company employs Tristan Burnham, son of James D. Burnham, and incurred payroll expenses of $148,461 and $84,792 during the nine months ended September 30, 2026 and 2025, respectively.

 

The Company employs Derek Villarreal, son of David Villarreal, Chief Executive Officer, and incurred payroll expenses of $105,000 during the nine months ended September 30, 2026 and 2025, respectively.

 

As part of the acquisition of Resource Group, the Company acquired an intangible asset in the amount of $6,368,100, which was originally owned by a related party of the members of Resource Group. The original owner is no longer a related party of the Company

 

14.

Commitments and Contingencies

 

At times the Company may be subject to certain claims and lawsuits arising in the normal course of business. The Company will assess liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that the Company will incur a loss and the amount of the loss can be reasonably estimated, the Company will record a liability in our condensed consolidated financial statements. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, the Company will not record an accrual, consistent with applicable accounting guidance. The Company is not currently involved in any material legal proceedings.

 

38


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

15.

Segment Reporting

 

The Company’s Chief Operating Decision Maker (“CODM”) as defined under GAAP, who is the Company’s Chief Executive Officer, determined that the Company organized its operations into three segments as of  September 30, 2026 (real estate development, compost sales, and logistics), compared with four segments in 2025 (real estate development, technology, compost sales, and logistics). The Compost Sales and Logistics segments are the Company’s main focus. These segments reflect the way our executive team evaluates the Company’s business performance and manages its operations. The CODM used the below financial information to assess financial performance and allocate resources. Information for the Company’s segments, is provided in the following table:

 

 

 

Real Estate

 

 

 

 

​

 

Compost

 

 

 

 

​

 

 

 

​

 

 

Development

 

 

Technology

 

 

Sales

 

 

Logistics

 

 

Consolidated

 

For the Nine Months Ended September 30, 2026

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenue

 

$

-

 

 

 

 

 

$

3,086,838

 

 

$

9,612,593

 

 

$

12,699,431

 

Cost of revenue

 

 

-

 

 

 

 

 

 

1,126,755

 

 

 

7,346,399

 

 

 

8,473,154

 

Operating expenses:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Payroll and related expenses

 

 

1,228,446

 

 

 

-

 

 

 

1,048,052

 

 

 

1,048,765

 

 

 

3,325,263

 

Professional and consulting fees

 

 

2,173,539

 

 

 

-

 

 

 

334,441

 

 

 

207

 

 

 

2,508,187

 

Other operating expenses

 

 

3,921,804

 

 

 

121

 

 

 

2,794,346

 

 

 

450,206

 

 

 

7,166,477

 

Total operating expenses

 

 

7,323,789

 

 

 

121

 

 

 

4,176,839

 

 

 

1,499,178

 

 

 

12,999,927

 

Operating (loss) income

 

 

(7,323,789

)

 

 

(121

)

 

 

(2,216,756

)

 

 

767,016

 

 

 

(8,773,650

)

Other income (expense)

 

 

(15,350,205

)

 

 

(1,062

)

 

 

(1,208,818

)

 

 

(704,921

)

 

 

(17,265,006

)

Net (loss) income

 

$

(22,673,994

)

 

$

(1,183

)

 

$

(3,425,574

)

 

$

62,095

 

 

$

(26,038,656

)

Total assets

 

$

1,756,916

 

 

$

1,821

 

 

$

31,604,936

 

 

$

2,962,826

 

 

$

36,326,499

 

 

 

 

Real Estate

 

 

 

 

​

 

Compost

 

 

 

 

​

 

 

 

​

 

 

Development

 

 

Technology

 

 

Sales

 

 

Logistics

 

 

Consolidated

 

For the Three Months Ended September 30, 2026

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenue

 

$

-

 

 

$

-

 

 

$

1,090,103

 

 

$

3,395,298

 

 

$

4,485,401

 

Cost of revenue

 

 

-

 

 

 

-

 

 

 

413,237

 

 

 

2,535,838

 

 

 

2,949,075

 

Operating expenses:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Payroll and related expenses

 

 

416,808

 

 

 

-

 

 

 

463,202

 

 

 

379,560

 

 

 

1,259,570

 

Professional and consulting fees

 

 

685,863

 

 

 

-

 

 

 

68,837

 

 

 

6

 

 

 

754,706

 

Other operating expenses

 

 

1,556,352

 

 

 

-

 

 

 

910,341

 

 

 

64,103

 

 

 

2,530,796

 

Total operating expenses

 

 

2,659,023

 

 

 

-

 

 

 

1,442,380

 

 

 

443,669

 

 

 

4,545,072

 

Operating (loss) income

 

 

(2,659,023

)

 

 

-

 

 

 

(765,514

)

 

 

415,791

 

 

 

(3,008,746

)

Other income (expense)

 

 

(5,022,111

)

 

 

-

 

 

 

(233,853

)

 

 

(425,729

)

 

 

(5,681,693

)

Net (loss) income

 

$

(7,681,134

)

 

$

-

 

 

$

(999,367

)

 

$

(9,938

)

 

$

(8,690,439

)

Total assets

 

$

1,756,916

 

 

$

1,821

 

 

$

31,604,936

 

 

$

2,962,826

 

 

$

36,326,499

 

 

39


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

15.

Segment Reporting (cont.)

 

 

 

Real Estate

 

 

 

 

​

 

 

 

 

 

 

​

 

 

 

​

 

 

Development

 

 

Technology

 

 

Resource

 

 

ZEI

 

 

Consolidated

 

For the Nine Months Ended September 30, 2025

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenue

 

$

-

 

 

$

18,170

 

 

$

1,184,894

 

 

$

3,733,324

 

 

$

4,936,388

 

Cost of revenue

 

 

-

 

 

 

11,800

 

 

 

389,568

 

 

 

3,075,073

 

 

 

3,476,441

 

Operating expenses:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Payroll and related expenses

 

 

1,254,391

 

 

 

11,214

 

 

 

460,221

 

 

 

449,745

 

 

 

2,175,571

 

Professional fees and consulting fees

 

 

877,910

 

 

 

741

 

 

 

318,808

 

 

 

30,561

 

 

 

1,228,020

 

Other operating expenses

 

 

2,513,814

 

 

 

-

 

 

 

688,334

 

 

 

359,722

 

 

 

3,561,870

 

Bad debt expense

 

 

3,025,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,025,000

 

Total operating expenses

 

 

7,671,115

 

 

 

11,955

 

 

 

1,467,363

 

 

 

840,028

 

 

 

9,990,461

 

Operating (loss) income

 

 

(7,671,115

)

 

 

(5,585

)

 

 

(672,037

)

 

 

(181,777

)

 

 

(8,530,514

)

Other income (expense)

 

 

(2,722,217

)

 

 

(5,707

)

 

 

(744,876

)

 

 

(250,958

)

 

 

(3,723,758

)

Net loss

 

$

(10,393,332

)

 

$

(11,292

)

 

$

(1,416,913

)

 

$

(432,735

)

 

$

(12,254,272

)

Total assets

 

$

8,593,933

 

 

$

7,432

 

 

$

28,316,806

 

 

$

1,462,567

 

 

$

38,380,738

 

 

 

 

Real Estate

 

 

 

 

​

 

 

 

 

 

 

​

 

 

 

​

 

 

Development

 

 

Technology

 

 

Resource

 

 

ZEI

 

 

Consolidated

 

For the Three Months Ended September 30, 2025

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Revenue

 

$

-

 

 

$

-

 

 

$

759,698

 

 

$

2,756,010

 

 

$

3,515,708

 

Cost of revenue

 

 

-

 

 

 

-

 

 

 

304,259

 

 

 

2,302,826

 

 

 

2,607,085

 

Operating expenses:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Payroll and related expenses

 

 

373,580

 

 

 

-

 

 

 

337,017

 

 

 

327,549

 

 

 

1,038,146

 

Professional fees and consulting fees

 

 

505,198

 

 

 

741

 

 

 

250,400

 

 

 

4,501

 

 

 

760,840

 

Other operating expenses

 

 

606,395

 

 

 

-

 

 

 

533,645

 

 

 

301,902

 

 

 

1,441,942

 

Bad debt expense

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total operating expenses

 

 

1,485,173

 

 

 

741

 

 

 

1,121,062

 

 

 

633,952

 

 

 

3,240,928

 

Operating (loss) income

 

 

(1,485,173

)

 

 

(741

)

 

 

(665,623

)

 

 

(180,768

)

 

 

(2,332,305

)

Other income (expense)

 

 

(1,285,671

)

 

 

(1,827

)

 

 

(548,961

)

 

 

(181,557

)

 

 

(2,018,016

)

Net loss

 

$

(2,770,844

)

 

$

(2,568

)

 

$

(1,214,584

)

 

$

(362,325

)

 

$

(4,350,321

)

Total assets

 

$

8,593,933

 

 

$

7,432

 

 

$

28,316,806

 

 

$

1,462,567

 

 

$

38,380,738

 

 

40


Table of Contents

 

RenX Enterprises Corp.

Notes to Financial Statements

 

For the Nine Months Ended September 30, 2026 and 2025

 

16.

Subsequent Events

 

April 2026 Note Conversions  

 

From October 1, 2026 to October 5, 2026, certain of the purchasers converted additional Initial April 2026 Notes in an aggregate amount of principal and accrued interest of $260,208 into an aggregate of  175,876 shares of common stock. As a result, as of October 5, 2026, Initial April 2026 Notes in the aggregate principal amount and accrued interest of $5,830,000 remained outstanding as of the date hereof.

 

Note Exchange

 

On November 2, 2026, the Company entered into an exchange agreement (the “Note Exchange Agreement”) with an accredited investor (the “Investor”), pursuant to which the Company exchanged $1,022,971.22 of principal and accrued interest outstanding under a February 2026 Note (the “Prior Note”), for (i) a new senior convertible note (the “New Note”) in the principal amount of $1,037,283.93 (an amount equal to 110% of the outstanding principal amount of the Prior Note), and (ii) a common stock purchase warrant to purchase 644,944 shares of common stock, which is equal to 180% of the face value of the New Note divided by $2.895. Pursuant to the Note Exchange Agreement, on November 2, 2026, the Company issued the New Note and the warrant, and the Prior Note and the outstanding debt due thereunder, was cancelled.

 

In the Note Exchange Agreement, the Investor acknowledged that the shares of common stock issuable upon conversion of the New Note and the exercise of the warrant are subject to an exchange cap (the “Exchange Cap”), such that the Company will not issue shares of common stock upon a conversion of the New Note or shares of common stock upon exercise of the warrant if the issuance of such shares of common stock would exceed the aggregate number of shares of common stock which the Company may issue without breaching its obligations under the rules or regulations of Nasdaq.

 

The Exchange Agreement

 

Pursuant to the Note Exchange Agreement, the Company agreed to hold a special meeting of stockholders at the earliest practicable date after the effective date of the agreement (and in no event later than 120 days thereafter) (the “Stockholder Meeting Deadline”) and use its reasonable best efforts to obtain such approval as may be required under the applicable rules of Nasdaq from the Company’s stockholders with respect to the issuance of shares of common stock upon conversion of the New Note at the Alternate Conversion Price (as defined in the New Note) (the “Stockholder Approval”). If, despite the Company’s reasonable best efforts, the Stockholder Approval is not obtained within 180 days of the effective date of the agreement, the Company is obligated to cause an additional stockholder meeting to be held within 120 days thereafter.

 

Additionally, pursuant to the Note Exchange Agreement, if at any time following the effective date of the agreement, the shares of common stock issuable upon conversion of the New Note or exercise of the warrant may not be resold by the Investor pursuant to Rule 144 under the Securities Act of 1933, as amended, without volume or manner-of-sale restrictions for a period of more than ninety (90) consecutive days, then, upon the written request of the Investor, the Company shall file within forty-five (45) days of such request, and use commercially reasonable efforts to cause to be declared effective within sixty (60) days of such request, a registration statement covering the resale of such shares.

 

The New Note

 

The New Note matures 12 months from its date of issuance (subject to extension under certain circumstances) (the “Maturity Date”), bears interest at a rate of 10% per annum, and is payable in full on the Maturity Date. The New Note is unsecured and is senior to all other Indebtedness (as such term is defined in the New Note) of the Company and its subsidiaries.

 

The New Note is initially convertible, at the option of the holder, at any time after the date of issuance, into that number of shares of common stock equal to the principal amount of the New Note, plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the initial conversion price of $2.895 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations and similar events. Subject to the receipt of Stockholder Approval, the holder of the New Note shall have the right, at any time after the receipt of the Stockholder Approval, to convert the New Note, or any portion thereof, into shares of common stock (an “Alternate Conversion”) at a conversion price (the “Alternate Conversion Price”) equal to the greater of (x) a floor price of $0.534 (the “New Note Floor Price”) and (y) 92% of the lowest VWAP in the ten trading days prior to the date of such Alternate Conversion. Assuming that the New Note accrued interest at 10% for a period of 12 months, the New Note would be convertible into an aggregate of 394,133 shares of common stock, based on the initial conversion price of $2.895 per share, and up to 2,136,728 shares of common stock, based on the New Note Floor Price.

 

On November 16, 2026, in connection with the November Additional Closing (as defined below), and as an inducement to the Investor’s agreement to purchase additional securities in the November Additional Closing, the Company and the Investor entered into an Amendment to Senior Convertible Note (collectively, the “New Note Amendment”), pursuant to which the New Note was amended to provide that, in the event that the Investor elects to convert all or a portion of the New Note in an Alternate Conversion, and the New Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the New Note being converted by the New Note Floor Price, the Company shall also pay to the Investor cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under the New Note shall not exceed the three times the original principal amount of the New Note. Any cash true-up t payments to be made pursuant to the New Note Amendment shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the New Note Amendment amended to the New Note to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities, while the New Note remains outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding New Note and the April 2026 Notes (based on the investors’ respective allocations) at a price equal to 110% of the amount of the New Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the New Note and April 2026 Notes in other cases.


 

The holder of the New Note is prohibited from converting the New Note into shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such conversion.

 

The New Note is redeemable by the Company at any time, at the Company’s option, in whole or in part, at a redemption price equal to 110% of the sum of the principal amount to be redeemed plus accrued interest, if any.

 

The New Note contains certain customary and other events of default. If an event of default occurs, from and after the occurrence, and during the continuance of, such an event of default, the interest rate of the New Note shall automatically increase to 18% per annum until such event of default is cured. Additionally, if an event of default occurs, the holder of New Note may, regardless of whether such event of default has been cured, require the Company to redeem all or any portion of the New Note at a price equal to the greater of (i) the product of (A) the value of the New Note to be redeemed multiplied by (B) 110% and (ii) the product of (X) the value of the New Note to be redeemed, divided by the initial conversion price, multiplied by (Y) the product of (1) 110% multiplied by (2) the greatest closing sale price of the common stock on any trading day during the period commencing on the date immediately preceding such event of default and ending on the date the Company makes the entire payment.

 

Pursuant to the New Note, the Company shall not enter into or be a party to a Fundamental Transaction (as such term is defined in the New Note) unless (i) the successor entity assumes in writing all of the obligations under the New Note and the other transaction documents and (ii) the successor entity is a publicly traded corporation whose common stock is quoted on or listed for trading on an eligible market, as set forth in the New Note. 

 

While the New Note is outstanding, subject to certain exempt issuances, if the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities, the holder of the New Note shall have the right, in its sole discretion, to require that the Company apply up to 2.39% of the gross proceeds from such sales or offers to redeem all, or any portion, of the New Note at a price equal to 110% of the amount of the New Note being redeemed.

 

The Warrant

 

The warrant shall be immediately exercisable upon issuance, have a term of six years from the date of issuance, and be exercisable for shares of common stock at the exercise price of $2.67 per share. If, after the date that is six months after the issuance date, there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the shares of common stock issuable upon exercise of the warrant, the warrant may be exercised, in whole or in part, by means of a “cashless exercise” in which case the holder will be entitled to receive a number of shares of common stock equal to the quotient obtained by dividing, (x) (A) as applicable, the VWAP of the common stock on the date immediately preceding the exercise date (if the notice of exercise is (1) both executed and delivered on a day that is not a trading day or (2) both executed and delivered on a trading day prior to the opening of “regular trading hours) or the bid price of the common stock as of the time of the holder’s execution of the applicable notice of exercise (if the notice of exercise is executed during “regular trading hours” on a trading day), less the exercise price of the warrant, multiplied by (B) the number of shares of common that would be issuable upon exercise of the warrant if the exercise were by means of a cash exercise rather than a cashless exercise, by (y) the price used in (A). The holder of the warrant is prohibited from exercising the warrant for shares of common stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of common stock issued and outstanding immediately after giving effect to such exercise.

 

Additional Closing of April 2026 Private Placement and April 2026 Note Amendments

 

On November 16, 2026, the Company and the purchasers in the April 2026 Private Placement completed an Additional Closing (the “November Additional Closing”), at which the Company sold and issued the purchasers April 2026 Notes in the aggregate principal amount of $3,000,000 together with the April 2026 Warrants to purchase 1,865,283 shares of common stock. Assuming that the April 2026 Notes sold in the November Additional Closing accrued interest at 10% for a period of 12 months, such notes would be convertible into an aggregate of 1,139,898 shares of common stock, based on the Initial April 2026 Conversion Price, and up to 6,179,776 shares of common stock, based on the April 2026 Note Floor Price. The net proceeds to the Company from the November Additional Closing were approximately $2.5 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company.  

 

On November 16, 2026, in connection with the November Additional Closing, and as an inducement to the purchasers’ agreement to purchase additional securities in the November Additional Closing, the Company and each of the purchasers of April 2026 Notes and April 2026 Warrants entered into Amendments to Senior Convertible Note (collectively, the “April 2026 Note Amendments”), pursuant to which each of the April 2026 Notes issued and sold to the purchasers in the Initial Closing and the Second Closing were amended to provide that, in the event that the holder of an April 2026 Note elects to convert all or a portion of their April 2026 Note in an Alternate Conversion, and the April 2026 Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the April 2026 Note being converted by the April 2026 Note Floor Price, the Company shall also pay to the holder cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under any April 20206 Note shall not exceed the three times the original principal amount of such April 2026 Note. Any cash true-up payments to be made pursuant to the April 2026 Note Amendments shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the April 2026 Note Amendment amended to the April 2026 Notes to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities while the April 2026 Notes remain outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding April 2026 Notes and New Note (based on the investors’ respective allocations) at a price equal to 110% of the amount of the April 2026 Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the April 2026 Notes New Note and in other cases.

 

Loeb Refinancing 

 

On November 6, 2026, the Company's subsidiaries ZEI and Resource issued a Second Amended and Restated Term Promissory Note (the “2nd A&R Loeb Note”) to Loeb Term Solutions LLC (“Loeb”) in the principal amount of $1,997,780, which amended and restated the Company's existing note payable to Loeb, dated September 7, 2023, in the original principal amount of $3,196,215. The 2nd A&R Loeb Note bears interest at the Wall Street Journal prime rate plus 6.5% per annum (the “Loeb Interest Rate”), computed on a 365-day year, and is payable in 35 monthly installments of principal and interest, calculated on a five-year amortization schedule, with a final balloon installment of all outstanding principal, accrued interest and other amounts due on the first day of the thirty-sixth month following the effective date ( November 1, 2029). Notwithstanding the foregoing, from and after the occurrence of a default under the 2nd A&R Loeb Note, and for so long as such default continues, the applicable interest rate shall be increased to the  Loeb Interest Rate plus 6% per annum. The 2nd A&R Loeb Note was issued to Loeb pursuant to a Second Amended and Restated Credit Agreement entered into by and among the parties, which amends and restates in all respects that Credit and Security Agreement entered into by and among the parties on September 7, 2023, remains secured by equipment of the borrowers, and did not constitute a novation of the existing indebtedness.

41


Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Introduction and Certain Cautionary Statements

 

As used in this Quarterly Report on Form 10-Q, unless the context requires otherwise, references to the “Company,” “RENX,” “we,” “us,” and “our” refer to RenX Enterprises Corp. and its subsidiaries. The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes and schedules included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements for the years ended December 31, 2025 and 2024 and the accompanying notes, which are included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission on April 1, 2026 (the “2025 10-K”). This discussion, particularly information with respect to our future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form10-Q. You should review the disclosure under the heading “Risk Factors” in this Quarterly Report on Form 10-Q and the 2025 10-K for a discussion for important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements.  

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed in the forward-looking statements. The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Statements contained in this Quarterly Report on Form 10-Q may use forward-looking terminology, such as “anticipates,” “believes,” “could,” “would,” “estimates,” “may,” “might,” “plan,” “expect,” “intend,” “should,” “will,” or other variations on these terms or their negatives. All statements other than statements of historical facts are statements that could potentially be forward-looking. We caution that forward-looking statements involve risks and uncertainties, and actual results could differ materially from those expressed or implied in these forward-looking statements or could affect the extent to which a particular objective, projection, estimate or prediction is realized. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, those discussed in the section titled “Risk Factors” included under Part II, Item 1A below and those discussed in the section titled “Risk Factors” included under Part I, Item 1A in the 2025 Form 10-K. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statement.

 

Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this Quarterly Report on Form 10-Q will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that the objectives and plans of ours will be achieved. Investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date on which such statements are made. Any forward-looking statements made by us or on our behalf speak only as of the date they are made, and we do not undertake to update any forward-looking statement that may be made from time to time on our behalf.

 

42


Table of Contents

 

Overview  

 

We are a vertically integrated, full-service operator in the engineered soils and organic recycling industry, operating through Resource Group US Holdings LLC (“Resource Group”), which we acquired in June 2025 in a transaction that marked a significant strategic shift in our core business. Resource Group, through its subsidiaries, centers its operations on the transformation of targeted organic green waste materials into environmentally friendly soil and mulch products. Through our subsidiary, Zimmer Equipment Inc. (“ZEI”), we provide comprehensive waste logistics and collection services for our own products as well as for products of third parties through ZEI’s owned fleet of high-capacity transportation equipment and third-party contractors engaged by us. ZEI offers year-round collection and disposal services through high-capacity grapple trucks, open-top walking floor trailers, and variable-sized containers serving green waste generators, landscaping companies, golf courses, communities, and municipalities. Resource Group works with ZEI to streamline operations by internalizing certain transportation services, reducing over-the-road mileage, lowering disposal costs, and maximizing efficiency. In July 2026, Resource Group launched a land clearing division, which provides vegetation, stump and woody debris clearing and removal services for a fee and processes the cleared material on site for transport to our Myakka City facility, where it is used as feedstock for our mulch and compost products. In September 2026, ZEI commenced a new municipal solid waste hauling route in the Tampa Bay region on a trial basis for an existing national waste management customer, which is in addition to ZEI’s existing transport agreements with that customer.In November 2026, ZEI was awarded the hauling contract for this route and acquired additional trailers to service it.

 

In addition to our organics processing and logistics operations, we are in the process of implementing the Microtec UTM 1200 Turbo Mill system at our Myakka City facility. The UTM 1200 is a high-efficiency milling and processing technology designed to enhance the throughput and output quality of our existing organics processing operations, including the production of engineered soils and mulch products.  The UTM 1200 system arrived at our Myakka City facility and installation of the mill and its related structure was substantially completed in October 2026. Remaining steps to place the system in service include electrical interconnection and energization, installation of the fire suppression system, completion of material handling fabrication, and commissioning, and we are targeting initial production in the first quarter of 2027. There can be no assurance that the UTM 1200 system will be deployed on the anticipated timeline or that it will perform as expected upon installation.

 

We currently operate in three segments: compost sales, logistics, and real estate development. For the quarter ended September 30, 2026, we operated in three segments and generated $4,485,401 in revenue, of which approximately $3,395,298 was generated from our logistics business and $1,090,103 was generated from our compost sales business. While our logistics business operated by our subsidiary, ZEI, and our compost sales business operated by our subsidiary, Resource Group, are expected to serve as our primary operational focuses going forward, we also currently intend to continue to try to monetize our legacy real estate assets and joint venture interests. 

 

Market Opportunity and Growth Strategy

 

We believe the market backdrop for organics recycling provides a durable tailwind for our business. State and local governments are increasingly adopting organics-diversion requirements and restrictions on the landfilling of green waste, expanding the feedstock available to permitted processors, while demand for engineered soils, mulch, compost and organic growing media continues to grow across agricultural, commercial, landscaping and infrastructure end markets. In particular, domestically produced, waste-derived substrates are increasingly preferred by commercial and municipal buyers over imported and mined alternatives, such as Canadian sphagnum peat, virgin topsoil and imported bark products, reflecting supply-chain disruptions, rising import costs and tariffs on imported inputs, and procurement mandates favoring recycled-content materials.

 

With that in mind, we are developing our permitted Myakka City, Florida facility into what we believe will be a differentiated organic substrate production platform. The planned deployment of the UTM 1200 system described above is designed to move our output beyond bulk mulch and compost into consistent, specification-grade engineered soils and organic growing substrates, including growing media formulated to serve as a domestically produced replacement for imported sphagnum peat-based products. Permitted organics processing facilities face significant barriers to entry, including capital intensity, land requirements and regulatory complexity, and our platform combines the permitted site and approximately 9 million tons of entitled sand reserves acquired in connection with the Resource Group acquisition with ZEI’s collection and logistics network, which helps secure feedstock supply and internalize transportation costs, allowing us to source raw organic material, process it and deliver finished products within a single vertically integrated system.

 

43


Table of Contents

 

Our two primary operating segments, compost sales and logistics, carry complementary margin profiles: for the nine months ended September 30, 2026, our compost sales segment generated a gross margin of approximately 64%, while our logistics segment generated a gross margin of approximately 24%. As our compost sales and substrate production business grows relative to our logistics business, we believe this segment mix has the potential to expand our consolidated gross margin over time. Revenue for the quarter ended September 30, 2026 of $4,485,401 represented an increase of approximately 5.4% over revenue of $4,255,906 for the quarter ended June 30, 2026. We have seen sequential growth in both our logistics and compost sales segments during 2026 as compared to 2025. Our growth strategy contemplates organic expansion, including increased processing throughput and new substrate products at Myakka City, the expansion of our land clearing services and expanded collection and logistics services, and we may from time to time evaluate acquisitions or investments that complement our vertically integrated platform. Any such expansion will require additional capital and is subject to the risks described under “Item 1A. Risk Factors” in this Quarterly Report and in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Company History

 

We were formed as a Delaware corporation in 2021 under the name SGB Development Corp. and, prior to our June 2025 acquisition of Resource Group, focused primarily on residential real property development and related real estate investments. In December 2025, we changed our name to RenX Enterprises Corp. to reflect our new strategic direction. See Note 1 — Description of Business for additional background.

 

Recent Developments

 

 

 

 

 

44


Table of Contents

 

 

 

 

 

April 2026 Private Placement

 

On April 30, 2026, we entered into a securities purchase agreement (the “April 2026 Purchase Agreement”) with certain institutional investors providing for a tranched private placement transaction (the “April 2026 Private Placement”) of senior convertible notes (the “April 2026 Notes”) and warrants (“April 2026 Warrants”) to purchase shares of Common Stock, consisting of: (i) April 2026 Notes in the aggregate principal amount of $6,300,000 (the “Initial April 2026 Notes”) and April 2026 Warrants to purchase 3,917,099 shares of Common Stock (the “Initial April 2026 Warrants”), issued at the initial closing on May 4, 2026 (the “Initial Closing”), for net proceeds of approximately $5.7 million; (ii) April 2026 Notes in the aggregate principal amount of $6,700,000 (the “Second April 2026 Notes”) and April 2026 Warrants to purchase 4,165,805 shares of Common Stock (the “Second April 2026 Warrants”), to be issued in a second closing (the “Second Closing”) promptly following effectiveness of a registration statement (the “Initial April 2026 Registration Statement”) registering the shares of Common Stock issuable upon conversion of the Initial April 2026 Notes and the Second April 2026 Notes, in each case calculated based on the initial conversion price of $2.895, and the shares of Common Stock issuable upon exercise of the Initial April 2026 Warrants and the Second April 2026 Warrants, with expected net proceeds of approximately $6.4 million, which we have agreed to apply to the repayment of the February 2026 Notes at 110% of their outstanding principal amount; and (iii) up to $87,000,000 of additional April 2026 Notes and related warrants at additional closings (“Additional Closings”), subject to mutual consent and certain conditions, as to which no assurance can be given. Pursuant to the April 2026 Purchase Agreement, we agreed to use the net proceeds from the April 2026 Private Placement, following the Second Closing, for the repayment of those senior convertible notes sold to certain investors on February 12, 2026 (the “February 2026 Notes”), in an amount equal to 110% of the outstanding aggregate principal amount of such February 2026 Notes. On August 26, 2026, we and the purchasers entered into an Amendment to Securities Purchase Agreement and Registration Rights Agreement (the “April 2026 SPA & RRA Amendment”), which amended the April 2026 Purchase Agreement to provide that: (i) the date of the Second Closing would be August 26, 2026 (the “Second Closing Date”); and (ii) on the Second Closing Date, the purchasers, severally and not jointly, shall have the right to purchase up to $6,700,000 (pro rata by initial subscription amounts with respect to the First Closing) of April 2026 Notes and April 2026 Warrants. The April 2026 SPA & RRA Amendment also amended certain terms of the registration rights agreement entered into with the purchasers.

 

The April 2026 Notes are initially convertible, at the option of the holder, at any time after the date of issuance, into that number of shares of Common Stock equal to the principal amount of the April 2026 Notes, plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the Initial April 2026 Conversion Price of $2.895 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations and similar events. Subject to the receipt of stockholder approval, which was obtained at our 2026 Annual Meeting on June 12, 2026, the holders of the April 2026 Notes shall have the right, at any time after the later of (i) the date of the receipt of the stockholder approval and (ii) 120 calendar days following the Initial Closing Date, to convert their April 2026 Notes or any portion thereof into shares of Common Stock (an “Alternate Conversion”) at a conversion price equal to the greater of (x) a floor price of $0.534 (which is equal to 20% of the Nasdaq Minimum Price applicable to the Initial April 2026 Notes) (the “April 2026 Note Floor Price”) and (y) 92% of the lowest volume weighted average price in the ten trading days prior to the date of such Alternate Conversion. See Note 7 — Notes Payable and Notes Payable – Related Party for a complete description of the April 2026 Private Placement.

 

The Initial Closing occurred on May 4, 2026 (the “Initial Closing Date”). The net proceeds to us from the Initial Closing were approximately $5.7 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by us. 

 

The Second Closing occurred on August 26, 2026, at which the Company sold and issued the purchasers April 2026 Notes in the aggregate principal amount of $5,662,716.07 together with the April 2026 Warrants to purchase 3,520,859 shares of common stock. The net proceeds to the Company from the Second Closing were approximately $5.4 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company. As required by the April 2026 Purchase Agreement, the Company utilized the net proceeds of the Second Closing to repay $5,100,000 due under the February 2026 Notes, in an amount equal to 110% of the outstanding aggregate principal amount of such February 2026 Notes.

 

On November 16, 2026, we completed an Additional Closing (the “November Additional Closing”), at which we sold and issued the purchasers April 2026 Notes in the aggregate principal amount of $3,000,000 together with the April 2026 Warrants to purchase 1,865,283 shares of common stock. The net proceeds to the Company from the November Additional Closing were approximately $2.5 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by us. 

 

On November 16, 2026, in connection with the November Additional Closing, and as an inducement to the purchasers’ agreement to purchase additional securities in the November Additional Closing, we and each of the purchasers of April 2026 Notes and April 2026 Warrants entered into Amendments to Senior Convertible Note (collectively, the “April 2026 Note Amendments”), pursuant to which each of the April 2026 Notes issued and sold to the purchasers in the Initial Closing and the Second Closing were amended to provide that, in the event that the holder of an April 2026 Note elects to convert all or a portion of their April 2026 Note in an Alternate Conversion, and the April 2026 Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the April 2026 Note being converted by the April 2026 Note Floor Price, we shall also pay to the holder cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under any April 20206 Note shall not exceed the three times the original principal amount of such April 2026 Note. Any cash true-up payments to be made pursuant to the April 2026 Note Amendments shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the April 2026 Note Amendment amended to the April 2026 Notes to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities while the April 2026 Notes remain outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding April 2026 Notes and New Note (based on the investors’ respective allocations) at a price equal to 110% of the amount of the April 2026 Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the April 2026 Notes New Note and in other cases.

 

Subject to the satisfaction of certain closing conditions, including the mutual agreement of the purchasers and us, further Additional Closings for an aggregate of up to $84,000,000 may occur from time to time hereafter. There can be no assurance that any further Additional Closings will occur.

 

At our 2026 Annual Meeting of stockholders (the “2026 Annual Meeting”), our stockholders approved, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to 26,779,029 shares of Common Stock upon conversion of the Initial April 2026 Notes and the Second April 2026 Notes and of up to an additional 179,213,485 shares of Common Stock upon conversion of Additional April 2026 Notes (in each case assuming that such notes accrue interest at 10% for a period of 12 months and that the conversion price is reduced to the floor price provided for in the April 2026 Notes). As a result of such approvals, commencing 120 calendar days following the date that the Initial April 2026 Notes were issued (September 1, 2026), the holders of outstanding April 2026 Notes shall have the right to complete an Alternate Conversion at the Alternate Conversion Price equal to the greater of (x) the April 2026 Note Floor Price and (y) 92% of the lowest VWAP in the ten trading days prior to the date of such Alternate Conversion.

 

From September 25, 2026 to October 1, 2026, certain of the purchasers converted Initial April 2026 Notes in the aggregate principal amount of $1,100,000, plus accrued interest of $44,000, into an aggregate of 773,236 shares of our common stock.

 

June 2026 Related Party Debt Exchange

 

On June 11, 2026, we entered into an exchange agreement with Index Equity US, LLC, a related party (“Index”), which was amended on June 15, 2026 (as amended, the “Index Exchange Agreement”), pursuant to which we exchanged $7,169,072.79 of principal and accrued interest outstanding (the “Index Outstanding Debt”) under an Amended and Restated Promissory Note, dated January 1, 2025, originally issued by us to MCS Lending, LLC, a related party, and assigned to Index on June 9, 2026, for (i) 7,169 shares of a newly designated series of Series C Convertible Preferred Stock, par value $0.001 per share (“Series C Preferred Stock”), with a stated value of $1,000.00 per share, which are initially convertible, at the option of the holder, into an aggregate of 2,476,338 shares of common stock at an initial conversion price of $2.895 per share, and (ii) a common stock purchase warrant to purchase up to 619,084 shares of common stock at an initial exercise price of $2.895 per share, in each case subject to adjustment, stockholder approval (to the extent required under the applicable rules of Nasdaq) and certain beneficial ownership limitations. On June 11, 2026, we issued the shares of Series C Preferred Stock and such warrant to Index, and the note, and the Index Outstanding Debt due thereunder, was cancelled. Bjarne Borg, a member of our Board of Directors, is the manager of Index.

 

The terms of the Series C Preferred Stock are set forth in a Certificate of Designation filed with the Secretary of State of the State of Delaware on June 10, 2026. The conversion price of the Series C Preferred Stock is subject to proportional adjustment for stock dividends, stock splits and similar events, and to full-ratchet adjustment in connection with certain dilutive issuances, in each case subject to a floor price of $1.50 per share (with a cash true-up payable if a holder converts following a dilutive issuance that would otherwise have reduced the conversion price below such floor price). If the Series C Preferred Stock were converted in full at the floor price, we would issue up to 4,779,333 shares of common stock, not taking into account any dividends that may be paid in additional shares of Series C Preferred Stock. Dividends accrue on the Series C Preferred Stock at a rate of 8% per annum, compounding quarterly (increasing to 9% per annum if not paid in cash), and may be paid in cash, in additional shares of Series C Preferred Stock or by an increase in the stated value of the Series C Preferred Stock. Holders of the Series C Preferred Stock may not convert shares of Series C Preferred Stock to the extent that, after giving effect to such conversion, the holder, together with its affiliates, would beneficially own in excess of 4.99% (or, upon at least 61 days’ prior notice to us, up to 19.99%) of our outstanding common stock. See Part I, Item 1. Financial Statements Note 10 – Stockholder’s Equity included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding the terms of the Series C Preferred Stock. 

 


 

 

July 2026 Board Resignation and Employment Agreement

 

On July 1, 2026, James D. Burnham notified us of his decision to resign, effective as of such date, from his position as a member of our Board of Directors. Mr. Burnham’s resignation was not related to any disagreement with us on any matter relating to our operations, policies or practices. In connection with his resignation, effective July 1, 2026, we entered into an employment agreement with Mr. Burnham, pursuant to which Mr. Burnham serves as our Director of Growth & M&A for an initial one-year term, subject to automatic one-year renewals unless either party provides notice of non-renewal at least 30 days prior to the expiration of the then-current term, at an annual base salary of $275,000, with a discretionary bonus of up to 15% of his base salary upon the achievement of objectives determined by our Board of Directors and eligibility for six months’ severance upon a termination of his employment by us without cause. The amended and restated consulting agreement, dated June 2, 2025, between us and JDB Consulting Services, Inc., a company controlled by Mr. Burnham, pursuant to which Mr. Burnham previously provided services to us, was deemed terminated as of July 1, 2026.

 

August 2026 Norman Berry Sale Agreement

 

On August 17, 2026, Norman Berry II Owner, LLC (“Norman Berry”), a limited liability company that is 50% owned by us, entered into a Purchase and Sale Agreement (the “Norman Berry Sale Agreement”) with Arbour Valley Development, LLC (the “Norman Berry Purchaser”), pursuant to which Norman Berry agreed to sell an approximately 7.7-acre parcel of land located in East Point, Fulton County, Georgia to the Norman Berry Purchaser for an aggregate purchase price of $2.6 million. Closing is subject to the satisfaction of various conditions, including the Norman Berry Purchaser’s receipt of an allocation of tax credits from the Georgia State Agency under its 2026 application round (the award date for which is expected in March 2027), the completion of the Norman Berry Purchaser’s due diligence and its ability to secure sufficient financing within 180 days following the expiration of the application period. At closing, Norman Berry is expected to apply approximately $800,000 of the proceeds, plus accrued interest, to repay two notes held by us that are secured by the property, with the remaining approximately $1.8 million to be split between the members of Norman Berry, of which our 50% share is expected to be approximately $900,000. There can be no assurance that the transaction will close or, if it closes, that the proceeds will be allocated as described above.

 

September 2026 Peak One Debenture

 

On September 17, 2026, we issued a debenture to Peak One Opportunity Fund, L.P. (“Peak One”) in the principal amount of $310,000 for a purchase price of $250,000, reflecting an original issue discount of $60,000. After payment of a $7,500 closing fee, we received net proceeds of $242,500. The debenture matures on September 17, 2027 and is payable in monthly amortization payments commencing November 18, 2026 with the remaining balance due at maturity. The debenture bears interest at a rate of 10% per annum and is otherwise on substantially the same terms as the debenture we issued to Peak One on January 16, 2026.

 

September 2026 Related Party Debt Exchange

 

On September 30, 2026, we entered into an exchange agreement (the “Burnham Exchange Agreement”) with James D. Burnham, our Director of Growth & M&A and a former member of our Board of Directors, pursuant to which we exchanged $1,446,774.32 of principal and accrued interest (the “Burnham Outstanding Debt”) outstanding under a promissory note, dated June 2, 2025 for (i) 1,441 shares of a newly designated series of Series D Convertible Preferred Stock, par value $0.001 per share (“Series D Preferred Stock”), with a stated value of $1,000.00 per share, which are initially convertible into an aggregate of 497,754 shares of Common Stock at an initial conversion price of $2.895 per share, and (ii) a common stock purchase warrant to purchase up to 124,438 shares of common stock at an initial exercise price of $2.895 per share, which is immediately exercisable and has a term of five years. On September 30, 2026, we issued such securities and the note, and Burnham Outstanding Debt due thereunder, was cancelled. We filed the Certificate of Designation for the Series D Preferred Stock with the Secretary of State of the State of Delaware on October 2, 2026.

 

The Series D Preferred Stock is convertible only following receipt of stockholder approval in accordance with Nasdaq rules, and the conversion of the Series D Preferred Stock and the exercise of the warrant are subject to an exchange cap under Nasdaq rules and to a beneficial ownership limitation of 4.99% (which may be increased by the holder to up to 19.99% upon 61 days’ prior notice). The conversion price of the Series D Preferred Stock is subject to proportional adjustment for stock dividends, stock splits and similar events and to full-ratchet adjustment in connection with certain dilutive issuances, in each case subject to a floor price of $1.50 per share (with a cash true-up payable if a holder converts following a dilutive issuance that would otherwise have reduced the conversion price below such floor price). If the Series D Preferred Stock were converted in full at the floor price, we would issue up to 960,666 shares of common stock, not taking into account any shares of Series D Preferred Stock or adjustments to the stated value that may result from the payment of dividends. Dividends accrue on the Series D Preferred Stock at a rate of 8% per annum, compounding quarterly (increasing to 9% per annum if not paid in cash). The Series D Preferred Stock carries a liquidation preference equal to 150% of its stated value, votes with the common stock on an as-converted basis (subject to the exchange cap and the beneficial ownership limitation) and may be redeemed by us after the 24-month anniversary of issuance at 115% of its stated value (or 110% of its stated value after the 36-month anniversary), plus accrued and unpaid dividends. If our common stock is delisted from Nasdaq for 30 or more consecutive trading days without relisting on an approved exchange, the holder may elect to exchange the Series D Preferred Stock for an unsecured promissory note bearing interest at 10% per annum with a 24-month maturity. See Part I, Item 1. Financial Statements Note 10 – Stockholder’s Equity included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding the terms of the Series D Preferred Stock.

 

November Debt Exchange

 

On November 2, 2026, we entered into an exchange agreement (the “Note Exchange Agreement”) with an accredited investor (the “Investor”), pursuant to which we exchanged $1,022,971.22 of principal and accrued interest outstanding under a February 2026 Note (the “Prior Note”), for (i) a new senior convertible note (the “New Note”) in the principal amount of $1,037,283.93 (an amount equal to 110% of the outstanding principal amount of the Prior Note), and (ii) a common stock purchase warrant to purchase 644,944 shares of common stock, which is equal to 180% of the face value of the New Note divided by $2.895. On November 2, 2026, we issued the New Note and the warrant, and the Prior Note and the outstanding debt due thereunder, was cancelled.

 

The New Note is initially convertible, at the option of the holder, at any time after the date of issuance, into that number of shares of common stock equal to the principal amount of the New Note, plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the initial conversion price of $2.895 per share, subject to adjustment for any stock splits, stock dividends, recapitalizations and similar events. Subject to the receipt of stockholder approval, the holder of the New Note shall have the right, at any time after the receipt of stockholder approval, to convert the New Note, or any portion thereof, into shares of common stock (an “Alternate Conversion”) at a conversion price (the “Alternate Conversion Price”) equal to the greater of (x) a floor price of $0.534 (the “New Note Floor Price”) and (y) 92% of the lowest VWAP in the ten trading days prior to the date of such Alternate Conversion

 

On November 16, 2026, in connection with the November Additional Closing, and as an inducement to the Investor’s agreement to purchase additional securities in the November Additional Closing, we and the Investor entered into an Amendment to Senior Convertible Note (collectively, the “New Note Amendment”), pursuant to which the New Note was amended to provide that, in the event that the Investor elects to convert all or a portion of the New Note in an Alternate Conversion, and the New Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the New Note being converted by the New Note Floor Price, the Company shall also pay to the Investor cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under the New Note shall not exceed the three times the original principal amount of the New Note. Any cash true-up t payments to be made pursuant to the New Note Amendment shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the New Note Amendment amended to the New Note to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities, while the New Note remains outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding New Note and the April 2026 Notes (based on the investors’ respective allocations) at a price equal to 110% of the amount of the New Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the New Note and April 2026 Notes in other cases. 

 

See Part I, Item 1. Financial Statements Note 16 – Subsequent Events included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding the terms of the Note Exchange Agreement, New Note and the warrant issued to the Investor, as well as the New Note Amendment.

 

 

Loeb Refinancing

 

On November 6, 2026, our subsidiaries ZEI and Resource issued a Second Amended and Restated Term Promissory Note (the “2nd A&R Loeb Note”) to Loeb Term Solutions LLC (“Loeb”) in the principal amount of $1,997,780, which amended and restated the note payable to Loeb described in Note 7 – Notes Payable and Notes Payable – Related Party. The 2nd A&R Loeb Note bears interest at the Wall Street Journal prime rate plus 6.5% per annum (the “Loeb Interest Rate”), and is payable in 35 monthly installments of principal and interest, calculated on a five-year amortization schedule, with a final balloon installment of all outstanding principal, accrued interest and other amounts due on the first day of the thirty-sixth month following the effective date (November 1, 2029). Notwithstanding the foregoing, from and after the occurrence of a default under the 2nd A&R Loeb Note, and for so long as such default continues, the applicable interest rate shall be increased to the  Loeb Interest Rate plus 6% per annum. The 2nd A&R Loeb Note was issued to Loeb pursuant to a Second Amended and Restated Credit Agreement entered into by and among the parties, which amends and restates in all respects that Credit and Security Agreement entered into by and among the parties on September 7, 2023, remains secured by equipment of the borrowers, and did not constitute a novation of the existing indebtedness. See Part I, Item 1. Financial Statements Note 16 – Subsequent Events included elsewhere in this Quarterly Report on Form 10-Q for additional information.


 

 

 

45


Table of Contents

 

Results of Operations for the Three Months Ended September 30, 2026 and Three Months Ended September 30, 2025

 

The following table sets forth, for the periods indicated, the dollar value represented by certain items in our Statements of Operations:

 

 

 

For the

 

 

For the

 

 

 

Three Months

 

 

Three Months

 

 

 

Ended

 

 

Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Revenues

 

$

4,485,401

 

 

$

3,515,708

 

Cost of revenue

 

 

2,949,075

 

 

 

2,607,085

 

Total payroll and related expenses

 

 

1,259,570

 

 

 

1,038,146

 

Total general and administrative expenses

 

 

1,496,332

 

 

 

1,275,276

 

Total professional and consulting fees

 

 

754,706

 

 

 

760,840

 

Total marketing and business development expenses

 

 

1,034,464

 

 

 

166,666

 

Total bad debt expense

 

 

-

 

 

 

-

 

Operating loss

 

 

(3,008,746

)

 

 

(2,332,305

)

Interest expense

 

 

(5,660,849

)

 

 

(2,004,260

)

Interest income

 

 

-

 

 

 

(62,325

)

Gain on sale of equipment

 

 

14,093

 

 

 

-

 

Loss on exchange transaction

 

 

(32,794

)

 

 

-

 

Other income

 

 

(2,143

)

 

 

48,569

 

Net loss

 

$

(8,690,439

)

 

$

(4,350,321

)

 

Revenues

 

During the three months ended September 30, 2026 and 2025, we generated revenues of $4,485,401 and $3,515,708, respectively, primarily from logistics, collection, processing and disposal services provided by our subsidiary ZEI ($3,395,298 for the 2026 period), and from the sale of materials, including compost, engineered soils, and mulch, by Resource Group ($1,090,103 for the 2026 period). Revenues also included proceeds from converting a portion of collected waste into saleable materials. This increase of $969,693 resulted from an increased focus in our core business which we acquired in June 2025.

 

Cost of Revenues

 

Cost of revenue for the three months ended September 30, 2026, were $2,949,075 compared to $2,607,085 for the three months ended September 30, 2025. This increase of $341,990 in costs resulted primarily from our corresponding increase in revenue during the three months ended September 30, 2026. Gross profit for the three months ended September 30, 2026 was $1,536,326, representing a gross margin of approximately 34.3%.

 

Payroll and Related Expenses

 

Payroll and related expenses for the three months ended September 30, 2026 were $1,259,570 compared to $1,038,146 for the three months ended September 30, 2025. This increase of $221,424 in expenses resulted primarily from additional employees hired to support the growth of our logistics and compost sales operations following the acquisition of Resource Group.

 

Marketing and Business Development Expenses

 

Marketing and business development expenses for three months ended September 30, 2026 were $1,034,464 compared to $166,666 for the three months ended September 30, 2025. This increase resulted from additional spending on marketing related activities during the three months ended September 30, 2026.

 

46


Table of Contents

 

General And Administrative Expenses

 

General and administrative expenses for three months ended September 30, 2026 were $1,496,332 compared to $1,275,276 for the three months ended September 30, 2025. This increase of $221,056 resulted primarily from increased overhead to support our continued growth in revenues.

 

Professional and Consulting Fees

 

Professional and consulting fees for three months ended September 30, 2026 were $754,706 compared to $760,840 for the three months ended September 30, 2025. 

 

Interest Expense

 

During the three months ended September 30, 2026 and 2025, we incurred $5,660,849 and $2,004,260 of interest expense. This increase of $3,656,589 resulted from an increase in the balance of our notes payable as well as an increase in amortization of debt issuance costs.

 

Interest Income

 

During the three months ended September 30, 2026 and 2025, we earned $0 and we removed $62,325 of interest income, respectively. This resulted from the reversal of accrued interest on loans due to uncertainty of collectability during the three months ended September 30, 2025.

 

Loss on Exchange Transaction

 

During the three months ended September 30, 2026 and 2025, we recognized a loss on exchange transactions of $32,794 and $0, respectively.

 

Results of Operations for the Nine Months Ended September 30, 2026 and Nine Months Ended September 30, 2025

 

The following table sets forth, for the periods indicated, the dollar value represented by certain items in our Statements of Operations:

 

 

 

For the

 

 

For the

 

 

 

Nine Months

 

 

Nine Months

 

 

 

Ended

 

 

Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Revenues

 

$

12,699,431

 

 

$

4,936,388

 

Cost of revenue

 

 

8,473,154

 

 

 

3,476,441

 

Total payroll and related expenses

 

 

3,325,263

 

 

 

2,175,571

 

Total general and administrative expenses

 

 

4,834,143

 

 

 

3,154,765

 

Total professional and consulting fees

 

 

2,508,187

 

 

 

1,228,020

 

Total marketing and business development expenses

 

 

2,332,334

 

 

 

407,105

 

Total bad debt expense

 

 

-

 

 

 

3,025,000

 

Operating loss

 

 

(8,773,650

)

 

 

(8,530,514

)

Interest expense

 

 

(9,802,032

)

 

 

(3,789,105

)

Change in fair value of derivative liability

 

 

(1,268,162

)

 

 

-

 

Loss on settlement of derivative liability

 

 

(3,881,922

)

 

 

-

 

Interest income

 

 

-

 

 

 

(14,653

)

Loss on sale of equipment

 

 

(66,196

)

 

 

-

 

Loss on exchange transaction

 

 

(2,247,921

)

 

 

-

 

Other income

 

 

1,227

 

 

 

80,000

 

Net loss

 

$

(26,038,656

)

 

$

(12,254,272

)

 

47


Table of Contents

 

Revenues

 

During the nine months ended September 30, 2026 and 2025, we generated revenues of $12,699,431 and $4,936,388, respectively, primarily from logistics, collection, processing and disposal services provided by our subsidiary ZEI ($9,612,593 for the 2026 period), and from the sale of materials, including compost, engineered soils, and mulch, by Resource Group ($3,086,838 for the 2026 period). Revenues also included proceeds from the conversion of a portion of collected waste into saleable materials. For the nine months ended September 30, 2025, we generated revenues from commissions on residential real estate purchases and sale transactions amounting to $18,170. This increase of $7,763,043 resulted from the acquisition of Resource Group during 2025 and the resulting change of focus in our core business.

 

Cost of Revenues

 

Cost of revenue for the nine months ended September 30, 2026, were $8,473,154 compared to $3,476,441 for the nine months ended September 30, 2025. This increase of $4,996,713 in costs resulted primarily from additional revenues generated as a result from the acquisition of Resource Group and the resulting change of focus in our core business. Gross profit for the nine months ended September 30, 2026 was $4,226,277, representing a gross margin of approximately 33.3%.

 

Payroll and Related Expenses

 

Payroll and related expenses for the nine months ended September 30, 2026 were $3,325,263 compared to $2,175,571 for the nine months ended September 30, 2025. This increase of $1,149,692 in expenses resulted primarily from additional employees hired to support the growth of our logistics and compost sales operations following the acquisition of Resource Group.

 

Marketing and Business Development Expenses

 

Marketing and business development expenses for nine months ended September 30, 2026 were $2,332,334 compared to $407,105 for the nine months ended September 30, 2025. This increase resulted from additional spending on marketing related activities during the nine months ended September 30, 2026.

 

General And Administrative Expenses

 

General and administrative expenses for nine months ended September 30, 2026 were $4,834,143 compared to $3,154,765 for the nine months ended September 30, 2025. This increase of $1,679,378 resulted primarily from a full nine months of Resource Group and ZEI operating overhead, including insurance, facility and vehicle-related costs, and from the increased costs of operating as a public company.

 

Professional and Consulting Fees

 

Professional and consulting fees for nine months ended September 30, 2026 were $2,508,187 compared to $1,228,020 for the nine months ended September 30, 2025. This increase of $1,280,167 resulted primarily from the increased cost of professional fees in relation of being a public company, including increased audit and accounting fees, legal fees associated with our financing transactions and registration statements, and consulting fees supporting the integration of Resource Group. 

 

Interest Expense

 

During the nine months ended September 30, 2026 and 2025, we incurred interest expense of $9,802,032 and $3,789,105, respectively. This increase of $6,012,927 resulted from an increase in the balance of our notes payable as well as an increase in amortization of debt issuance costs.

 

48


Table of Contents

 

Change in fair value of derivative liability

 

During the nine months ended September 30, 2026 and 2025, we incurred $1,268,162 and $0 of change in fair value. This increase of $1,268,162 resulted from a derivative liability balance during the nine months ended September 30, 2026.

 

Loss on settlement of derivative liability

 

During the nine months ended September 30, 2026 and 2025, we incurred $3,881,922 and $0 of loss on settlement. This increase of $3,881,922 resulted from the settlement of derivative liability balance during the nine months ended September 30, 2026.

 

Interest Income

 

During the nine months ended September 30, 2026 and 2025, we earned $0 and we removed $14,653 of interest income, respectively. This resulted from the reversal of accrued interest on loans due to uncertainty of collectability during the three months ended September 30, 2025.

 

Loss on Exchange Transaction

 

During the nine months ended September 30, 2026 and 2025, we recognized a loss on exchange transactions of $2,247,921 and $0, respectively.

 

Income Tax Provision

 

A 100% valuation allowance was provided against the deferred tax asset consisting of available net operating loss carry forwards and, accordingly, no income tax benefit was provided.

 

Liquidity and Capital Resources

 

We have generated limited revenue and have incurred significant net losses in each year since inception. For the nine months ended September 30, 2026, we incurred a net loss of $26,038,656 as compared to a net loss of $12,254,272 for the nine months ended September 30, 2025. We expect to incur increasing losses in the future. As of September 30, 2026 and December 31, 2025, we had cash of $201,379 and $54,066, respectively. Since becoming a public company, we have funded our operations through note financings, project level financings, and the issuance of our equity and debt securities. See Part I, Item 1. Financial Statements; Note 7– Notes Payable and Notes Payable– Related Party, Note 10 – Stockholder’s Equity and Note 16-Subsequent Events. We intend to continue to finance our operations and finance Resource Group’s expansion if needed from the proceeds of future financings, proceeds from the sale of properties, and future revenues from operations. As of the date of the filing of this Quarterly Report on Form 10-Q, we do not have any committed sources of financing.  Although the April 2026 Purchase Agreement provides for the funding of up to an additional $84,000,000, such funding is subject to the purchasers’ discretion and our ability to meet certain conditions and there can be no assurance that we will be able to access such funding. Additional financing will be required to continue operations, which may not be available at acceptable terms, if at all. There is no guarantee we will be successful in raising capital outside of our current sources. In addition, under the purchase agreements from our recent private placement offerings, we are subject to certain restrictive covenants that may make it difficult for us to procure additional financing.Our current cash, together with the net proceeds of the November Additional Closing under the April 2026 Purchase Agreement completed in November 2026, is anticipated to be sufficient to fund operations into the first quarter of 2027.  We expect that we will need additional future financing in the near term which may not be available on acceptable terms, if at all. These and other factors raise substantial doubt about our ability to continue as a going concern. The report of our independent registered public accounting firm includes an explanatory paragraph that our auditors have expressed substantial doubt that we will be able to continue as a going concern.

 

49


Table of Contents

 

Financing Activities

 

The following table represents our financing activities during the nine months ended September 30, 2026. See Part I, Item 1. Financial Statements Note 7– Notes Payable and Notes Payable– Related Party, Note 10 -Stockholder’s Equity to the financial statements included elsewhere in this Quarterly Report for additional information regarding our financing activities.

 

 

 

Balance as of

 

 

 

 

​

 

 

 

​

 

Balance as of

 

 

 

December 31,

 

 

 

 

​

 

Payments or

 

 

September 30,

 

 

 

2025

 

 

Additions

 

 

Conversions

 

 

2026

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

LV Note

 

$

1,000,000

 

 

$

-

 

 

$

-

 

 

$

1,000,000

 

2nd Lien Note

 

 

1,000,000

 

 

 

-

 

 

 

-

 

 

 

1,000,000

 

New BCV Loan Agreement

 

 

2,000,000

 

 

 

1,738,400

 

 

 

-

 

 

 

3,738,400

 

1800 Diagonal Notes

 

 

478,610

 

 

 

489,310

 

 

 

(493,480

)

 

 

474,440

 

Cedar Cash Advances

 

 

427,000

 

 

 

138,000

 

 

 

(514,944

)

 

 

50,056

 

CFG Merchant Solutions

 

 

-

 

 

 

278,000

 

 

 

-

 

 

 

278,000

 

Boot Capital

 

 

87,750

 

 

 

-

 

 

 

(87,750

)

 

 

-

 

Sixth Borough

 

 

250,000

 

 

 

-

 

 

 

(250,000

)

 

 

-

 

Member Note

 

 

480,000

 

 

 

-

 

 

 

-

 

 

 

480,000

 

Peak One

 

 

-

 

 

 

620,000

 

 

 

(310,000

)

 

 

310,000

 

Anson East Master Fund LP

 

 

-

 

 

 

6,720,000

 

 

 

(1,275,000

)

 

 

5,445,000

 

Anson Investment Master Fund LP

 

 

-

 

 

 

9,105,000

 

 

 

(4,462,500

)

 

 

4,642,500

 

Alto Opportunity Master Fund, SPC

 

 

-

 

 

 

3,376,973

 

 

 

(212,500

)

 

 

3,164,473

 

Acquisition Related Notes and Additional Equipment Loan and Cash Advances *

 

 

15,788,293

 

 

 

2,143,051

 

 

 

(7,344,820

)

 

 

10,586,524

 

 

 

$

21,511,653

 

 

$

24,608,734

 

 

$

(14,950,994

)

 

$

31,169,393

 

 

 

*

Includes notes payable amounts acquired in connection with the Resource Group acquisition, as well as additional financing needs of our Resource and ZEI activities.

 

Cash Flow Summary

 

 

 

For the

 

 

For the

 

 

 

Nine Months

 

 

Nine Months

 

 

 

Ended

 

 

Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Net cash provided by (used in):

 

 

 

​

 

 

 

​

Operating activities

 

$

(7,398,530

)

 

$

(425,565

)

Investing activities

 

 

(2,191,941

)

 

 

129,774

 

Financing activities

 

 

9,737,784

 

 

 

(107,079

)

Net change in cash and cash equivalents

 

$

147,313

 

 

$

(402,870

)

 

50


Table of Contents

 

Operating activities used net cash of $7,398,530 during the nine months ended September 30, 2026, and used net cash of $425,565 during the nine months ended September 30, 2025. Cash used in operating activities increased by $6,972,965 due to an increase of net loss of $13,784,384, partially offset by a $5,150,084 increase in the change in fair value of and loss on settlement derivative liabilities as well as $2,247,921 in loss on exchange transaction. Additional factors impacting operating cash flows included an increase in depreciation expense of $1,005,747, an increase in amortization of debt issuance costs of $4,514,817, and a decrease in stock-based compensation of $177,011, as well as common stock issued for services of $221,558 in 2026 compared to no such issuance in 2025. Changes in operating assets and liabilities also contributed to the increase in cash used, which amounted to $2,473,635 during 2026 compared to $5,414,752 during 2025.

 

Investing activities used net cash of $2,191,941 during the nine months ended September 30, 2026, and provided net cash of $129,774 during the nine months ended September 30, 2025, which is an increase in cash used of $2,321,715. This change results from an increase in proceeds from sale of property and equipment of $39,093, decrease in intangible assets of $6,668, increase in the purchase of property and equipment of $2,033,169, and an increase in additions to equity based investments $21,300.

 

Cash provided from financing activities was $9,737,784 during the nine months ended September 30, 2026, which resulted from $2,416,365 in debt issuance costs paid, $191,245 in finance lease payments, increased by $18,582,820 proceeds from short-term note payable, $3,468,237 in repayments of short-term notes payable and $2,769,189 of cash payments on derivative liabilities. Cash used in financing activities was $107,079 during the nine months ended September 30, 2025, which resulted from $361,477 debt issuance costs paid, increased by $1,756,892 proceeds from short-term note payable, $2,276,653 in repayments of short-term notes payable, $233,414 received from warrant exercises, $602,835 received from the issuance of common stock, $62,032 payments on finance lease and $58 from payment related to stock splits. 

 

Off-Balance Sheet Arrangements

 

As of September 30, 2026 and December 31, 2025, we had no material off-balance sheet arrangements to which we are a party.

 

Critical Accounting Estimates

 

Our financial statements have been prepared using generally accepted accounting principles in the United States of America (“GAAP”). In connection with the preparation of the financial statements, we are required to make assumptions and estimates and apply judgments that affect the reported amounts of assets, liabilities, revenue, and expenses, and the related disclosures. We base our assumptions, estimates, and judgments on historical experience, current trends, and other factors that we believe to be relevant at the time the financial statements are prepared. On a regular basis, we review the accounting policies, assumptions, estimates, and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

 

Our significant accounting policies are discussed in “Note 2— Summary of Significant Accounting Policies” of the notes to our financial statements for the nine months ended September 30, 2026 and the year ended December 31, 2025 included elsewhere in this Form 10-Q. We believe that the following accounting policies are the most critical in fully understanding and evaluating our reported financial results.

 

51


Table of Contents

 

Investment Entities — The Company obtained a 50% membership interest in Norman Berry. The purpose of the investment in Norman Berry is to develop and provide affordable housing in the Atlanta, Georgia metropolitan area. The Company has determined it is not the primary beneficiary of Norman Berry and thus does not consolidate the activities in its financial statements. The Company uses the equity method to report the activities as an investment in its condensed consolidated financial statements. As of September 30, 2026 the Company continued to hold a 50% interest in Norman Berry. The Norman Berry partnership recently obtained final city council and entitlement approval for the project. The next step involves completing the consolidation of the various lots into a single parcel, and the Company’s development team and surveyors are preparing the required documentation and submittals for city review and approval. Survey documents reflecting the approved M-I zoning designation are expected to be submitted to the city’s Planning Department for administrative review to obtain final parcel-map approval.In August 2026, Norman Berry entered into the Norman Berry Sale Agreement to sell the East Point property for $2.6 million, subject to the closing conditions described under “Recent Developments” above.

 

During the nine months ended September 30, 2026 and 2025, Norman Berry did not have any material earnings or losses as the investments are in development. In addition, management believes there was no impairment as of September 30, 2026 and December 31, 2025.

 

Property, plant and equipment — Property, plant and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated lives of each asset. Repairs and maintenance are charged to expense when incurred. Included in property, plant and equipment, are recoverable reserves acquired in connection with the Resource acquisition described below. Such reserves represent the approximately 9 million tons of entitled sand reserves on the land obtained in connection with the Resource acquisition as well. The estimated amount was based on third-party engineering and appraisal reports. Cost depletion on these depletable reserves is based upon units-of-production.

 

Intangible assets — Intangible assets consist of $22,210 of website costs that will be amortized over 5 years, $5,458,400 of trade name that will be amortized over 15 years, and $6,368,100 of a license agreement that will be amortized over 10 years which is the life of the license.

 

Project Development Costs — Project development costs are stated at cost. At September 30, 2026 and December 31, 2025, the Company’s project development costs are expenses incurred related to development costs on various projects that are capitalized during the period the project is under development.

 

JOBS Act

 

The JOBS Act permits an emerging growth company such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to avail ourselves of the extended transition period for complying with new or revised financial accounting standards.

 

We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year (a) following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act, (b) in which we have total annual revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which generally means the market value of our common equity that is held by non-affiliates exceeds $700 million as of the end of the prior fiscal year’s second fiscal quarter; and (2) the date on which we have issued more than $1 billion in non-convertible debt securities during the prior three-year period.

 

52


Table of Contents

 

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.  

 

ITEM 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation, as of the end of the period covered by this report, of the effectiveness of our disclosure controls and procedures, as such term is defined in Exchange Act Rule 13a-15(e). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that as of the end of the period covered by this report, our disclosure controls and procedures, as defined in Rule 13a-15(e), were effective at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

During the fiscal quarter ended September 30, 2026 there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Controls

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

53


Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. Legal Proceedings

 

The information included in “Note 14 - Commitments and Contingencies” of our condensed consolidated financial statements included elsewhere in this Quarterly Report Form on 10-Q is incorporated by reference into this Item.

 

ITEM 1A. Risk Factors  

 

Except as set forth below, there have been no material changes in our risk factors from the risks previously reported in Part I, Item 1A, “Risk Factors” of our 2025 10-K. You should carefully consider the factors discussed here and in our 2025  10-K, which could materially affect our business, financial condition or future results. The risks described here and in our 2025  10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

 

Our auditors have expressed substantial doubt about our ability to continue as a going concern.

 

We have generated limited revenue and have incurred significant net losses in each year since inception. For the nine months ended September 30, 2026, we incurred a net loss of $26,038,656 as compared to a net loss of $12,254,272 for the nine months ended September 30, 2025. We expect to incur increasing losses in the future. We cannot offer any assurance as to our future financial results. Our inability to achieve profitability from our current operating plans or to raise capital to cover any potential shortfall would have a material adverse effect on our ability to meet our obligations as they become due. If we are not able to secure additional funding, if, and when needed, we would be forced to curtail our operations or take other action in order to continue to operate. These and other factors raise substantial doubt about our ability to continue as a going concern. If we are unable to meet our obligations and are forced to curtail or cease our business operations, our stockholders could suffer a complete loss of any investment made in our securities.

 

We will need to raise additional capital to support our long-term business plans and our failure to obtain funding when needed may force us to delay, reduce or eliminate our development plans.

 

During the nine months ended September 30, 2026, our operating activities used net cash of $7,398,530 and as of September 30, 2026, our cash was $201,379. We have experienced significant losses since inception and have a significant accumulated deficit as of September 30, 2026 totaling $58,450,625. We expect to incur additional operating losses in the future and therefore expect our cumulative losses to increase. To date, we have not derived substantial revenue from the properties we own or have an interest in. We expect to potentially generate revenue through our growth of our compost and logistics businesses and sales of property, if any. There is uncertainty as to our ability to monetize our real estate properties or to generate sales proceeds. We expect our expenses to increase as operations increase from our compost and logistics businesses.

 

54


Table of Contents

 

Although we have raised approximately $24.3 million  from the sale of securities in the past twelve months, unless we generate significant revenue from our compost and logistics businesses, we believe we will need to raise additional capital to fund our business expansion plans and we cannot be certain that funding will be available to us on acceptable terms on a timely basis, or at all. To meet our financing needs, we are considering multiple alternatives, including, but not limited to, additional equity and debt financings. As of the date of the filing of this Quarterly Report on Form 10-Q, we do not have any committed sources of financing. Although the April 2026 Purchase Agreement provides for the funding of up to an additional $84,000,000, such funding is subject to the purchasers’ discretion and our ability to meet certain conditions and there can be no assurance that we will be able to access such funding. Our ability to raise capital through the sale of securities may be limited by various rules of the SEC and Nasdaq that place limits on the number and dollar amount of securities that we may sell. Any additional sources of financing will likely involve the issuance of our equity or debt securities, which will have a dilutive effect on our stockholders. To the extent that we raise additional funds by issuing equity securities, our stockholders may experience significant dilution. Any debt financing, if available, may involve restrictive covenants that may impact our ability to conduct our business. Our current outstanding debentures prohibit us from engaging in certain types of financing while the debentures are outstanding. If we fail to raise additional funds on acceptable terms, we may be unable to complete planned development work.

 

Under the February 2026 Purchase Agreement and April 2026 Purchase Agreement, we are subject to certain restrictive covenants that may make it difficult to procure additional financing.

 

The February 2026 Purchase Agreement and April 2026 Purchase Agreement contain restrictive covenants which restrict our ability to issue securities or file additional registration statements , including, under the April 2026 Purchase Agreement, restrictions on the issuance of common stock and common stock equivalents until 30 trading days following the effectiveness of each applicable resale registration statement, a prohibition on Variable Rate Transactions (as defined therein) for so long as the April 2026 Notes remain outstanding, and the right of the purchasers to participate in up to 50% of certain subsequent financings, including debt financings, until 12 months after the April 2026 Notes are no longer outstanding.  If we require additional funding while these restrictive covenants remain in effect, we may be unable to effect a financing transaction on terms acceptable to us, or at all, while also remaining in compliance with the terms of the respective purchase agreements, or we may be forced to seek a waiver from the purchasers party to the February 2026 and April 2026 Purchase Agreements, which such purchasers are not obligated to grant to us.

 

On April 8 and April 9, 2026, we entered into a consent and waiver agreement extending certain deadlines under the February 2026 Purchase Agreement; our failure to satisfy our remaining obligations thereunder could result in additional covenant remedies or require further negotiation with the investors.

 

Pursuant to the consent and waiver agreement entered into with the investors in the February 2026 Private Placement on April 8 and April 9, 2026, we obtained extensions of the deadlines by which we must (i) file a proxy statement and hold a stockholder meeting to obtain stockholder approval of the exercise of the Second February Warrants; and (ii) cause an initial registration statement registering the resale of the shares of Common Stock issuable upon conversion and exercise of the February 2026 Notes and certain of the February 2026 Warrants to be declared effective by the SEC. Stockholder approval was obtained at our 2026 Annual Meeting held on June 12, 2026, satisfying the extended proxy and stockholder meeting deadlines and the initial resale registration statement related to the February 2026 Private Placement was declared effective on April 15, 2026. However, as of the date of this Quarterly Report on Form 10-Q, we have not filed an additional registration statement to register the shares of common stock issuable upon exercise of the Second February 2026 Warrants, and are therefore not in compliance with all of our remaining obligations.

 

55


Table of Contents

 

A registration default under the Registration Rights Agreement we entered into in connection with the April 2026 Private Placement could result in liquidated damages obligations that would adversely affect our cash position.

 

Pursuant to the Registration Rights Agreement, as amended by the April 2026 SPA & RRA Amendment  (the “April 2026 RRA”) that we entered into with the investors in connection with the April 2026 Private Placement, we are obligated to file and maintain the effectiveness of one or more registration statements covering the resale of the shares of common stock issuable upon conversion of the Initial April 2026 Notes and Second April 2026 Notes, additional shares of our common stock that may become issuable under the Initial April 2026 Notes and Second April 2026 Notes as a result of an Alternate Conversion, as well certain additional shares of our common stock that may be issuable upon conversion or exercise of additional April 2026 Notes or April 2026 Warrants  that we may sell and issue to the purchasers in one or more Additional closings pursuant to the April 2026 Purchase Agreement. Pursuant to the April 2026 RRA, if we fail to satisfy our registration obligations under the April 2026 RRA, including by failing to file or obtain or maintain the effectiveness of the required registration statements within specified time frames, we may be required to pay liquidated damages to the investors.


 

Unless waived by the investors, we may be required to pay liquidated damages due to our failure to fulfill all of our obligations under the April 2026 RRA. 

 

Our processing and transportation operations depend on a fleet of specialized equipment financed through multiple lenders, and the unavailability of equipment or equipment financing could impair our operational capacity.

 

Our biomass recycling and logistics operations rely on a fleet of specialized processing equipment and transportation vehicles, including trommel screeners, grinders, shredders, and grapple trucks, a significant portion of which is financed through secured lending arrangements with third-party lenders. Effective December 30, 2025, our wholly owned subsidiary Resource Group LLC entered into two Negotiable Promissory Notes and Security Agreements with Commercial Credit Group in the aggregate original principal amount of approximately $2.55 million to finance the acquisition of a Komptech Crambo shredder and a Diamond Z horizontal grinder. These notes are secured by substantially all of the assets of Resource Group LLC. A default under any of our equipment financing arrangements, or our inability to obtain financing for additional equipment on commercially reasonable terms, could impair our operational capacity and adversely affect our business, financial condition, and results of operations.

 

Our legacy real estate monetization efforts are subject to significant execution risk, and we may not realize the anticipated proceeds from our legacy real estate portfolio.

 

We continue to pursue the monetization of our legacy real estate holdings, including through sales, joint ventures, and conveyances to secured creditors. On January 6, 2026, our wholly owned subsidiary LV Peninsula Holding, LLC delivered a Deed in Lieu of Foreclosure conveying title to our Lake Travis project site in Lago Vista, Texas, to an institutional lender in exchange for the conditional extinguishment of $5.0 million of outstanding secured debt. Although we retain the right to receive 70% of any net sale proceeds above $5.0 million upon the lender’s disposition of the Lago Vista property, and we may receive payment on a conditional $5.0 million promissory note issued by LV Peninsula in certain circumstances, there can be no assurance that any such proceeds or payments will be realized or that the amounts realized will be material. Additional risks affect our remaining legacy real estate holdings, including the Norman Berry Village joint venture in East Point, Georgia (as to which the first lien note held by us matured on March 11, 2025 and remains in default),and as to which the joint venture entered into an agreement in August 2026 to sell the property for $2.6 million, subject to the purchaser’s receipt of an allocation of state tax credits, its ability to obtain financing and other conditions that may not be satisfied),  our interest in JDI-Cumberland Inlet, LLC (which filed for bankruptcy protection in May 2025, and from which we have not received any proceeds as of the date of this Quarterly Report), and the McLean Mixed Use Site in Durant, Oklahoma (subject to a Lis Pendens filed by the Durant Industrial Authority). Any failure to monetize our legacy real estate holdings on commercially reasonable terms, or at all, could adversely affect our liquidity and financial position.

 

We are dependent on a limited number of customers and a limited number of commercial drivers, and the loss of key customers or drivers could adversely affect our business.

 

Our biomass recycling and logistics businesses currently serve a limited set of customers, including municipal entities, construction contractors, landscaping companies, and a multi-billion-dollar national waste management company. In addition, our logistics operations depend on a small number of licensed commercial drivers. The loss of any significant customer, or an inability to recruit, train, and retain qualified drivers, could materially impair our transportation capacity and revenues, adversely affect our margins, and require us to incur incremental costs to replace lost business or personnel.

 

56


Table of Contents

 

We are subject to extensive federal, state, and local environmental laws and regulations, and changes in those laws and regulations may increase our operating costs or expose us to liability.

 

Our engineered soils, remediation, organics processing, and logistics operations involve the handling, transport, and processing of materials that are subject to federal, state, and local environmental laws and regulations, including without limitation the Comprehensive Environmental Response, Compensation, and Liability Act. Liability under such laws may be imposed on a strict, joint and several basis, and may be imposed even for contamination not caused by our own operations. Changes in environmental laws, regulations, or enforcement priorities including policies relating to landfill bans, organics diversion mandates, air quality, and water quality could impose additional costs and limitations on our operations and adversely affect our competitive position.

 

We face risks related to supply of organic feedstocks, vehicle and equipment supply chains, fuel costs, and material price volatility, any of which could adversely affect our margins.

 

Our operations rely on a consistent and cost-effective supply of organic feedstocks, amendments, vehicle fuel, and specialized equipment. Disruptions in the supply chain for any of these inputs, or sustained increases in fuel or input costs, could reduce our operating margins, impair our ability to fulfill customer orders, and adversely affect our business, financial condition, and results of operations.

 

A substantial portion of our outstanding indebtedness has matured or requires significant payments in the near term, and our failure to repay, refinance or restructure such indebtedness could materially and adversely affect our business, financial condition and results of operations.

 

A significant portion of our outstanding indebtedness has matured or requires substantial debt service payments in the near term.  The Initial April 2026 Notes, of which $5,200,000 aggregate principal amount was outstanding as of the date hereof, mature on May 4, 2027,  the Second April 2026 Notes, in the aggregate principal amount of $6,228,988 mature on August 26, 2027, and t and the Second April 2026 Notes, of which $5,662,716.07 aggregate principal amount was outstanding as of the date hereof, mature on August 26, 2027. he additional April 2026 Notes, in the aggregate principal amount of $3,000,000, sold in the November Additional Closing mature on November 16, 2027, in each case subject to extension in certain circumstances, to the extent not earlier converted. The New Note, in the principal amount of $1,037,283.93, will mature on November 2, 2027. In addition, as a result of the April 2026 Note Amendments and the New Note Amendment entered into on November 16, 2026, we may be required to make significant cash true up payments, in an amount not to exceed three times the original principal amount of such notes, in the event that the holders of the April 2026 Notes or the New Note convert all or a portion of their notes in an Alternate Conversion at the Floor Price and may also be required to use a significant portion of any amounts that we receive from future payments to redeem outstanding April 2026 Notes and the New Note.  Our note payable to Loeb requires a payment of approximately $1.8 million at its September 7, 2027 maturity. In November 2026, we refinanced our note payable to Loeb; the 2nd A&R Loeb Note, in the principal amount of $1,997,780, bears interest at the prime rate plus 6.5% per annum, amortizes on a five-year schedule and requires a balloon payment of the remaining balance at its maturity three years after issuance; provided, however, that such interest rate shall be increased by 6% in the event of, and for the duration of, any event of default under the 2nd A&R Loeb Note. In addition, certain of our notes payable, including a $2.5 million mortgage note payable to the Gail Baird Foundation that matured on April 21, 2025 and a $50,000 note that matured on April 30, 2025, were not repaid at maturity; although the applicable lenders have not declared these notes in default and we have continued to pay interest thereon, the lenders could elect to exercise remedies, and unpaid matured indebtedness could trigger cross-default provisions in our other debt instruments. If we are unable to pay, refinance, restructure or otherwise satisfy our indebtedness as it becomes due, whether with the proceeds of other financings or cash from operations, our lenders could exercise remedies against us and our assets, including collateral securing certain of these obligations, and we could be forced to curtail our operations, which would materially and adversely affect our business, financial condition and results of operations.

 

We have made a significant investment in the Microtec UTM 1200 Turbo Mill system at our Myakka City facility, and we may not complete commissioning on our anticipated timeline or realize the anticipated benefits of the system.

 

We have invested in excess of $1.8 million (payments to date approximately $1.8 million against an approximately $2.0 million program) in the UTM 1200 system and its related structure at our Myakka City facility. As of the date of this Quarterly Report on Form 10-Q, material handling integration, electrical interconnection and energization, and commissioning of the system have not been completed. The completion of these milestones depends on third-party contractors, equipment suppliers and the regional electric utility, which are out of our control and may be delayed or cost more than we anticipate. Even if the system is commissioned on our expected timeline, it may not achieve its anticipated throughput or product specifications, and we may be unable to develop customer demand for engineered substrate products at the volumes, prices and margins we anticipate. Any of these events could materially adversely affect our business, financial condition and results of operations.


 

 

Risks Related to Our Common Stock

 

The 1-for-20 Reverse Stock Split may not achieve its intended effect and may adversely affect the liquidity of our common stock.

 

On March 26, 2026, we effected the 1-for-20 Reverse Stock Split. The Reverse Stock Split reduced the number of our outstanding shares of common stock from approximately 50,000,000 to approximately 2,507,537. Although the Reverse Stock Split was effected to, among other things, raise the per-share trading price of our common stock to allow for continued listing on The Nasdaq Capital Market, there can be no assurance that the Reverse Stock Split will have the desired effect of sufficiently raising the per-share trading price of our common stock over the long term, that any resulting price level will be maintained, or that the Reverse Stock Split will not adversely affect the liquidity of our common stock. For example, since completion of the Reverse Stock Split, the price of our common stock has dropped and, as of November 10, 2026, the closing price of our common stock was $1.03,  which is below the $1.00 minimum price required by Nasdaq.  In addition, the reduction in the number of outstanding shares may decrease trading volume, increase price volatility, and adversely affect the market price of our common stock. In addition, on June 12, 2026, our stockholders approved an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of our Board of Directors, an additional reverse stock split of our issued and outstanding common stock at a ratio of between 1-for-5 and 1-for-10. If our stock price does not increase, we may be required to effect another reverse stock split in order to satisfy the continued listing requirements of Nasdaq. If our Board of Directors effects such a reverse stock split, it would further reduce the number of our outstanding shares of common stock and would be subject to the same risks described above, and there can be no assurance that it would achieve its intended effects.

 

57


Table of Contents

 

If we fail to comply with the continued listing requirements of Nasdaq, our common stock may be delisted and the price of our Common Stock and our ability to access the capital markets could be negatively impacted.

 

Our common stock is currently listed for trading on Nasdaq. We must satisfy Nasdaq’s continued listing requirements, including, among other things, a minimum stockholders’ equity of $2.5 million and a minimum closing bid price of $1.00 per share or risk delisting, which would have a material adverse effect on our business. A delisting of our common stock from Nasdaq could materially reduce the liquidity of our common stock and result in a corresponding material reduction in the price of our common stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities.

 

On January 26, 2026, we received a letter from Nasdaq notifying us that for the preceding 30 consecutive business days (December 5, 2025 through January 20, 2026), our common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”). The notice had no immediate effect on the listing or trading of our common stock, which continues to trade on the Nasdaq Capital Market under the symbol “RENX.” In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we had a compliance period of 180 calendar days, or until July 27, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). On December 8, 2025, our stockholders approved and authorized us to amend our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split at a ratio of 1-for-5 to 1-for-20, and on March 26, 2026, we effected the 1-for-20 reverse stock split of our then-outstanding common stock. Nasdaq Listing Rule 5810(c)(3)(A)(iv) states that any listed company that fails to meet the Minimum Bid Price Requirement and has effected a reverse stock split over the prior one-year period, or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, will not be eligible for an automatic 180-day grace compliance period and the Nasdaq Listing Qualifications Department is obligated to immediately issue a delisting determination if it should fail to meet any continued listing requirements. Therefore, if we were to fail to meet any continued listing requirements within the applicable time periods we would immediately be issued a delisting determination. Further, the Nasdaq rule provides that a company will not be considered to have regained compliance with the minimum bid price requirement if the company takes an action to achieve compliance (such as a reverse split) and that action results in its security falling below the numeric threshold for another listing requirement.

 

On April 10, 2026, we received written notice (“Listing Notification”) from the Listing Qualifications staff of Nasdaq notifying us that we had regained compliance with the Minimum Bid Price Requirement and, accordingly, we had regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter was now closed. However, as of November 10, 2026, the closing price of our common stock was $1.03, which is below the Minimum Bid Price Requirement. If our common stock were to fail to satisfy the Minimum Bid Price Requirement for a period of thirty consecutive business days before the one-year anniversary of our last reverse stock split, we would not be eligible for a compliance period, and Nasdaq would be required to immediately issue a delisting determination. If our stock price does not increase, we may be required to effect another reverse stock split in the near term in order to satisfy the continued listing requirements of Nasdaq, which we have the right to do, at a ratio of between 1-for-5 and 1-for-10, pursuant to the approvals that we received from our stockholders on June 12, 2026.  Conversions of the April 2026 Notes at Alternate Conversion Prices that are below prevailing market prices, the resale of the underlying shares of common stock and continued net losses that reduce our stockholders’ equity could each make it more difficult for us to maintain compliance with Nasdaq’s continued listing requirements.

 

Additionally, Nasdaq recently proposed a new rule change (as amended on June 18, 2026) to (i) adopt Listing Rules 5450(a)(3) and 5550(a)(6) to require issuers listed on the Nasdaq Global and Capital Markets, respectively, to maintain a minimum Market Value of Listed Securities (as defined in Nasdaq Listing Rule 5005(a)(23)) of at least $5.0 million for a period of 30 consecutive business days, and (ii) amend Rule 5810 to suspend trading and immediately delist from Nasdaq securities of issuers that do not satisfy the proposed new requirements, and Rule 5815 to set forth the procedures for requesting a hearing before a Hearings Panel and the scope of the Panel’s discretion (collectively, the “Proposed $5 Million MVLS Rule”). On April 28, 2026, the SEC notified Nasdaq that it had determined to delay the implementation of the new standards to seek additional public feedback on the Proposed $5 Million MVLS Rule, providing the public at least 21 days to comment on the proposed rule. On July 22, 2026, the SEC approved the Proposed $5 Million MVLS Rule, permitting Nasdaq to implement the rule. However, subsequently on July 29, 2026, the implementation of the Proposed $5 Million MVLS Rule was automatically stayed after notices of petition were filed. As of November 10, 2026, the market value of our listed securities was approximately $3.3 million, which is below the $5.0 million minimum that would be required under the Proposed $5 Million MVLS Rule. If the stay on the implementation of the Proposed $5 Million MVLS Rule is lifted and the market value of our listed securities does not meet the $5.0 million requirement as of the date it goes into effect, our securities will be subject to delisting.

 

 

 

58


Table of Contents

 

There is no assurance that we will maintain compliance with all applicable requirements for continued listing on Nasdaq. If our common stock were delisted from Nasdaq, trading of our common stock would most likely take place on an over-the-counter market established for unlisted securities, such as the OTCQB or the Pink Market maintained by OTC Markets Group Inc. An investor would likely find it less convenient to sell, or to obtain accurate quotations in seeking to buy, our common stock on an over-the-counter market, and many investors would likely not buy or sell our common stock due to difficulty in accessing over-the-counter markets, policies preventing them from trading in securities not listed on a national exchange or other reasons. In addition, as a delisted security, our common stock would be subject to SEC rules as a “penny stock,” which impose additional disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with the typically higher cost per trade to the investor of penny stocks due to factors such as broker commissions generally representing a higher percentage of the price of a penny stock than of a higher-priced stock, would further limit the ability of investors to trade in our common stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities. For these reasons and others, delisting would adversely affect the liquidity, trading volume and price of our common stock, causing the value of an investment in us to decrease and having an adverse effect on our business, financial condition and results of operations, including our ability to attract and retain qualified employees and to raise capital.

 

The conversion of our senior convertible notes and the exercise of our outstanding warrants, preferred stock, and other convertible securities could result in substantial dilution to our stockholders.

 

As of the date hereof, we had outstanding First February 2026 Warrants (exercisable for shares of our common stock at an initial exercise price of $3.1188 per share), Second February 2026 Warrants (which became exercisable upon receipt of stockholder approval on June 12, 2026, at an initial exercise price of $3.1188 per share), Initial April 2026 Notes, the Second April 2026 Notes and the additional April 2026 Notes issued in the November Additional Closing (each convertible into shares of common stock at an initial conversion price of $2.895, which is subject to adjustment down to the April 2026 Note Floor Price), Initial April 2026 Warrants, the Second April 2026 warrants, and additional April 2026 Warrants issued in the November Additional Closing (each exercisable at an exercise price of $2.67 per share) shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock (convertible into shares of our common stock at an initial conversion price of $2.895 per share, subject to full-ratchet adjustment for certain dilutive issuances with a floor price of $1.50 per share and a cash true-up in certain circumstances), Series D Preferred Stock (convertible, following receipt of stockholder approval, into shares of our common stock at an initial conversion price of $2.895 per share, subject to full-ratchet adjustment for certain dilutive issuances with a floor price of $1.50 per share and a cash true-up in certain circumstances) a warrant to purchase up to 619,084 shares of our common stock issued to Index Equity US, LLC in June 2026, which is exercisable at an initial exercise price of $2.895 per share, a warrant to purchase up to 124,438 shares of our common stock issued to James D. Burnham in September 2026, which is exercisable at an initial exercise price of $2.895 per share and various other warrants and rights to acquire shares of our common stock.  The conversion of the foregoing convertible notes, the exercise of the foregoing outstanding warrants, the conversion of outstanding shares of our preferred stock, and the conversion and exercise of derivative securities, could result in the issuance of a substantial number of additional shares of our common stock and substantial dilution to our existing stockholders. Such issuances could also cause the market price of our common stock to decline. In addition, the April 2026 Purchase Agreement provides for the potential funding of up to an additional $84,000,000 and the issuance of additional notes and warrants in additional closings, subject to the purchasers’ discretion and our ability to meet certain conditions, which issuances could also result in substantial dilution to our existing stockholders and also cause the market price of our common stock to decline.

 

A single holder affiliated with a member of our Board of Directors holds shares of Series C Preferred Stock representing substantial voting power, which allows it to exert significant influence over us.

 

In June 2026, pursuant to the Index Exchange Agreement, we issued 7,169 shares of Series C Preferred Stock and a warrant to purchase up to 619,084 shares of common stock to Index Equity US, LLC, an entity managed by Bjarne Borg, a member of our Board of Directors, in exchange for the extinguishment of approximately $7.2 million of related-party indebtedness. The Series C Preferred Stock votes together with our common stock as a single class on an as-converted basis, subject to the applicable beneficial ownership limitation, which is currently set at 4.99% of the number of shares of our common stock outstanding immediately after giving effect to the issuance of shares of common stock as if such shares of Series C Preferred stock had been converted but may be increased up to 19.99% at the election of the holder. As a result, Index Equity US, LLC has significant voting power. Additionally, the holders of a majority of the outstanding Series C Preferred Stock have consent rights over certain corporate actions, including the creation of securities ranking senior to or pari passu with the Series C Preferred Stock. As a result, Index Equity US, LLC is able to exert significant influence over matters submitted to a vote of our stockholders and over corporate actions requiring the consent of the Series C Preferred Stock, and its interests may differ from those of our other stockholders.

 

59


Table of Contents

 

The rights, preferences and privileges of our Series C Preferred Stock and Series D Preferred Stock are senior to those of our common stock and could adversely affect holders of our common stock.

 

Our Series C Preferred Stock and Series D Preferred Stock rank senior to our common stock with respect to the payment of dividends and distributions upon liquidation, accrue dividends at a rate of 8% per annum (increasing to 9% per annum if not paid in cash), and are subject to full-ratchet anti-dilution adjustments in connection with certain dilutive issuances, subject to a floor price. The Series C Preferred Stock and Series D Preferred Stock carry a liquidation preference equal to 150% of its stated value, and the holders of a majority of the outstanding shares of Series C Preferred Stock and Series D Preferred Stock have consent rights over certain corporate actions, including the creation of securities ranking senior to or on parity with the Series C Preferred Stock and Series D Preferred Stock.  In addition, if our common stock is delisted from Nasdaq for 30 or more consecutive trading days, the holder of the Series C Preferred Stock and Series D Preferred Stock may elect to exchange their respective  shares for  unsecured promissory notes bearing interest at 10% per annum. These rights could reduce the amounts available for distribution to holders of our common stock, limit our ability to raise capital or engage in certain transactions, and increase our indebtedness upon a delisting.

 

 The April 2026 Notes are convertible  into shares of our common stock at prices below the prevailing market price, which has resulted, and could continue to result,  in substantial dilution and could depress the trading price of our common stock.

 

 

The holders of the April 2026 Notes have the right, at any time after the later of (i) the date of receipt of stockholder approval, which was obtained on June 12, 2026, and (ii) 120 calendar days following the Initial Closing Date (September 1, 2026) to convert their April 2026 Notes, in whole or in part, into shares of common stock in an Alternate Conversion at a conversion price equal to the greater of (x) the April 2026 Note Floor Price of $0.534 and (y) 92% of the lowest volume-weighted average price of our common stock during the ten trading days preceding the applicable conversion; provided, however, that, in the event that the holder of an April 2026 Note elects to convert all or a portion of their April 2026 Note in an Alternate Conversion, and the April 2026 Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the April 2026 Note being converted by the April 2026 Note Floor Price, we shall also pay to the holder cash as a true-up in an amount equal to the product of  (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under any April 20206 Note shall not exceed the three times the original principal amount of such April 2026 Note. Because Alternate Conversions are priced at a discount to prevailing market prices, they may result in the issuance of a substantial number of shares of common stock at prices below the then-current market price of our common stock, would dilute the interests of our existing stockholders, and could place sustained downward pressure on the trading price of our common stock, particularly if holders convert and sell shares of common stock on a recurring basis. From September 25, 2026 to October 1, 2026, holders of the Initial April 2026 Notes converted $1,100,000 aggregate principal amount of Initial April 2026 Notes, plus $44,000 of accrued interest, into an aggregate of 773,236 shares of common stock at an Alternate Conversion Price of $1.4795 per share. If all of the outstanding Initial April 2026 Notes, Second April 2026 Notes and April 2026 Notes issued in the November Additional Closing were converted at the April 2026 Note Floor Price, assuming that such notes accrue interest at 10% for a period of twelve months, we would be obligated to issue an aggregate of 10,711,613 shares, 11,664,772 and 6,179,776 shares of common stock, respectively, compared to 3,501,979  shares of common stock outstanding as of November 16, 2026. We have registered the resale of up to 30,587,579 shares of common stock issuable upon conversion of the Initial April 2026 Notes and the Second April 2026 Notes and exercise of the Initial April Warrants and Second April 2026 Warrants pursuant to registration statements declared effective on August 5, 2026 and October 14, 2026, and are required to file another registration statement with the SEC to register the up to 8,045,059 shares of common stock that may be issuable upon conversion of the April 2026 Notes and April 2026 Warrants that were issued in the November Additional Closing, and the resale of such shares, or the perception that such resales may occur, could depress the market price of our common stock.


 

 

We currently do not intend to pay dividends on our common stock; consequently, a stockholder’s ability to achieve a return on an investment in our common stock will depend on appreciation in the price of our common stock.

 

We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. The payment of dividends is restricted by the terms of  the April 2026 Notes  and the terms of our Series C Preferred Stock and Series D Preferred Stock, and may be restricted by the terms of future financings. As a result, a stockholder’s ability to achieve a return on an investment in our common stock will depend on appreciation in the price of our common stock.

 

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

We did not sell any equity securities during the quarter ended September 30, 2026, in transactions that were not registered under the Securities Act other than as previously disclosed in our filings with the SEC and as described below.

 

On July 29, 2026, we issued 25,000 restricted shares of our common stock to a consultant with a total value of $43,000 for services provided. The shares were issued in reliance on the exemption from registration provided for under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated thereunder.

 

ITEM 3. Defaults Upon Senior Securities

 

None. 

 

ITEM 4. Mine Safety Disclosures

 

Not applicable.  

 

ITEM 5. Other Information

 

During the third quarter of 2026, none of our directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408(a) of Regulation S-K).

 

Additional Closing of April 2026 Private Placement and April 2026 Note Amendments

 

On November 16, 2026, the Company and the purchasers in the April 2026 Private Placement completed the November Additional Closing, at which the Company sold and issued the purchasers April 2026 Notes in the aggregate principal amount of $3,000,000 (the “November Additional Closing Notes”) together with the April 2026 Warrants to purchase 1,865,283 shares of common stock (the “November Additional Closing Warrants”). Assuming that the November Additional Closing Notes accrued interest at 10% for a period of 12 months, such notes would be convertible into an aggregate of 1,139,898 shares of common stock, based on the Initial April 2026 Conversion Price, and up to 6,179,776 shares of common stock, based on the April 2026 Note Floor Price. The net proceeds to the Company from the November Additional Closing were approximately $2.5 million, after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the Company. 

 

On November 16, 2026, in connection with the November Additional Closing, and as an inducement to the purchasers’ agreement to purchase additional securities in the November Additional Closing, the Company and each of the purchasers of April 2026 Notes and April 2026 Warrants entered into Amendments to Senior Convertible Note (collectively, the “April 2026 Note Amendments”), pursuant to which each of the April 2026 Notes issued and sold to the purchasers in the Initial Closing and the Second Closing were amended to provide that, in the event that the holder of an April 2026 Note elects to convert all or a portion of their April 2026 Note in an Alternate Conversion, and the April 2026 Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the April 2026 Note being converted by the April 2026 Note Floor Price, the Company shall also pay to the holder cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under any April 20206 Note shall not exceed the three times the original principal amount of such April 2026 Note. Any cash true-up payments to be made pursuant to the April 2026 Note Amendments shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the April 2026 Note Amendment amended to the April 2026 Notes to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities while the April 2026 Notes remain outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding April 2026 Notes and New Note (based on the investors’ respective allocations) at a price equal to 110% of the amount of the April 2026 Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the April 2026 Notes New Note and in other cases.

 

The  November Additional Closing Notes and  November Additional Closing Warrants were offered and sold in a private placement pursuant to Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The  November Additional Closing Notes and  November Additional Closing Warrants, and the shares of common stock issuable upon their conversion and exercise, have not been registered and, to the extent not yet issued, will not be registered, under the Securities Act or applicable state securities laws. Accordingly, these securities may not be reoffered or resold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. 

 

The Company relied, in part, on representations made by the purchasers in the April 2026 Purchase Agreement. Each purchaser has represented that it is an “accredited investor” as defined in Regulation D under the Securities Act and that it is acquiring the securities for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof, and appropriate legends will be affixed to the securities. The sale of the securities did not involve a public offering and was made without general solicitation or general advertising. 

 

The foregoing descriptions of the November Additional Closing Notes, November Additional Closing Warrants and the April 2026 Note Amendments do not purport to be complete and are qualified by reference to the full text of the forms of Senior Convertible Note, Warrant and Amendment to Senior Convertible Note, copies of which is attached to this Quarterly Report on Form 10-Q as Exhibits 4.6, 4.2 and 4.7, respectively, and incorporated herein by reference.

 

New Note Amendment

 

On November 16, 2026, in connection with the November Additional Closing, and as an inducement to the Investor’s agreement to purchase additional securities in the November Additional Closing, the Company and the Investor entered into an Amendment to Senior Convertible Note (collectively, the “New Note Amendment”), pursuant to which the New Note was amended to provide that, in the event that the Investor elects to convert all or a portion of the New Note in an Alternate Conversion, and the New Note Floor Price is greater than 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date, then in addition to receiving a number of shares of common stock equal to the quotient obtained by dividing the dollar amount of the New Note being converted by the New Note Floor Price, the Company shall also pay to the Investor cash as a true-up in an amount equal to the product of (i) any bid price of the Company’s common stock, as reported by Bloomberg, selected by the holder from within the twenty minutes immediately preceding the delivery of the applicable conversion notice (or, if such conversion notice is delivered other than during regular trading hours on a trading day, the closing bid price on the most recent trading day ended prior to such delivery) and (ii) the difference obtained by subtracting (I) the number of shares of common stock delivered (or to be delivered) to the holder with respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable amount of the note being converted in the Alternate Conversion by (y) the conversion price calculated using 92% of the lowest VWAP in the ten trading days prior to the applicable conversion date; provided, however, that any cash true-up payments that may be required under the New Note shall not exceed the three times the original principal amount of the New Note. Any cash true-up t payments to be made pursuant to the New Note Amendment shall be paid by the Company to the holder within two business days after the applicable conversion date. In addition to the foregoing, the New Note Amendment amended to the New Note to provide that, subject to certain exempt issuances, in the event that the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity security or equity-linked or related security, any convertible securities any preferred stock or other securities, while the New Note remains outstanding, the holder shall have the right to require the Company to (i) initially, pay any then unpaid and outstanding cash true-up amounts in full and (ii) thereafter, to apply up to 50%, in the event any cash true-up payments are owed as of such date, or 80%, in the event that the holder participates as an investor in such financing, of the gross proceeds from such financings to redeem all, or any portion, of the outstanding New Note and the April 2026 Notes (based on the investors’ respective allocations) at a price equal to 110% of the amount of the New Note being redeemed, which are increases from the 30% of gross proceeds that the holder may require the Company to use to redeem the New Note and April 2026 Notes in other cases.

 

The foregoing description of the New Note Amendment does not purport to be complete and is qualified by reference to the full text of the form of Amendment to Senior Convertible Note, a copy of which is attached to this Quarterly Report on Form 10-Q as Exhibit 4.7 and incorporated herein by reference.

 

Loeb Refinancing 

 

On November 6, 2026, the Company's subsidiaries ZEI and Resource issued a Second Amended and Restated Term Promissory Note (the “2nd A&R Loeb Note”) to Loeb Term Solutions LLC (“Loeb”) in the principal amount of $1,997,780, which amended and restated the Company's existing note payable to Loeb, dated September 7, 2023, in the original principal amount of $3,196,215. The 2nd A&R Loeb Note bears interest at the Wall Street Journal prime rate plus 6.5% per annum (the “Loeb Interest Rate”), computed on a 365-day year, and is payable in 35 monthly installments of principal and interest, calculated on a five-year amortization schedule, with a final balloon installment of all outstanding principal, accrued interest and other amounts due on the first day of the thirty-sixth month following the effective date ( November 1, 2029). Notwithstanding the foregoing, from and after the occurrence of a default under the 2nd A&R Loeb Note, and for so long as such default continues, the applicable interest rate shall be increased to the  Loeb Interest Rate plus 6% per annum. The 2nd A&R Loeb Note was issued to Loeb pursuant to a Second Amended and Restated Credit Agreement entered into by and among the parties, which amends and restates in all respects that Credit and Security Agreement entered into by and among the parties on September 7, 2023, remains secured by equipment of the borrowers, and did not constitute a novation of the existing indebtedness.   

 

The foregoing description of the 2nd A&R Loeb Note does not purport to be complete and is qualified by reference to the full text of the Second Amended and Restated Term Promissory Note, a copy of which is attached to this Quarterly Report on Form 10-Q as Exhibit 10.6 and incorporated herein by reference. 

 

 

 


 

 

60


Table of Contents

 

ITEM 6. Exhibits

 

EXHIBIT INDEX

 

Exhibit 
Number

 

Description

 

 

 

3.1

 

Certificate of Designation of Series D Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on May 5, 2026).

 

 

 

4.1

 

Form of Senior Convertible Note (incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on May 5, 2026).

 

 

 

4.2

 

Form of Warrant (incorporated by reference to Exhibit 4.2 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on May 5, 2026).

 

 

 

4.3

 

Warrant, dated September 30, 2026 (incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on October 5, 2026).

 

 

 

4.4

 

Senior Convertible Note, dated November 2, 2026 (incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on November 6, 2026).

 

 

 

4.5

 

Warrant, dated November 2, 2026 (incorporated by reference to Exhibit 4.2 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on November 6, 2026).

 

 

 

4.6

 

Form of Senior Convertible Note dated November 16, 2026 

 

 

 

4.7

 

Form of Amendment to Senior Convertible Note dated November 16, 2026 

 

 

 

10.1

 

Employment Agreement, effective as of July 1, 2026, by and between the Company and James D. Burnham (incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on July 7, 2026 (File No. 001-41581).

 

 

 

10.2

 

Purchase and Sale Agreement, dated August 17, 2026, by and between Norman Berry II Owner, LLC and Arbour Valley Development, LLC (incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on August 21, 2026 (File No. 001-41581).

 

 

 

10.3

 

Form of Amendment to Securities Purchase Agreement and Registration Rights Agreement, dated August 26, 2026 (incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on August 28, 2026 (File No. 001-41581).

 

 

 

10.4

 

Exchange Agreement, dated September 30, 2026, by and between the Company and James D. Burnham (incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on October 5, 2026).

 

 

 

10.5

 

Note Exchange Agreement, dated November 2, 2026, by and between the Company and Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B (incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on November 6, 2026).

 

 

 

10.6

 

Second Amended and Restated Term Promissory Note dated November 6, 2026.

 

61


Table of Contents

 

31.1+

 

Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2+

 

Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1+

 

Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2+

 

Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS+

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File as the XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH+

 

Inline XBRL Taxonomy Extension Schema Document.

 

 

 

101.CAL+

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

 

101.DEF+

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

 

 

 

101.LAB+

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

 

 

 

101.PRE+

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

+

Filed or furnished herewith.

 

 

^

Management contract or compensatory plan or arrangement

 

 

*

Exhibits and schedules have been omitted pursuant to Items 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish copies of any of the omitted exhibits and schedules upon request by the Securities and Exchange Commission.

 

62


Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 

Date: November 16, 2026 

RENX ENTERPRISES CORP.

 

(Registrant)

 

 

 

 

By:

/s/ David Villarreal

 

 

David Villarreal

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

 

By:

/s/ Nicolai Brune

 

 

Nicolai Brune

 

 

Chief Financial Officer

 

 

(Principal Financial Officer and

 

 

Principal Accounting Officer)

 

63

Keep reading